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Abstract of Thesis 
The lethal cardiac arrhythmias ventricular fibrillation (VF) and ventricular tachycardia 
(VT) are a leading cause of death in heart disease. We hypothesised that dynamic 
activation and repolarisation interactions will vary according to autonomic tone and the 
nature of the myocardial substrate as affected by disease states. This hypothesis was 
tested in a series of human and murine experiments. 
Incorporation of data from human electrophysiological studies into a linear computer 
model was able to predict activation dynamics of sequential extrastimuli. This served as 
a validation of the concept of dynamic interactions between activation and 
repolarisation in man.  
A human model of mental stress demonstrated that activation and repolarisation 
dynamics are altered by intrinsic autonomic stimulation. Specifically, a reduction in 
activation potential duration and an increase in dispersion of repolarisation occurred at 
short coupling intervals during stress. A weak increase in conduction velocity and 
excitability was also observed. 
Patients with early-stage arrhythmogenic right ventricular cardiomyopathy (ARVC) 
were seen to exhibit conduction changes prior to the onset of structural disease. This 
was used to determine potential diagnostic criteria based on surface ECG correlates of 
intracardiac observations. These criteria are able to distinguish early ARVC from 
benign right ventricular outflow tract tachycardia.  
Finally, the mechanism of modulation of tissue level activation dynamics were further 
studied using a novel thin-tissue slice murine model. Conduction velocity and 
excitability were modulated by both sympathetic and parasympathetic stimuli, 
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parasympathetic modulation is demonstrated to be dependent on the Gαi2 regulatory 
pathway at the tissue level. The tissue slice method provides a novel tissue-level 
platform for the study of cardiac electrophysiology in genetically modified mice. 
In conclusion, this work demonstrates that modulations of activation and repolarisation 
dynamics are seen in pro-arrhythmic states, specifically in sympathetically active states 
and in arrhythmogenic right ventricular cardiomyopathy.  
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Chapter 1 Introduction 
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1.1 General Introduction 
Cardiac arrhythmia claims over 70,000 lives per year in the UK, and roughly 300,000 in 
the USA. The majority of these deaths are due to ventricular fibrillation (VF) or 
ventricular tachycardia (VT) (Papadakis et al., 2009; Zheng et al., 2001), the majority of 
which occur in the context of acute cardiac ischemia. A smaller proportion are as a 
result of inherited conditions, which can occur in people seemingly in peak physical 
condition. The death of an athlete or young person from cardiac arrhythmia carries an 
impact over and above that conveyed by mortality statistics alone.  
Acute treatments for fibrillation exist. Direct current cardioversion is highly effective at 
restoring normal cardiac rhythm, and the introduction of the implantable cardioverter-
defibrillator (ICD) stands as one of the major advances in clinical cardiology over the 
last 30 years (Moss et al., 1996; AVID investigators, 1997; Buxton et al., 1999; Moss et 
al., 2002). Medical treatments aiming to prevent the occurrence of ventricular 
arrhythmia have been universally disappointing however. Both the CAST trial (Moss et 
al., 1998) and the SWORD trial (Waldo et al., 1996) were stopped early after interim 
analyses showed excess of deaths in the antiarrhythmic assignment. Similarly, the 
sudden cardiac death in heart failure (SCD-HeFT) trial showed amiodarone to be 
equivalent to placebo and inferior to ICD therapy in preventing death for patients with 
heart failure (Bardy et al., 2005).  Only beta-receptor blockade has shown a defined 
benefit in preventing sudden death in randomized clinical trials (Hjalmarson et al., 
2000). These findings highlight our lack of understanding of the mechanism and causes 
of ventricular arrhythmias.  
The increased appreciation of severe complications associated with long term ICD 
implantation, i.e. device infection (Tolosana et al., 2009; Moore et al., 2009) and 
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inappropriate therapy delivery (Sakhuja et al., 2009; Duncan et al., 2010), brings the 
imperfections in our assessments of patient risk into focus. Risk stratification tools 
developed to predict a cardiac electrical event have resorted to using a general 
assessment of contractile function (left ventricular ejection fraction) as the best 
predictor of arrhythmic risk, well illustrated by the multicentre automated defibrillator  
implantation trial (MADIT, Moss et al., 1996). Direct, patient specific investigation of 
cardiac electrophysiology has generally been disappointing in aiding this risk 
stratification, and this paradox underlines the lack of understanding of the genesis of 
ventricular arrhythmia in clinical practice (Cutler and Rosenbaum, 2009; Selvaraj et al., 
2007; Gold et al., 2008). Specifically, the VT stimulation study has been shown 
repeatedly to have little or no useful clinical role in clinical risk stratification (Moss et 
al., 1996; Buxton et al., 1999).  
Although a number of surface markers have been proposed, it appears that dynamic 
markers of electrical function show the greatest promise for risk stratification.  This 
indicates that interrogation of conduction and repolarisation kinetics is likely to yield 
predictive arrhythmic markers (Verrier et al., 2011). Recent work from André Ng’s 
group in Leicester has highlighted dynamic changes in the paced ECG as a predictor of 
VT risk in patients with cardioverter defibrillators who underwent electrophysiological 
studies (Nicolson et al., 2012). Such work demonstrates the importance of dynamically 
induced heterogeneities in cardiac electrophysiology in arrhythmogenisis, and could be 
a clinically useful approach to risk stratification in patients at risk of cardiac arrhythmia. 
Further validation of this specific test is required in larger prospective cohorts before its 
adoption into clinical use. A more fundamental assessment of what this index actually 
represents at the myocardial tissue substrate level is also required.  
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The classic understanding of arrhythmia generation first arose from the work of Mines, 
who established the concept of re-entry as the basis of cardiac arrhythmia (Mines, 1914). 
A century of investigation has expanded on potential mechanisms of arrhythmia to 
describe in detail triggered activity and the various manifestations of circus movement 
re-entry, including spiral rotors, figure-of-eight re-entry and leading circle re-entry, 
where no anatomical boundary was required for arrhythmia to manifest.    
Such basic and theoretical studies have provided a wealth of data indicating 
mechanisms by which a stable cardiac conduction can degenerate into the self-
perpetuating & chaotic rhythm of VF (Watanabe et al., 2001; Pastore et al., 1999, 
Circulation, 99, 1385-1394). These generally involve the interplay of two conditions: a 
change in the cycle length or coupling interval of cardiac activation, and heterogeneity 
in the electrophysiological properties of the conducting tissue (Gilmour et al., 2007). 
Though a large body of work has concentrated on the ability of sustained, raised heart 
rates, to induce unstable beat-to-beat variations in repolarisation times (T-wave 
alternans), the common clinical observation is that of only one or two extrasystoles as 
the trigger of ventricular arrhythmias.  Common to both of these modes of arrhythmia 
induction is the concept of interactions between activation and repolarisation, which 
may ultimately lead to block of a wave of activation when that activation wave 
impinges on the repolarisation of a previous beat (Bernus et al., 2002; Zaitsev et al., 
2003). This mechanism of “functional block” can cause the transition from orderly 
activation to chaotic re-entry, the hallmark of VF (Chow et al., 2004). The process of 
functional block disturbing a homogeneous conduction wavefront is termed wavebreak 
and is discussed in detail below. 
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There remains a gap in understanding between basic cellular electrophysiology and the 
clinical phenomena of cardiac arrhythmia (Pandit, 2010). A particular question exists as 
to the temporal promotion of clinical arrhythmia, i.e. why should an individual develop 
a specific arrhythmia at a particular time? In some cases a systemic upset can be 
pinpointed as being responsible for predilection to arrhythmia e.g. thyroid dysfunction, 
drug treatment or myocardial ischaemia. In many clinical arrhythmias no specific major 
structural or functional change is ever identified coincident with the onset of arrhythmia. 
This can be highlighted in the occurrence of inherited arrhythmia syndromes. 
Individuals may carry a propensity to arrhythmia throughout their entire childhood and 
early adult life, yet this only becomes manifest at a specific time. e.g. J-point elevation 
before onset of VF in early repolarisation syndromes.  
The autonomic nervous system is a prime suspect in the transient changes of the 
excitable properties of cardiac tissue accounting for the apparent randomness of events. 
Detailing how it may modulate activation and repolarisation properties (thereby 
promoting or supressing clinical arrhythmia) is a key challenge of arrhythmia research.  
The autonomic effects of mental stress on cardiac electrophysiology are discussed in 
detail later in this chapter. 
The presented work attempts to translate basic measurements of cardiac 
electrophysiology to clinical arrhythmias, concentrating on tissue-level 
electrophysiology of the heart.   
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1.2 Chapter Aims 
Cardiac electrophysiology and arrhythmia must be understood in context. In this chapter 
the basic tenants of cardiac electrophysiology will be introduced, and activation and 
repolarisation interactions reviewed with emphasis on their dynamics and modulation. 
Furthermore, the concepts of mental stress provoked arrhythmia and arrhythmogenic 
right ventricular cardiomyopathy will be presented as potential pro-arrhythmic states.  
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1.3 Normal cardiac electrophysiology 
The cardiac action potential, first described in the 1880s (Burdon-Sanderson, 1880), is 
fundamental for our understanding of the electrical function of the heart. Its distinctive 
spike-and-plateau shape implies its function; the sharp activation allowing rapid 
conduction and activation, the lengthy plateau activating intracellular calcium release, 
which in turn allows contraction of cardiac muscle (Grant, 2009). The ionic basis of the 
cardiac action potential was first described in the seminal work of Hodgkin and Huxley, 
and a basic model has been refined over decades to include a multitude of channels 
(Noble, 1962; Noble, 2007). Nonetheless, an appreciation of a simple model of the 
cardiac action potential is an important pre-requisite for further detailed appreciation of 
cell-to-cell, tissue and organ functioning. 
 
Figure 1-1 Currents contributing to the normal cardiac ventricular action potential in humans 
Currents are shown with their molecular correlates. Red indicates sodium current, green calcium and blue potassium 
currents. There is a far greater heterogeneity in repolarising currents than in depolarising or plateau currents. 
Molecular correlates are given as: principal gene (principal pore forming protein (Redrawn and adapted from Pond 
and Nerbonne, 2001; Gray et al., 2013).  
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The ionic currents and their molecular correlates are summarised in Figure 1-1. In the 
resting, non-exited, state, the cardiac cell membrane maintains a voltage gradient of 
around -70mV by actions of the Na+-K+ and Na+-Ca++ ion exchange currents (Pond and 
Narbonne, 2001). A minor depolarization of the membrane triggers a rapid 
depolarization of the cardiac cell. This depolarization (phase 0) of the cardiac action 
potential is governed by the fast sodium current, flowing through the Nav1.5 voltage-
gated sodium channel. A rapid influx of Na+ ions arrives into the cell down a steep 
concentration gradient, causing membrane depolarization, and subsequent 
hyperpolarization to around +20mV. The rapid increase in sodium concentration in turn 
produces conformational change on sarcolemmal calcium channels and allows calcium 
release into the cell. The rising intracellular calcium concentration itself further triggers 
opening of calcium channels on the sarcoplasmic reticulum. This positive feedback loop 
is termed calcium-induced calcium release.  
The continued rise in the intracellular calcium concentration is maintained for up to 
200ms and is responsible for the continued depolarization of the cardiac cell. The 
opening of slowly activating outward potassium currents allows membrane 
repolarisation and restoration of the resting membrane potential. This restoration of the 
membrane potential signals the end of cellular refractoriness, and the cell will once 
again respond to electrical stimuli (Pond and Nerbonne, 2001; Noble, 2007). Stimuli 
occurring prior to the full restoration of the resting membrane potential may still excite 
an action potential, but increasingly greater stimuli are required. Eventually a 
prematurity occurs where absolute refractoriness is reached. 
This general and simplistic model of cardiac cellular electrophysiology serves as an 
introduction to the ionic model of cardiac cellular activation. The action potential 
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varies between species, between cardiac chambers and is even distinct between cell 
layers in vitro (though the in-vivo significance of this can be debated). Importantly, the 
profile of the cardiac action potential is dynamic. Variations in ionic currents causing 
changes in action potential morphology.  The action potential can thus be changed not 
only by extreme insults, such as cellular ischemia or disturbances in cellular ionic 
environment, but also by physiological changes, such as autonomic tone and cardiac 
rate (Kuo and Surawicz, 1976).  
The very specific adaptation to heart rate by cardiac cells is termed “restitution” 
(Elzinga et al., 1981), and deserves detailed consideration. 
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1.4 Cardiac Action Potential Duration (APD) Restitution, 
adaptation and conduction velocity restitution 
The cardiac action potential tends to shorten in response to a decrease in coupling 
interval of successive beats. Specifically, action potential duration (APD) restitution can 
be defined as a shortening of the APD in response to a decrease in the diastolic interval 
(DI) preceding that activation. A slower rate-dependence shortening, termed adaptation, 
may occur as a steady state cycle length is reduced (Taggart et al., 2003). The functional 
effects of APD restitution and adaptation can be discussed in terms of molecular 
mechanisms, arrhythmic (or anti-arrhythmic) effects and functional adjustment of the 
myocyte to increases in heart rate. Furthermore, slowing of conduction velocities occurs 
at very short diastolic intervals, observed in response to short coupling intervals (Figure 
1-2). 
 
Figure 1-2 Conduction velocity restitution and Action Potential Resitution 
Typical activation time and action potential duration (APD) responses to decreases in coupling interval are shown. 
APD responses are conventionally displayed as a function of local diastolic interval (i.e. time since repolarisation of 
prior excitation), whereas activation time responses are best displayed as a function of pacing interval (a.k.a. coupling 
interval, stimulus interval). The activation repolarisation interval (ARI, time between local activation and local 
repolarisation determined from the unipolar electrogram) is often used as a surrogate for APD. 
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1.4.1 The molecular basis of APD restitution and adaptation  
Initially APD restitution was described in isolated cat papillary muscle (Moore et al., 
1965), followed by dog (Toyoshima et al., 1981), guinea pig (Laurita et al., 1996), 
mouse and human cardiac tissue. The ionic basis of cardiac restitution has been 
determined from experimental and computational studies, principally in guinea pig and 
canine myocytes, and human cellular computation models. At long coupling intervals, 
the majority of respolaristaion currents are through the IKr channel. The IKs (slow 
inward rectifying potassium) current appears to contribute very little to the 
repolarisation time course in the resting state at slow heart rates but its contribution 
increases at higher rates.  
Markov modelling has revealed how the IKs channel may contribute to cardiac 
restitution and adaptation (Silva and Rudy, 2005, Decker et al., 2009). IKs consists of 
four pore forming KCNQ1 subunits, which associate with the KCNE single 
transmemrane regulatory unit. Each of these subunits can exist in an active, inactive or 
deep-inactive state, thus a total of 17 different channel states can exist. The transition 
from a deep-inactive to inactive state is slow, whereas the time course of opening from 
an inactive state is rapid. Zones can be grouped into two inactive zones depending 
whether a voltage sensor exists in the deep-inactive state, as well as the channel open 
zone. In Zone 2, at least one channel subunit must transfer to the inactive state from the 
deep-inactive to allow channel opening to occur, whereas in Zone 1 all voltage sensors 
are in the inactive state. Thus a channel in Zone 1 is able to rapidly open, whereas those 
in Zone 2 have to make at least one slow voltage sensor to transition to an inactive state 
before they are able to open.  
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This provides an elegant model of how the contribution of IKs to repolarisation can 
increase at short coupling intervals. During adaptation (i.e. at sustained short coupling 
intervals), there is accumulation of channels in Zone 1. As these are able to rapidly open, 
a "repolarisation reserve" of channels in state Zone 1 builds up, and the action potential 
shortens.  
Action potential restitution can be seen as being due to a similar, albeit transient, 
increase in IKs at short coupling intervals. At long coupling intervals, almost all IKs 
channels exist in the deep inactive state at the start of the action potential. IKs will 
transition to the inactive state with each action potential, but the long diastolic intervaI 
between activations allows the channels to fall back to the deep inactive state. IKs thus 
contributes very little to the overall repolarisation current in the long steady state. A 
close-coupled S2 beat will activate the cell prior to the full transition of IKs to deep-
inactive Zone 2 states, the proportion of channels in Zone 1 will still be elevated as a 
consequence of the previous activation. The more premature the S2, the greater the 
proportion of channels available in Zone 1 to rapidly open, and hence the greater the 
contribution to repolarisation from IKs. The net consequence is a greater repolarising 
current and a shorter action potential. 
A “repolarisation reserve” becomes present as the cell membrane returns to the resting 
potential, ensuring an action potential arising after a subsequent premature stimulation 
will be shorter than one at steady state (Figure 1-3; Silva and Rudy, 2005). 
Accomodation may be seen as a separate but related phenomenon.  It is observed that 
action potential duration does not reach a steady state following a change in constant 
pacing cycle length immediately, but requires several minutes before stabilisation. This 
phenomenon has not been fully explored at the molecular level, but changes in 
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intracellular ionic concentrations, particularly of intracellular Na+, may play a key role. 
At short constant diastolic intervals, the Na+-Ca++ exchanger is unable to extrude all the 
Ca2+ entering the cytoplasm through the L-type calcium channel. Steady-state low 
intracellular Ca2+ is not preserved, and increasing intracellular Ca2+ directly inhibits the 
L-type calcium channel by Ca2+-dependent inactivation. This prevents further increase 
of intracellular Ca2+ and Ca2+ efflux through the Na+-Ca++ exchanger acting in forward-
mode, is increased. 
There is a consequent increase in intracellular Na+.  As a result, the Na+-K+ exchanger is 
unable to extrude all the intracellular Na+ entering the cell during phase 0 of the action 
potential. The secondary effects on intracellular Na+ from increasing intracellular Ca2+ 
compound this & the combined result is an increase in intracellular Na+. Such an 
increase in intracellular sodium ions in turn promotes an increase in repolarising Na+-K+ 
exchange currents, shortening the action potential and shifting the restitution curve to 
shorter APDs (Silva and Rudy, 2005). Furthermore, a shift in the steady state 
equilibrium of rectifying potassium channels, including IKs and IKr, is predicted to occur, 
allowing a shorter action potential to persist (O’Hara et al., 2011). 
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Figure 1-3 Restitution and Adaptation 
A schematic illustration of action potential restitution and adaptation is shown. In restitution, a reduction in the 
diastolic interval results in a change in the APD of the subsequent activation. Adaptation can be represented as a 
steady state phenomenon, where increases in intracellular sodium and calcium ions act to shorten the action potential.  
 
1.4.2 Wavebreak and the generation of cardiac arrhythmia 
The genesis of re-entrant chaotic cardiac arrhythmia (in contrast to spontaneous focal 
arrhythmia e.g. ventricular ectopy) can be understood through the concept of wavebreak 
(Weiss et al., 2005). Cardiac excitation can be considered as a wave of excitation 
proceeding through tissue, the wavefront corresponding to the upstroke of the cardiac 
action potential and the waveback to repolarisation. As the wave of excitation 
propagates through cardiac tissue, the wavefront and waveback never come into contact 
under normal circumstances. However, tissue heterogeneity (either functional or fixed) 
can allow the wavefront of one wave to touch the waveback of the preceding wave, the 
so-called “wavebreak”. If the entire excitation wave is thus extinguished, no arrhythmia 
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will occur. On the other hand if the wavebreak is localised, a wavefront of excitation 
can curl around the loose end of the wavebreak and re-enter previously excited, but now 
no longer refractory, tissue (Cabo et al., 1994). The point at which this occurs can 
signify either an anatomical obstacle (e.g. scar) or functional heterogeneity in the tissue. 
This re-entry in normal tissue is termed a rotor. Alessi and colleagues first described 
these rotors as spiral waves in atrial tissue (Allessie et al., 1973), 3D scroll waves were 
later demonstrated in fibrillating ventricular tissue (Davidenko et al., 1992).  
The wavebreak as an index event in the onset of fibrillation is generally accepted, but 
the mechanisms of maintenance of fibrillation remain contentious. The mother rotor 
hypothesis places a circus re-entry principal spiral or scroll wave as the driving 
phenomena in fibrillation, with subsequent wavebreaks occurring as epiphenomena in 
regions unable to support rapid activations from the principal rotor. An alternative 
interpretation is termed the multiple wavelet hypothesis, where on going wavebreaks 
continue to drive chaotic fibrillatory activity. 
Both of these interpretations of arrhythmia require heterogeneity in cardiac 
electrophysiology in order to establish, either a fixed or functional (induced) 
heterogeneity. 
1.4.3 Cardiac restitution and arrhythmia  
Initially electrical restitution was described as being important in governing the 
contractile force generated following a premature beat (Kruta and Braveny, 1963). 
Interest in restitution properties grew as it became apparent that restitution could also be 
critical in explaining induction of heterogeneity in tissue that appeared homogenous 
during steady state activation. One manifestation of this is the conversion from stable to 
unstable APD alternans at short coupling intervals (Weiss et al., 2005). Indeed, half a 
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century ago, Nolasco and Dahlen proposed a theoretical model predicting that APD 
restitution slopes of >1 would produce unstable responses to rapid cardiac stimuli, 
cumulating in APD alternans (Nolasco and Dahlen, 1968). This concept has been 
further refined via mathematical biodomain models, in one and two dimensions 
(Clayton and Taggart, 2005). Even heterogeneity in restitution properties alone has been 
shown to be sufficient to enable fibrillation to be induced by 2 premature stimuli, at 
least in theoretical models (Clayton and Taggart, 2005). Restitution properties became 
an attractive site for targeting pharmaceutical agents, and Garfinkel and colleagues 
showed that flattening the APD restitution curve with bretylium suppressed spiral wave 
break up and prevented VF in an animal model (Weiss et al., 2002).  
But the measurement of APD restitution slope as a lone measure for risk prediction has 
been singularly unsuccessful, some recent data in animal models even points to steeper 
APD restitution in hearts resistant to VF induction (Osadchii et al., 2010). Little has 
been published linking the extensive theoretical and basic understanding of restitution to 
VF induction in the clinical context, despite extensive theoretical investigations into the 
mechanisms of ventricular fibrillation (Lambiase et al., 2009; Chow et al., 2004).  
Of course, the fact that discrepancies exist in the understanding of relationships between 
restitution (a cellular-level phenomenon) and risk of fibrillation (a tissue-level 
phenomenon) can be understood as cardiac cells do not exist in isolation, but within 
their tissue and organ:  each cell is connected to its neighbours both structurally and 
electrically. The principal intra-cellular structural connection is the desmosome, a 
transmembrane multipler of proteins, which enables strong anchoring of intracellular 
structural components with those of the neighbouring cell (Gallicano et al., 1998; 
Saffitz et al., 2010). Closely associated with this are the freely porous gap junctions, so 
called because of their distinctive electron-microscopic appearance. These junctions 
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consist of hexamers of connexon proteins, allowing the unimpeded passage of small 
ions, and hence electrical signalling and the action potential, from cell to cell.  Indeed, 
so closely are the gap-junctions and the desmosome thought to associate, that the 
concept of a connexosome has arisen. Likewise, recent evidence suggests that ion-
channels, particularly the Nav1.5 channel, is also associated with this membrane 
multipler and the interactions between the different membrane constituents may be 
functionally relevant (Rizzo et al., 2012). Whatever the exact interactions on the atomic 
scale, though, it is apparent that the intracellular connections in the normal myocardium 
allow exquisite coupling of the cellular components to form a functional tissue 
syncytium.  
It is tempting to assume that conduction velocity through such syncytial tissue would be 
dictated principally by cell-coupling (King et al., 2012). If this were the case, marked 
reductions in connexin expression would be expected to markedly reduce conduction 
velocity. This does not appear to be true, indeed marked conduction slowing only 
becomes apparent if connexin levels are reduced >90% in the murine heart (van Rijen et 
al., 2004). However, reductions in sodium channel function do significantly reduce 
conduction velocities, both in experimental models (Stein et al., 2011) and in disease of 
the sodium channel (such as Brugada syndrome, Lambiase et al., 2009). Furthermore, 
interactions between the sodium channel and Cx43 exist, these interactions may account 
for conduction velocity reductions in very low-levels of Cx43 (Jansen et al., 2012). 
Action potential propagation along the cell membranes in a continuous manner, more 
than conduction from cell to cell, would thus appear to be the key determinant of 
cardiac conduction velocity (King et al., 2013). 
1.4.4 Conduction Velocity Restitution 
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Many theoretical assessments of reentry with VF induction assume a homogeneous 
conduction velocity (CV) in tissue (Xie et al., 2004; Paz et al., 2006; Gilmour et al., 
2007; ten Tusscher and Panfilov, 2006). Yet the key electrophysiological phenomena 
associated with clinical and experimental arrhythmogenisis, be it organized or chaotic, 
is that of slow conduction. Conduction velocity also undergoes restitution at short 
coupling intervals. Termed CV restitution (but previously a.k.a. / analogous to: 
dispersion curve, activation restitution), this is only apparent at much shorter coupling 
intervals than APD restitution. Relatively little direct data exist on the contribution of 
CV restitution to induction of arrhythmia, and its manifestations have been overlooked 
in many theoretical models. Nonetheless, we can hypothesise several ionic and cellular 
mechanisms by which conduction velocity may be decreased at very short coupling 
intervals. 
As is seen in APD restitution, at short DIs, intracellular Na+ increases as a result of 
inadequate extrusion via the Na+-K+  exchanger and as a sequelae of intracellular Ca2+  
increase. At very short coupling intervals, intracellular Na+ could be high enough to 
reduce the velocity of the action potential upstroke by reducing the transmembrane Na+ 
gradient and thereby slow conduction velocity. Sodium channels exists in several states, 
Markov models predict that at short coupling intervals fewer of them will have cycled 
through the conformational changes necessary to return them to a resting state. Thus at 
short DIs, membrane sodium channel availability will be reduced (O’Hara et al., 2011).  
Locational cycling of channels and pores may also contribute to conduction slowing at 
short diastolic intervals. Though active at the cell membrane, the Nav1.5 protein and the 
Connexin proteins exist in a state of equilibrium with subcellular apparatus (Hallaq et 
al., 2006). It is possible, but as yet unproven, that altering the membrane locational 
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equilibrium of either of these proteins will reduce cellular conductivity or excitability.  
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1.5 The autonomic nervous system and cardiac 
electrophysiology 
Powerful direct and indirect evidence points to the role of modulation of autonomic tone 
in arrhythmogenisis, and the effects of the autonomic nervous system on cardiac 
conduction. The reduction of cardiac arrhythmic death by beta-blockade during 
myocardial infarction (MI) is the most widely known of these data, and is best 
illustrated by the one-third risk-reduction in arrhythmic death in MI patients who were 
taking a beta-blocker in the CAST trial (Moss et al., 1989). Similarly, a significantly 
decreased mortality was observed in those patients taking beta-blockers in the 
Multicenter Unsustained Tachycardia Trial (MUST, Buxton et al., 1999) and in the 
Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure 
(MERIT-HF, Hjalmarson et al., 2000). Despite the concerns that a treatment bias may 
confound some beta-blockade trial results (beta-blockade may have been withheld from 
some of the sickest patients over fears regarding their modest negative-inotropic effects), 
pharmacological inhibition of cardiac beta-receptors is a mainstay of current 
antiarrhythmic therapy (Zipes et al., 2006; Ellison, 2002).  
The multi-tiered contribution of autonomic tone to cardiac arrhythmia onset is 
illustrated by numerous striking observations of increased arrhythmia frequency 
coincident with major psychological stress. These include earthquakes (Voridis et al., 
1983; Trichopoulos et al., 1983; Leor et al., 1996; Lampert et al., 2000; Huang et al., 
2001), missile (or threatened missile) attack (Meisel et al., 1991) and in the 9-11 World 
Trade Centre attacks (Shedd et al., 2004, Steinberg et al. 2004). Eye-catching 
associations have also been made with the phenomenon of voodoo death (Samuels, 
2007; Lester, 2009) and as an explanation for increased arrhythmic events during world 
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cup football supporters (Wilbert-Lampen et al., 2008). More controlled data have 
showed ICD shocks to be associated with mental stress (Lampert et al., 2005).  
Controlled laboratory experiments have solidified these associations. This work has 
been pioneered by Lampert and coworkers at Yale, Connecticut. In a series of elegant 
studies, mental stress was induced using a standardized series of psychometric tests, 
including mental arithmetic (reverse serial sevens with harsh encouragement) and anger 
recall (Lampert et al., 1994; Lampert et al., 2000; Lampert et al., 2002; Stopper et al., 
2007; Lampert et al., 2007; Lampert et al., 2009; Lampert, 2010; Abisse et al., 2011). 
This series of works has examined the physiological effects on the 12-lead ECG and T-
wave in particular of patients at risk of arrhythmia. Furthermore, they have documented 
increased frequencies of ICD discharges/therapies during periods of intense stress in 
ischaemic heart disease patients (e.g. Steinberg et al., 2004).  A history of stressful life 
events prolonged mental stress has also been associated with arrhythmia burden in 
Long-QT syndrome patients (Hintsa et al., 2010). Previous works have also documented 
increased arrhythmogenicity in animal models during induced stress (Verrier & Lown, 
1984; Lown, 1977, 1978, Parker et al., 1987, Parker et al., 1990). 
The effects of sympathomimetic agents on direct cardiac electrophysiology have been 
investigated. The principal effects of sympathetic stimulation by pharmacological 
intervention include a reduction in action potential duration and steepening of the APD 
restitution curve. This has been observed in both animal and human studies (Taggart et 
al., 2009; Taggart et al., 2003; Ng et al., 2007; Mantravadi et al., 2007). Animal work 
has also described cardiac electrophysiological effects of direct vagal stimulation, 
notably the reduction in arrhythmic thresholds during parasympathetic stimulation (e.g. 
Myers et al., 1974).  
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Direct experimental evidence derived from human work has been limited, though. It has 
been hypothesized that mental stress can contribute to arrhythmia by increasing 
heterogeneities of repolarisation and activation (or conduction velocity) throughout the 
heart (Kop et al., 2004; Toivonen et al., 1997; Kovach et al., 2001). These effects may 
thus amplify pre-existing heterogeneity, for example, due to ischemic heart disease or 
cardiomyopathy. But it is important to note that these observations have been derived 
from the surface electrocardiogram, rather than action potential or electrogram 
measurements.  Few descriptions of the electrophysiological effects of intrinsic 
autonomic stimulation exist at the cardiac tissue level in humans.  
Mental stress induced arrhythmia is not a simple case of increased sympathetic drive. 
Rather, the sympathetic and parasympathetic axes appear to work in unison to optimise 
physiology to the perceived requirements of both bodily homeostasis and higher-level 
neuronal inputs. 
1.5.1 Autonomic effects on cellular electrophysiology 
It is clear then that the autonomic nervous system has critical modulatory effects on 
cardiac electrophysiology. The consequences of sympathetic stimulation on cellular 
repolarisation have been extensively described (e.g. van der Hayden et al. 2005). In the 
ventricle, sympathetic stimulation predominantly acts via the β1 receptor. This seven-
transmembrane domain G-protein coupled receptor protein exerts its affects via the Gαs 
subunit’s activation of adenyl-cyclase. The subsequent rise in intracellular cyclic 
adenosine monophosphate (cAMP) enables cAMP-dependent Protein Kinase A (PKA), 
which exerts intracellular effect via a multitude of phosphorylation events. Furthermore, 
resulting increases in calcium transients can increase Calmodulin Protein Kinase 2 
(CaMKII) activity, and a direct mechanism in its upregulation may also be active but 
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this is controversial (Grimm and Brown, 2010). Downstream consequences of 
phosphorylation events include increasing the calcium transients that underpin the 
sympathetic inotropic response. The shortening of the action potential and the 
steepening of the APD restitution curve observed with sympathetic can be principally 
explained by an increase in IKs, phosphorylation of the KCNQ1 protein (at position 
Ser27), leading to current upregulation (Kurowara et al., 2009; Silva and Rudy, 2005).  
The sympathetic effects on conduction are less well characterised. Only a single study 
has examined the effects of isoprenaline on conduction velocities, canine Purkinje fibres 
were isolated and conduction velocities measured in this pseudo-1D-model (Cragun et 
al., 1997). Sympathomimetic stimulation increased the conduction velocity and 
excitability of this tissue.  
On the other hand, a large body of work has examined calcium-driven excitability in 
response to sympathetic stimulation. This has predominantly concentrated on 
examination of calcium related phenomena of automaticity, sparks and after 
depolarisations (Pogwizd et al., 2001; Desantiago et al., 2012; Myles et al., 2012).  
Several major questions remain regarding the mechanisms of autonomic-promoted 
arrhythmias, particular in the mechanistic translation of known cellular phenomena to 
clinical arrhythmia. There has not been a description of differential regional responses 
to autonomic stimulation; indeed even the differences between atria and ventricle in 
electrophysiological responses to autonomic stimulation are not fully described. The 
extent to which laboratory-observed cellular phenomena act in the in vivo human heart 
have not been established, nor has there been a convincing connection between cellular 
phenomena and the development of clinical arrhythmia. 
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1.6 Electrophysiology-based risk prediction  
Attempts at establishing effective clinical risk prediction for cardiac ventricular 
arrhythmias based on electrical criteria have met with limited success. Early 
descriptions of the benefits of ventricular stimulation protocols at risk stratification have 
not been substantiated in the contemporary era (Wellens et al.,1972; Grimm et al., 1998). 
The transient effects of the autonomic nervous system on cardiac electrophysiology is 
well established, and a wealth of evidence connects the development of VF with raised 
sympathetic tone in ischaemic heart disease, and increased parasympathetic tone in 
several inherited cardiac arrhythmias (Lampert et al., 2000; Rashba et al., 2002; Hintsa 
et al., 2010; Volders et al., 2010). Variations in autonomic tone thus appear critical in 
providing the milieu in which an arrhythmia may occur, and the artificial environment 
in which VT stimulation protocols have traditionally occurred (i.e. in the catheter 
laboratory under conscious sedation) would be expected to be significantly different 
from that occurring in everyday life.  
Another postulated reason for failure of risk stratification is the reliance of the surface 
12-lead ECG for establishing normality of cardiac conduction, yet the dynamic nature 
of ECG abnormalities has been established in observational studies (Quarta et al., 2010; 
Sy et al., 2011; Schwartz and Crotti, 2011; Antzelevitch and Yan, 2010). Examination 
of the underlying cardiac electrophysiology of such conditions with invasive techniques 
may reveal marked abnormalities of electrophysiological behaviour that are not 
apparent at rest. In these cases, such patients may never even have been recruited into 
studies assessing more complex risk predictive strategies. 
Several endeavours at risk stratification have used more subtle and elegant assessments 
of cardiac electrophysiology, aiming for a continuous risk stratification rather than 
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binary outcome. Samaurez developed an invasive technique by which fractionation of 
electrograms during pacing was assessed (Saumarez et al., 1995b; Saumarez et al., 
1995a; Saumarez and Grace, 2000; Saumarez et al., 2003; Saumarez, 2009). Unlike the 
VT stimulation protocol, the responses to premature stimuli over several cardiac sites 
were assessed in a continuous manner. Both fractionation and electrogram delay were 
assessed, and a computerized algorithm was used to define a measure to be compared to 
cutoff. This was shown to be predictive of future cardiac arrhythmia events in a 
population with hypertrophic cardiomyopathy. This technique was assessed in a 
randomized trial, and appeared to show efficacy in risk prediction (Saumarez et al., 
2008). The conclusions from this trial were disputed, however, as this technique failed 
to match more conservative, non-invasive, risk predictors and was underpowered for 
sudden death events (Elliott and Spiro, 2009). 
Microvolt T-wave alternans testing refers to a beat-to-beat variation in T-wave 
amplitude during cardiac exercise testing. T-wave alternans has been observed to occur 
more frequently in patients at risk of cardiac ventricular arrhythmia in several key 
studies (Bloomfield et al., 2004; Paz et al., 2006; Gold et al., 2008; van der Avoort et al., 
2009; Costantini et al., 2009). However, a consensus has not been reached on how T-
wave alternans testing should be used in clinical risk stratification (Cutler et al., 2009).  
The most common risk-stratification tool employed in clinical practice involves both an 
assessment of ventricular function and observation of the resting ECG. A combination 
of abnormal ventricular conduction (usually a reduced LV ejection fraction measured by 
echocardiography) and conduction disturbance (a prolonged QRS duration) has been 
shown to be associated with a markedly increased risk of sudden cardiac death. These 
criteria (supported by numerous clinical trials e.g. Bardy et al., 2005; Moss et al., 2002; 
Moss et al., 1996) have formed the basis of primary-prevention ICD implantation 
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guidelines worldwide (Epistein et al., 2008). But this strategy remains far from perfect; 
the majority of patients who will be eligible for ICD implantation under these criteria do 
not have their lives saved by their implant. Similarly, when absolute numbers are 
considered, many more patients who fall outside of these guidelines will die of 
ventricular arrhythmia than those included (Al-Khatib et al., 2011).  
It is incorrect to dismiss the low ejection fraction as a purely empirical marker of 
arrhythmic risk; several mechanistic strands can link poorly functioning muscle with 
predisposition to arrhythmia (reviewed in Nattel et al. 2009). First, myocardial scar and 
fibrosis reduce pump function and form lines of conduction block that can act as 
substrate for re-entrant arrhythmia. Second, calcium handling is known to be impaired 
in adaptations to heart failure. This can be either as a primary or secondary phenomenon, 
and lead to further decreased calcium sensitivity of tissues and increased calcium 
transients. Third, heart failure is associated with a breakdown in the syncytial 
conductive nature of heart muscle. Increased anisotropy and preferential conduction 
slowing may be a powerful substrate for arrhythmia. 
With the exception of epinephrine testing for Long QT syndrome (Vyas et al., 2006), 
none of the clinically employed arrhythmia-risk strategies routinely take changes in 
electrophysiology during autonomic stress into account during their assessment. This is 
perhaps unsurprising; there is little contemporary data regarding underlying in vivo 
electrophysiological changes that may be induced by autonomic stimuli, and detailed in 
vivo electrophysiological responses to non-pharmacological autonomic stimuli have not 
been studied. Yet the increased susceptibility to arrhythmia during autonomic stress is 
well recognised, and is used as a routine clinical tool in the electrophysiology laboratory 
to promote arrhythmia (Brownstein et al., 1998). 
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1.7 One dimensional modelling incorporating CV restitution 
A further step is required to complete the translation of basic understanding of dynamic 
activation/repolarisation interactions to clinical arrhythmia, i.e. the tissue characteristics 
and consequences of modulation of these responses must be defined. The development 
of complex computational models has enabled tissue-level sequelae to be examined in 
situations where experimental validation or measurement may be very difficult.  
The contribution of CV restitution to instabilities in cardiac conduction was first 
explored following Alain Vinet’s theoretical questioning: “Imagine this hypothetical 
experiment: A circulating wave of excitation is set up in a thin ring of tissue. As time passes you 
reduce very slowly the length of the ring. Which kind of dynamic will you observe: a) if the 
excitable tissue is nerve-like (no electrical restitution, i.e. APD is constant); and b) if the 
excitable tissue is cardiac-like (electrical restitution present)?” (Gilmour and Chialvo, 1999). 
This line of reasoning cumulated in Courtemanche’s (1993) theoretical assertion 
whereby the effect of CV restitution was included in a linear-ring model predicting 
instabilities resulting from CV/APD restitution interactions. 
Further progress on examining the electrical properties via a single-fibre model was 
made by the groups of Fenton, Cherry, Gilmour, Garfinkle and Weiss over the 
subsequent decades (Watanabe et al., 2001; Cherry and Fenton, 2004; Cherry and 
Fenton, 2007; Fenton et al., 2009; Weiss et al., 2010). Much of this has centred on the 
assertion that functional block is a necessary condition, but not necessarily sufficient, 
for chaotic re-entry and the initiation of VF to occur (Weiss et al., 2000; Qu et al., 
2000b; Garfinkel et al., 2000; Qu et al., 2000a; Xie et al., 2002; Weiss et al., 2002). 
Otani and Fox developed this framework to demonstrate that functional block can occur 
through heterogeneities induced by sequential extrastimuli in otherwise homogeneous 
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tissue (Fox et al., 2003; Otani, 2007; Gilmour et al., 2007; Siso-Nadal et al., 2008). This 
work provided an avenue by which these theoretical models could be tested in vivo. The 
validation work of Gelzer and colleagues (2008) incorporated data from canine 
myocardial restitution into a single-fibre model, and used this model to predict whether 
or not VF would be induced with a series of long-short coupling interval extrastimuli. 
Here, a head-meets-tail phenomenon causing function block was taken to be a surrogate 
of the first stage of wavebreak. It was assumed that if functional block occured, a 
reentrant (and chaotic) arrhythmia (i.e. VF) would follow. This work was repeated in a 
canine cardiomyopathy model with success, implying relevance to human disease 
(Gelzer et al., 2011).  
It is tempting to postulate that an application of Gelzer’s technique to patients could aid 
risk stratification, an in silico assessment of cardiac arrhythmic risk could be performed 
based on patient-specific electrophysiological data. This is a proposition that will be 
examined in this thesis. 
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1.8 Arrhythmogenic cardiomyopathy as an example of 
electrical phenotype 
Our discussions regarding the generation of arrhythmia have focused on the interactions 
between activation and repolarisation, particular the dynamic interactions that may lead 
to wavefront collision, wavebreak and ventricular arrhythmia. The most common 
underlying cause of arrhythmia in human ventricles is myocardial ischemia, which 
remains an important public health problem. It is relatively straightforward to explain 
the onset of arrhythmia in the ischaemic myocardium by virtue of the large 
heterogeneities in conduction and repolarisation induced; this would clearly form 
substrate for arrhythmogenisis (Gilmour et al., 2007; Coronel et al., 2009).  
Still, several important conditions are also associated with life-threatening arrhythmias 
without such overt structural disease. These include Brugada syndrome, the association 
of abnormal surface ECG patterns (saddle-shaped ST elevation in the precordial chest 
leads) with ventricular arrhythmia, and arrhythmogenic right ventricular 
cardiomyopathy. Our group has extensively studied Brugada syndrome. Slow 
conduction, particularly in the right ventricle and right ventricular outflow tract has 
been shown to be present and represents a clear substrate for arrhythmia (Lambiase et 
al., 2009; Morita et al., 2008).  
Arrhythmogenic right ventricular cardiomyopathy has emerged over the last 20 years as 
an important cause of sudden arrhythmic death, and is the commonest cause of sudden 
deaths in competitive athletes in Italy. It was first characterized in the later stages of 
disease, where the hallmark of fibrofatty replacement of cardiomyocytes in the right 
ventricle is established (Marcus et al., 2010). Yet it is increasingly recognised that 
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ventricular arrhythmia can be the initial presentation, manifesting as sudden death in the 
absence of significant structural heart disease (Thiene et al., 1988a). Recent advances in 
genetics have established ARVC as a disease of cardiac cell adhesion; mutations in 
desmosomal proteins are primarily associated with the condition. To date, mutations in 
seven desmosomal and five extra-desmosomal proteins have been described (Basso et 
al., 2012, Table 1-1). Interestingly, the extra-desmosomal mutations appear to have 
distinct phenotypes. Diagnosis of ARVC remains complex, partially because of the 
subtly of early phenotypes.  
Recently, consensus diagnostic criteria have been updated and modified (Marcus et al., 
2010). A major change has been the inclusion of new genetic markers of disease. These 
enable confirmation of diagnosis more frequently, and even in the absence of structural 
disease. Patients who have confirmed ARVC but who lack major structural features of 
the condition present an ideal opportunity to study activation and repolarisation 
dynamics in people at risk of arrhythmia.  
 
Benign right ventricular outflow tract tachycardia or ectopy (benign RVOT ectopy) is a 
benign condition characterized by frequent unifocal ectopic beats arising from the right 
ventricular outflow tract in the absence of structural heart disease. This condition is 
difficult to differentiate from the early stages of ARVC, yet patients have ostensibly 
structurally normal hearts and it is clear they do not develop progressive ventricular 
disease (Morady et al., 1990; Tsai et al., 1997). We thus have two conditions that are 
overtly very similar, both with ventricular ectopy as a major feature, but patients with 
ARVC appear at increased risk of arrhythmic death. We hypothesized that investigation 
of activation repolarisation interactions would enable differentiation of these conditions, 
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and may explain increased arrhythmogenicity in patients with ARVC as opposed to 
benign RVOT ectopy. 
Reference Gene Chromosome 
locus 
Protein Mode of 
inheritance 
Comment 
Desmosomal genes     
McKoy et al. 
(2000) 
JUP 17q21 Junction plakoglobin AR* Cardiocutaneous 
syndrome 
Asimaki et al. 
(2007) 
JUP 17q21 Junction plakoglobin AD None 
Norgett et al. 
(2000) 
DSP 6p24 Desmoplakin AR‡ Cardiocutaneous 
syndrome 
Rampazzo et al. 
(2002) 
DSP 6p24 Desmoplakin AD None 
Gerull et al. 
(2004) 
PKP2 12p11 Plakophilin­‐2 AD, 
AR 
None 
Pilichou et al. 
(2006) 
DSG2 18q12 Desmoglein­‐2 AD None 
Syrris et al. 
(2006b)  
DSC2 18q12 Desmocollin­‐2 AD, 
AR 
None 
Extradesmosomal genes     
Tiso et al. (2001) RYR2 1q42–q43 Ryanodine receptor 2 AD CPVT (AC 
phenocopy) 
Beffagna et al. 
(2005) 
TGF 
B3 
14q23–q24 Transforming growth 
factor β3 
AD Pathogenic or 
modifier? 
Merner et al. 
(2008) 
TMEM4
3 
3p25 Transmembrane protein 
43 (protein LUMA) 
AD None 
van Tintelen et al. 
(2009) 
DES 2q35 Desmin AD Overlap syndrome 
(DC and HC 
phenotype, early 
conduction disease) 
Taylor et al. 
(2011) 
TTN 2q31 Titin AD Overlap syndrome 
(early conduction 
disease, AF) 
Table 1-1 Genes associated with ARVC 
Genes currently known to be associated with ARVC are shown. *Naxos disease. ‡Carvajal disease. Abbreviations: 
AC, arrhythmogenic cardiomyopathy; AD, autosomal dominant; AF, atrial fibrillation; AR, autosomal recessive; 
CPVT, catecholaminergic polymorphic ventricular tachycardia; DC, dilated cardiomyopathy; HC, hypertrophic 
cardiomyopathy. Adapted from (Basso et al., 2012). 
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1.9 Conclusion and Key hypotheses 
1.9.1 Conclusion 
Cardiac risk prediction is currently imperfect, and a great deal of this can be subscribed 
to our incomplete understanding of basic mechanisms of arrhythmia, particularly at a 
tissue level.  
A major determinant of the unpredictability of arrhythmia initiation appears to be 
autonomic tone, which has defined effects on cardiac cellular repolarisation. Other 
abnormalities may exist in patients with predispositions to ventricular arrhythmia. In 
early ARVC, where sympathetic stimulation is associated with arrhythmia in patients 
with otherwise structural hearts, the dynamics of repolarisation may be significantly 
different from normal individuals. 
1.9.2 Hypothesis 
This work addresses the following major hypothesis: 
Modulation of dynamic activation and repolarisation interactions varies according to the 
level autonomic tone (parasympathetic/sympathetic balance) and the nature of the 
myocardial substrate.  
This hypothesis has been addressed by a series of experiments on conscious humans 
and murine cardiac tissue. Signal analysis techniques have been developed in order to 
acquire and analyse recorded data. One-dimensional cell-fibre models have been used to 
allow further understanding of observed phenomena, and as a validation of 
experimental techniques and measurements. The normal human electrophysiological 
responses to conscious stimuli (mental stress) are defined. A murine cardiac tissue slice 
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technique was developed in order to investigate the relative contribution of the 
sympathetic and parasympathetic stimuli to stress-induced arrhythmias. Finally, these 
concepts have been applied to a disease-condition characterised by predisposition to 
ventricular arrhythmia (early ARVC), and contrasted this to both normal patients and 
patients with benign right ventricular outflow tract ectopy.  
This thesis will detail: 
• Principal signal analysis methods,  
• Activation-repolarisation interaction measurements in humans,  
• Modelling of activation-repolarisation interactions based on human endocardial 
recordings 
• Modulation of dynamic activation-repolarisation by mental stress  
• Activation-repolarisation interaction in disease,  
• Surface ECG correlates of intracardiac activation-repolarisation interactions 
• Examination of intracellular mechanisms by which modulation of dynamic 
activation-repolarisation may occur 
Chapter 2 Methods 
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2.1 Cardiac signal analysis 
2.1.1 Introduction 
Any investigation into cardiac electrophysiology relies on the measurement of electrical 
potentials from the cardiac tissue. Though it is possible to directly measure the cardiac 
action potential from single cells in vitro by means of a sharp electrode (the cellular 
patch clamp), this technique is not possible with current technology in vivo. In vivo 
cardiac electrophysiology thus relies upon measurement of extracellular potentials. 
Potential differences are measured between two electrodes. Both electrodes may contact 
with cardiac tissue, the bipolar signal thus generated is referred to as the biopolar 
electrogram. This is often used in clinical cardiac electrophysiology coupled with high-
pass filtering, as it gives a clear inscription of local activation timing as an activation 
wavefront passes across the electrodes. The unipolar electrogram refers to a signal 
produced where only one of the poles is in contact with cardiac tissue, the reference 
anode is either distant (e.g. in the inferior vena cava) or is a mathematical mean of 
surface potentials acquired from the ECG limb leads (Wilsons’ central terminal) (Potse 
et al., 2009). The unipole thus actually represents a widely-spaced bipole, but with only 
the cathode in contact with cardiac tissue.  
The cardiac unipolar EGM is infrequently used in clinical electrophysiology as analysis 
of timepoints relating to local phenomena are less easily discernable than in the bipolar 
electrogram. Less filtering is usually applied to unipolar signals, enabling a clear T-
wave to be visualized. The unipolar EGM thus has an advantage of potentially allowing 
both local activation and repolarisation timings to be determined.  
Theoretical work provides clear assessments of how local activation can be related to 
the unipolar EGM (Wyatt RF, 1981; Steinhaus, 1989; Haws and Lux, 1990). As a 
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cardiac wavefront approaches and passes a cathode electrode, that electrodes potential 
will undergo a very rapid change. But as the cathode is referenced to a distant anode, 
the summed result is that the greatest negative change in cardiac potential occurs as the 
wavefront passes. This can be expressed mathematically as:  
Local activation time = dV/dTmin 
 
Figure 2-1 The relation of the Unipolar T-wave to the underlying action potential 
The unipolar T-wave (A & C) can be related to the underlying action potential (B & D) in early (A & B) and late (C 
& D) activating sites. Several different differential points have been examined theoretically, Tup , the sharpest 
upstroke of the T-wave, provides a good approximation of APD90 the end of the action potential. 
This theory is well validated in both theoretical and biological models as well as in 
clinical practice (Potse et al., 2009). The assessment of a precise local activation time to 
the intracardiac electrode gives a theoretical advantage over the bipolar EGM, though 
providing an easy-to-interpret visual signal, the precise onset of activation is harder to 
pinpoint, as deflection in the signal is seen with any potential difference between the 
two electrodes.  
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More controversial is the assessment of local repolarisation time with the unipolar 
electrogram. The unipolar T-wave relates to the repolarisation phase of the cardiac 
action potential. Its interpretation is harder and less clear-cut than that of the activation 
inflection. The unipolar T-wave represents a lower frequency phenomenon and the 
instantaneous local repolarisation current is thus small. When this is superimposed onto 
the far-field electrogram (representing repolarisation of the entire heart) interpretation 
can be challenging. However, it is generally accepted that the best approximation to the 
local repolarisation time is given by the most positive upstroke of the T-wave (Figure 2-
1, Potse et al., 2007). 
This has been validated against the “gold standard” for measurement of intracardiac 
action potentials, the sharp monophasic action-potential (MAP) catheter (Franz et al., 
1987). It is worthwhile considering the technique of action potential recording in-vivo. 
The MAP electrode (also known as a Franz catheter) uses a sharp central electrode as a 
reference anode surrounded by a ring cathode. An injury current, i.e. a fixed cell 
depolarization, is created when the catheter is pressed against the myocardial wall, and 
the potential difference between this and the surrounding tissue allows a waveform 
similar to a transmembrane action potential to be visualized. Unlike the action potential 
of Hodgkin and Huxley (which describes the action potential across a membrane of a 
single cell), this waveform is created by the summed potentials of the extracellular field 
of a small area of tissue referenced against an “intracardiac” potential, which appears as 
a fixed potential reference. From this AP waveform it is easy to determine both 
activation and repolarisation timings. But several practical considerations are serious 
drawbacks to the routine employment of this technique in intracardiac investigations.  
• Only single point APs can be acquired with this catheter. Separate catheters are 
required if APs are to be assessed simultaneously at multiple sites.  
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• The signals achieved are highly dependent on pressure applied, and the resulting 
waveforms are transient. This is due to the tissue damage caused by the sharp 
anodal electrode. Initially a robust injury current is obtained, but after several 
minutes these currents equalize and the AP wans. AP-type signals can be 
restored by application of transient further pressure to the catheter. This causes 
further tissue injury and restores a fixed electrical reference. But the transitory 
nature of directly acquired AP signals reduces the utility of these catheters for 
acquisition of APs under varying conditions.  
• The Franz catheters themselves are difficult to obtain, and we have found them 
unwieldy in clinical use. Although no complications from their use have been 
reported, the sharp electrode certainly has the potential to cause cardiac 
perforation. This adds to the reticence regarding their employment for research, 
the caution they entreat further reduces the chances of completing data 
acquisition during research involving a clinical case.  
These shortcomings of the MAP technique inspired efforts in derivation of local 
repolarisation times from unipolar electrograms (Wyatt RF, 1981). Again, initially 
derived from theory but later validated in vivo, the Wyatt or classical technique 
essentially takes the same theory used for determining the activation time, i.e. the rate of 
change of electrical potentials being greatest as a repolarisation passes the cathode 
(Potse et al., 2007; Potse et al., 2009). As the potential change during repolarisation is 
reversed though, the most positive differential of the repolarisation wave is taken as the 
point of local repolarisation i.e. dV/dTmax.  
This technique has been put under intense scrutiny, with validation for contact 
measurements both in mathematical, in-vivo and extensively in-vitro (Yue et al., 2004; 
Yue, 2006; Yue, 2007). The derivation of repolarisation times from unipolar 
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measurements is very much more convenient in the clinical setting than using MAP 
catheter recordings. Multiple electrode sites can be recorded simultaneously, and 
unipolar EGMs are stable over time thus allowing recordings under different conditions 
can be compared to one another. Unipolar EGMs can be derived from almost any 
standard clinical electrophysiological catheter. The most appropriate catheter for each 
patient and recording site can be chosen allowing a high success in recording from 
targeted sites. 
As with any indirect technique, there remain some weaknesses associated with 
derivation of timings of activation and repolarisation from the unipolar EGM. Foremost, 
the repolarisation time is highly correlated to the dV/dTmax of the unipolar T wave. Yet 
repolarisation time tends to be underestimated if the t-wave is positive. Thus the 
activation-repolarisation index (ARI), for the positive T-wave tends to be slightly 
shorter than the action-potential duration (APD), measured from the action potential 
upstroke of phase 0 to 90% repolarisation voltage (APD90).  The negative T-wave 
appears unaffected by this phenomenon, thus any comparisons between ARIs derived 
from unipolar EGMs with different T-wave morphology should be accompanied by an 
in-depth appreciation of this snag. Nonetheless, as long as T-wave morphology remains 
constant, changes and relative changes between electrograms can reasonably be 
compared.  
We used unfiltered, unipolar signals for clinical data acquisition during our clinical 
work.  
2.1.2 Signal analysis 
Large quantities of data were acquired during clinical studies. Each patient typically had 
around 30 electrodes from which data was analysed for activation and repolarisation 
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times following each paced drive train and premature stimulus. It was immediately 
apparent that semi-automated software was a requirement for data processing. 
A series of customized software scripts was written to run within Matlab (The 
Mathworks Inc., MA, USA). These allowed a multi-staged workflow (Figure 2-2) : 
• Import of electrogram data from ASCII format, and display 
• Automatic recognition of paced stimuli, and calculation of exact stimuli timing 
• Automatic selection of penultimate drive train and premature stimuli, and export 
of these electrogram segments for further analysis 
• Analysis of selected segments for activation time, repolarisation time and 
electrogram morphology (according to the classical (Wyatt) method) 
• Review of all raw electrogram data, checking for outliers, erroneous calculations 
and allowing manual override correction of misallocated points. 
• Export of data to a standardized format that could be further analysed 
statistically with other scripts or other software packages (e.g. R). 
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Figure 2-2 Methodological workflow for signal analysis 
This chapter will summarise the function and operation of each section of script in turn. 
Where other authors and co-authors have contributed to each script is acknowledged. 
2.1.2.1 Import of electrogram data 
The Ensite (St Jude Medical, MN, USA) or Labsystem Pro (Bard Inc, MN, USA) 
systems were used for all clinical studies. Each system allows the export of ECG, 
electrogram and pacing data to text formats (ASCII). Matlab scripts were written 
allowing the import of this data, and recognition of the recording frequency of the data. 
An individual workflow script was required for each iteration of the software export. 
This became a technical issue with the Ensite system, during the course of the research 
study five separate updates to the export formats were made by St Jude Medical. Each 
required a new import script to enable full compatibility. After import, electrogram or 
ECG data was held in random access memory (RAM) by the microcomputer as a 
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common variable, which could be displayed as a signal on screen. Though the import 
scripts were able to operate as generic functions within Matlab, for practical purposes 
they were integrated into the “ECG splitter” program. The ECG splitter was developed 
from a signal analysis graphical user interface (GUI, wave_inspector.m) created by David 
Western, UCL.  
2.1.2.2 Automatic recognition of paced stimuli and calculation of exact 
stimuli timing 
ECG splitter is a simple graphical user interface (GUI) allowing import, analysis and export 
of signals exported from a commercial electrophysiology system. Our adaptations 
allowed recognition of pacing spikes (either by examining the time differential of signal, 
or signal magnitude), QRS complexes (an original function of wave_inspector) as well as 
functionality involving filtering and selection of electrogram channel for analysis.  
 
Figure 2-2-3: The ECGSplitter GUI window 
The EcgSplitter allows automatic import of electrogram data from .txt or .csv files. Pink lines show positions of 
automatically detected pacing spikes. The lower window shows automatically detected timing intervals and 
positions. The control panel on the right allows filtering, selection of electrode to examine and several elements of 
legacy functionality, including the ability to calculate activation time intervals.  
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2.1.2.3 Automatic selection of penultimate drive train and premature 
stimuli, and export of these electrogram segments for further 
analysis 
A key adaptation was the automatic recognition of the final 3 complexes in an S1S2 
pacing protocol drivetrain. After inputting the drive train constant, the script was able to 
recognize the final beats of a drivetrain, and select these for export. These “snippets” of 
the large electrogram data could then be checked for accuracy, before exporting as a 
variable structure, named “Curve”. As well as including the electrogram data, this structure 
variable included information on drive train, signal frequency, electrode names and 
locations and pacing stimulus timings. The Curve variable was then saved in a user-
defined location. 
2.1.2.4 Analysis of selected segments for activation time & 
repolarisation time (according to the classical (Wyatt) method) 
Working with the assistance of Vadim Kositsky, I adapted a series of scripts originally 
written by Ben Hanson, UCL, to automate analysis of the Curve data. Dubbed ARI_tools, 
these scripts were initially developed to analyse ARI and DI interactions from manually 
selected ultimate 3 beats from S1S2 protocols. Initial versions of these scripts simply 
allowed analysis of Ensite data. We developed these tools to allow determination of 
activation and repolarisation, and to determine interactions with coupling intervals of 
stimuli, rather than just the local responses to DI changes.  
These changes ultimately required the rewriting of analytic scripts, though the workflow 
structure remained similar to Dr Hanson’s original.  
Thus far, all signals had been processed in an unfiltered manner as much as was 
possible. For accurate determination of activation and repolarisation times, filtering 
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was necessary to remove artefact. A high pass filter of 0.1Hz was employed for all 
signals to remove baseline wander. A Savitzky-Golay FIR smoothing filter was applied 
to minimise high-frequency noise. A 15ms sample window with 1st degree polynomial 
fitting was used. This filtering technique applies a local polynomial regression to the 
signal, with the advantage that local maxima, minima and width of signal features tend 
to be maintained, without adjusting of the time course (i.e. highly non-destructive). This 
filtering technique is ideally suited to intracardiac signal analysis, where preservation of 
both precise time course and signal features is required.  
The controversy regarding differential methods of analysing the unipolar electrogram 
for repolarisation highlighted shortcomings in the alternative method as a reliable 
indicator of repolarisation times. Although absolute values of repolarisation determined 
with the Wyatt method may be underestimated in the positive T-wave (especially when 
non-contact mapping is employed), this method of selecting the sharpest upstroke of the 
T-wave as the point of local repolarisation appears robust at determining the dynamics 
of repolarisation. We used the long-established and well-validated Wyatt method 
throughout the analysis presented.  
Selection of the window in which to analyse the T-wave is problematic. Automatic 
signal analysis is often poor at determining activation times and repolarisation times 
because of the dependence of “windowing” on the signal. We wrestled with this 
problem in many iterations of our tool, attempting complex analytics to determine the 
boundaries within which activation and repolarisation would lie. This allowed the 
computer algorithm to select the time differential of just the region of interest in the 
electrogram signal. Unfortunately, biological signals rarely conform to the ideals that 
signal analytic scripts seek; invariably some signals were contaminated by noise, 
rendering selection of activation and repolarisation timings inaccurate. Furthermore, 
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determination of repolarisation time depended completely on accurate measurement of 
the time point of activation (given by most negative dV/dT on the unipolar electrogram).  
Therefore a manual script was instituted enabling selection of windows in which to 
search for repolarisation and activation times. “Windowing” is performed by selecting 
the start of the T-wave on the shortest coupled S2 beat (restitution theory indicates that 
the short coupled beats should have the shortest repolarisation time), and the end of the 
T-wave from a drive train beat (which should have relatively long repolarisation times). 
Generous windows were allowed to ensure that very early repolarisation times were not 
missed. Activation windows are selected with the latest activation being the end of the 
activation QRS signal on the shortest coupled S2 beat (again, which should display 
most latency or delay in activation) and the earliest activation being the earliest 
activation during steady state pacing (essentially just following the pacing spike). 
Windowing is performed separately for electrograms from each chamber (e.g. Right 
ventricle, Left ventricle, Epicardium). 
This approach allowed reliable and reproducible determination of activation (using 
dV/dT min of QRS) and repolarisation (using dV/dT max of T-wave) times. 
2.1.2.5 Review of electrogram data  
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Figure 2-4 Representation of ARI-DI restitution curve for data checking 
Calculated ARI-DIs are displayed as blue circles. The red circle shows a selected point (see Figure 2-5).  
Following analysis of all electrograms, ARItools displays series of plots of ARI against DI 
for each and every electrode (Figure 2-4). This allows quick determination of outlier 
points visually. Clicking on a point brings up a window displaying original data and the 
differentiated data (Figure 2-5). At this point a data point can be either deleted or moved 
to a correct manual position. In extreme cases, for example where poor electrogram 
quality prevented clear determination of activation or repolarisation times, data from 
entire electrodes can be deleted at once. Similarly if a single S1S2 series was anomalous, 
all data from that coupling interval could be removed at this point e.g. when an ectopic 
activation fused with paced data. Such manual checking provided a robust method of 
checking electrograms analysis for inaccuracies or artefacts, whilst reducing operator 
bias (data acquisition remained primarily automatic). 
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Figure 2-5 Raw Electrogram data with selection of inflection points 
Coloured dots represent activation and repolarisation times as selected by the automatic algorithm. These can be 
adjusted with the computer mouse. The light blue interrupted line represents the time differential of the electrogram; 
this assists in visual selection of electrogram points. 
 
2.1.2.6 Export of data. 
Finally, ARItools offers a GUI script that saves all calculated values from its analysis to a 
single structure variable. This export function allows data to be added to a previously 
saved variable, essentially allowing build up of large database of analysis results, with 
raw data staying intact. These can be interrogated and exported in various formats by 
other scripts to allow statistical analysis. We exported scripts to .csv format, this could 
be read by a wide variety of statistical programmes, including Excel (Microsoft, WA, 
USA) & R (Team R, Vienna, Austria). 
 
2.1.3 Sinus rhythm analysis 
2.1.3.1 Import & analysis of sinus rhythm electrograms 
ECGSplitter has functionality to allow user-determined selection and export of electrogram 
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segments, not just those automatically selected at the end of a pacing drive train. If sinus 
beats are selected, these can be passed onto a curve structure and analysed in a similar 
way to signals from paced drive trains, including activation, repolarisation and 
fractionation of signals.  
2.1.3.2 Import & analysis of surface electrogram signals 
The 12-lead electrocardiogram (ECG) is the most common investigation for cardiac 
abnormalities, and is formed by body surface potentials resulting from cardiac 
activation. 12-lead ECGs were recorded throughout all mapping studies performed, and 
these can be examined for changes concurrent to changes observed in intracardiac 
signals. Thus we hypothesized that our simultaneous recordings would allow 
correlations of surface ECG changes arising from intracardiac phenomena. 
12 lead ECG data was imported in a similar manner to the intracardiac electrograms. 
Analysis was performed semi-automatically, with manual windowing for determining T 
wave parameters, but manual selection of P-QRS-T timepoints. 
2.1.4 Fractionation analysis 
Fractionation of intracardiac signals has been proposed as a sign of myocardial disarray, 
if there is heterogeneity of wavefront propagation at a point, several variations in the 
QRS time course may be inscribed on the electrogram. These variations may be 
quantified by counting the peaks on the mathematical differentiation of the unipolar 
electrogram. The resulting trace can be held as equivalent to the bipolar electrogram, 
though of course the latter represents a spatial differential rather than a time differential.  
We sought to quantify this during our analysis, particularly during studies regarding 
arrhythmogenic cardiomyopathy. A script incorporating fractionation determination 
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was incorporated into ARItools. The time differential of the unipolar electrogram was 
examined from just following the stimulus artefact to 100ms following the local 
activation time. Signal peaks of absolute amplitude greater than 0.6 times maximal 
absolute of the differentiated, filtered signal were counted, and this total was given as 
the signal fractionation index (Figure 2-6).    
 
Figure 2-6 Examples of fractionated electrograms 
Examples of Fractionation testing. The first electrogram is clean, and has a Fractionation Index (FI) of 4, the 
electrogram displayed on the right has multiple sharp components on filtered & unfiltered signals, and has an FI of 9. 
Unfiltered 
150Hz 
40Hz 
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2.2 Modelling of 1D conduction 
2.2.1 One-dimensional conduction model and CV restitution 
modelling 
A novel method of conduction velocity restitution quantification from biologically 
acquired data using a linear cell fibre model was derived by Lei Xu (UCL). This is 
given in detail below.  
Arbitrary length of cells of 0.1mm was used for model derivation. Each cell within a 
fibre was assumed to have homogenous CV and APD restitution properties. Both of 
these factors were described by exponential functions.  
If the length of a tissue unit (e.g. a myocyte) is assumed as xΔ , and the conduction 
velocity within tissue as CV, the activation time and repolarisation time of a cell ix  can 
be calculated as: 
Activation time: )(
)()( 1
in
inin xCV
xxATxAT Δ+= −
                                      Equation 1 
Repolarisation time: )()()( ininin xARIxATxRT +=                                  Equation 2 
Where: AT and RT are the activation time and repolarisation time; ARI is the activation 
recovery interval; n is the number of beat. 
Hence, the activation time and recovery time at cell ix  can be expressed as: 
∑
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                                                              Equation 3 
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Where: 0x  represents the site of stimulation.  
Thus the period between activation n and activation n+1 for site ix  can be calculated as: 
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Here, the period between activation n and activation n+1 for site 0x  equals to the 
coupling interval  1+nCI () applied at site 0x  
1001 )()( ++ =− nnn CIxATxAT                                                                    Equation 6 
The period between activation n and activation n+1 for site ix  can also be calculated as: 
)()()()( 11 inininin xDIxARIxATxAT ++ +=−                                               Equation 7 
Combining equation 5, 6, and 7, the basic equation for one-dimensional conduction 
model can be expressed as: 
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The conduction velocity )( ixCV  is assumed to be a function of its preceding diastolic 
interval (DI): 
DIC
CVSSi
CVeBCVxCV ⋅⋅−=)(                                                                     Equation 9 
where SSCV  is the steady-state conduction velocity, a constant defined to be 0.72 (Fox, 
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2002); CVB  and CVC  are two constants determining the steepness of CV restitution 
curve. 
 
Referring to the experimental data, )(1 in xDI +  is the diastolic interval of premature beat 
S2, nARI  is the ARI of the steady-state activation following S1 SSn ARIARI = (), 1+nCI  
is the S1S2 coupling interval. These three parameters were directly obtained from 
experimental data. )( in xCV  is the conduction velocity of a steady-state activation, i.e. is 
equal to SSCV .  
For each investigated site, the activation conduction pathway from the pacing site to the 
investigated site was assumed to be an independent one-dimensional conduction 
pathway with uniform restitution properties. From the experimental data, an assumed 
length of the conduction pathway (given the assumed steady state conduction velocity) 
can be calculated by the product of steady-state conduction velocity and the steady-state 
conduction time, )( iSS xAT  , from the pacing site to the investigated site: 
)()( iSSSSi xATCVxL ⋅=                                                                          Equation 10 
Hence, the number of cells included in the conduction pathway is x
xLi i
Δ
=
)(
. 
Equation 8 can be rearranged into the following form, which allows its solution using 
experimental data: 
∑
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All the dynamics in the left hand side of equation 11 are those obtained from 
experimental data. For each investigated site, the one-dimensional conduction model 
and CV restitution model can be fitted with its dynamics from experimental data. An 
iterative approach was taken, adjusting CVB  and CVC  in equation 9, and a minimum 
least-squares error method was employed to select optimum parameters.  
2.2.2 Incorporation of patient data into one dimensional models 
Data acquired from patient studies was applied to the model, and a separate (and 
independent) model was created for each electrode site. ARI and conduction velocity 
restitution was modelled using a mono-exponential equation of the form specified in 
equation 13.  
A standard value of 0.72ms-1 was assumed as baseline conduction velocity, changing 
this absolute value by ±0.2ms did not significantly affect derived CV dynamics. Despite 
model fitting being computationally intense, the use of simplified exponential dynamics 
allowed modern desktop machines to derive CV parameters reasonably quickly. For a 
typical patient, 100-2000 cells were included, depending on the distance of the 
conduction pathway. For example, if the steady-state conduction time was 100ms at the 
investigated site, assuming the steady-state conduction velocity to be 0.72 ms-1 and cell 
length to be 100µm, the number of cells included in the conduction model was 720. 
Conduction velocity restitution “fitting” was performed by a recursive method. Similar 
conduction velocity restitution and repolarisation parameters were assumed along the 
entire conduction path, multiple different exponential restitution parameters (of the form 
given in equation 13) were tried and simulated along the conduction path. These were 
automatically adjusted according to closeness of fit, and the simulation repeated until 
the best fit of the measured activation times with simulation was achieved. Each 
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recursive cycle thus calculated activation and repolarisation along the entire conduction 
path, and the conduction velocity parameters were adjusted accordingly. A least-squares 
fit method was used running within the Matlab environment.   
Validation of our method was performed in two ways, comparison with ionic cellular 
model system and comparison with experimentally acquired patient data. 
Once both ARI and CV restitution parameters had been derived from patient data, the 
cell fibre model was used to predict conduction dynamics of a second extrastimuli (S3) 
introduced following a short S1S2 coupling interval. Modelling of sequential beats was 
only attempted if the r2 for fitting to S2 data was >0.7 at that electrode site, and sites 
where electrograms were of poor quality were excluded. Activation times following the 
S3 beat (obtained experimentally) were quantitatively compared to those obtained from 
the cell fibre model.  
2.2.3 Comparing the exponential model of repolarisation 
dynamics against data ionic cellular simulation 
At short S2S3 coupling intervals, the QRS complex of the unipolar electrogram 
following an S3 can widen to fuse with the repolarisation complex. This precludes using 
unipolar electrograms to validate our simple model for prediction of repolarisation times. 
We thus performed preliminary validation of our model for prediction of S3 
repolarisation times against data taken from an ionic cellular model. The ion channel 
model is obtained from ten Tusscher et al. (2009) from their studies of human 
ventricular tissue. 
The ten Tusscher human ventricular ionic model includes 16 types of currents, and 30 
ionic gate variables. It is practically impossible with current technology to obtain 
detailed information of each type of ion current or gate variables on an individual 
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patient. However, the experimental data provides information on key cellular properties 
such as APD, activation time, and repolarisation time. These three interdependent 
properties were fitted with the restitution models, which are then used to simulate 
interactions of activation and repolarisation. 
The ten Tusscher human ventricular model can be summarised in a general form below 
(the forward Euler method was used to integrate the model): 
m
stimion
C
II
t
V +
−=
∂
∂
       Equation 12 
Where: V is voltage,  
t is time,  
Iion is the sum of all transmembrane ionic currents,  
Istim  is the stimulus current,  
Cm is cell capacitance per unit surface area.  
Action potential duration (APD) is defined to be action potential duration at 90% 
repolarisation (APD90).  
Diastolic interval (DI) equals to the coupling interval of S2 minus APD from steady-
state beat (APDss). 
The form of exponential model tested against data acquired from the ionic cellular 
model was: 
       Equation 13 
The pacing protocols applied to ion channel model were the same as those used 
DIC
SS eBAPDAPD
⋅⋅−=
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clinically (i.e. a sequential extrastimulus study). Data acquired from the ion channel 
model was compared against S3 repolarisation times modelled using our simple 
exponential-based approach. 
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2.3 Human studies 
2.3.1 Introduction 
Human electrophysiological studies were first performed in the 1960s (Damato et al., 
1969; Scherlag et al., 1969; Goldreyer and Bigger, 1971). Several concurrent 
developments in cardiac therapy, namely cardiac pacing, angiography (and fluoroscopy) 
and the development of high-sensitivity recording equipment allowed the recording of 
cardiac potentials from humans using catheters placed via the venous system. These 
early innovations enabled the first detailed descriptions of human electrophysiology, 
and were rapidly followed by development of mapping technologies during the late 
1990s into the early 21st century. These depended on advances in computation and 
electronic recording as well as new manufacturing techniques and innovations, enabling 
the production and use of multipolar recording catheters.  
2.3.1.1 Non-contact mapping 
Non-contact mapping, (Ensite System) was developed in the late 1990s as a method of 
calculating electrograms on the entire cardiac chamber wall from far-field signals (St. 
Jude Medical, MN, USA) (Schilling et al., 1998). In brief, a specialized balloon catheter 
is advanced via the femoral veins to the heart and placed within the chamber of interest 
(e.g. right ventricular outflow tract). The catheter has 64 electrodes laser-etched into 
splines surrounding a fluid-filled balloon that may be inflated or deflated (Figure 3-1). 
This balloon prevents clots forming amongst the metal splines within the blood pool. 
When deployed inside the heart, far field signals received by these 64 electrodes can be 
used to reconstruct “virtual” electrograms projected onto the cardiac wall. This requires 
knowledge of the specific anatomy in which the device is deployed. This anatomy is 
created by a steerable ablation or mapping catheter, moved by the operator within the 
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cardiac chamber. High frequency electrical impedance changes are used to track the 
motion of the mapping catheter relative to the Ensite balloon within 3D space, and by 
moving the catheter around the chamber, the limits of its motion, and hence the 
chamber endocardial location can be determined. This is displayed as a 3D image on a 
computer console, and “virtual” electrogram data projected upon it.  
 
Figure 2-7 The Non Contact Array 
The non-contact array is illustrated. Panel A shows a computer display of the array within a 3-D cardiac geometry, 
panel B shown the non-contact isochronal map typical for clinical display on the Ensite system. Panel C illustrates 
the physical appearance of the non-contact array when deployed (from St. Jude literature). Panel D shown an 
electromicrograph of a single electrode from the array. From St Jude literature, MN, USA. 
 
2.3.1.2 Advantages and disadvantages of non-contact mapping 
Non-contact mapping offers the possibility of high-density simultaneous measurement 
of electrical activity throughout a heart chamber. However, it has several disadvantages 
that limited its usefulness for our studies. First, the current iteration of the non-contact 
mapping balloon catheter is unwieldy and is often difficult to place. The procedure 
requires expert knowledge & experience of the Ensite system and is often lengthy, 
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requiring sedation. This technique was not appropriate for mental stress studies, , where 
sedation must be minimised. Placement in the RVOT is usually possible though, thus it 
was suitable for comparisons involving right ventricular outflow tract 
tachycardia/ectopy (RVOTE) and arrhythmogenic right ventricular cardiomyopathy 
(ARVC) (Lambiase et al., 2004; Yue et al., 2005). 
Second, the quality of the derived virtual electrograms is limited, especially in dilated 
chambers. Initial validation of activation and repolarisation concentrated on the 
ventricular chambers, but later studies highlighted the inability of non-contact mapping 
to reliably resolve signals from chambers with an internal dimensions exceeding >5.5 
cms (Abrams et al., 2007). We concentrated our use in ventricles with normal internal 
dimensions.  
Finally, a huge amount of data can be generated from each study, considering the >3000 
virtual electrograms possible. Analysis of all data was unfeasibly lengthy. We selected 
four columns consisting of six virtual electrodes, covering apex, mid-ventricle and base. 
These 24 electrode locations gave excellent coverage of the entire endocardial surface 
without overwhelming data.  
This chapter will describe the basic methods we have employed in collection of human 
electrophysiological data, namely contact and non-contact mapping.  
2.3.2 Cardiac Electrophysiological Studies 
2.3.2.1 Catheter placement and clinical studies 
Human contact-mapping electrophysiological studies were performed by Dr. Malcolm 
Finlay (author), with assistance and supervision from Dr Pier Lambiase, Dr Ron Ben 
Simon, Dr Martin Lowe, Dr Syed Ashan, Dr Gopi Gopalarugan and Dr Edward 
Rowland. Studies were performed in patients undergoing cardiac electrophysiological 
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studies with a view to diagnosis and ablation of supraventricular tachycardia. All gave 
prior informed consent. Studies were performed under minimal conscious sedation with 
local anaesthetic (lignocaine 1%) or with local anaesthetic only (mental stress studies) 
in the post-absorptive state. Antidysrhythmic drugs were discontinued for 5 days prior 
to the study. The study protocols had local ethics committee approval (UCL REC no. 
10/H0715/19) and conformed to the standards set by the Declaration of Helsinki.  
 
Figure 2-8 Catheter positions for in-vivo studies 
Schematic (left) and x-ray fluoroscopy (right) catheter positions are shown. RA: Right Atrium, LA: Left Atrium, RV: 
Right Ventricle, LV: Left Ventricle, epi: epicardial, endo: endocardial. 
Catheters were placed via venous sheaths (6F to 8F), with 4F arterial access (LV 
retrograde catheter, Figure 2-8). All patients received 5000 units of unfractionated 
heparin. Decapolar catheters were placed in an epicardial coronary vein via the coronary 
sinus, at the RV apex and retrogradely within the LV cavity adjacent to the epicardial 
catheter (St Jude Pathfinder). X-ray fluoroscopy was used to guide catheter electrode 
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placement. A reference anodal electrode was placed in the inferior vena cava. Further 
catheters were placed according to clinical requirements. Electrograms were digitized 
and recorded at 1000Hz (Bard Clearsign, Mn, USA, Figure 2-2). If no arrhythmia was 
initiated by ventricular pacing during the initial clinical study, restitution studies were 
performed prior to further clinical testing. Surface 12 lead ECGs were recorded 
throughout the study.  Oxygen saturations were measured continuously using pulse 
oximetry & blood pressure was measured non-invasively at 5-minute intervals.  
Following the clinical procedure, venous and arterial sheaths were removed and 
haemostasis achieved with manual pressure. 
2.3.2.2 Non-contact array mapping 
Non-contact mapping was performed by Dr Pier Lambiase, UCL, with assistance from 
Dr Akbar Ahmed, Dr Justine Bhar-Amato, Dr Martin Lowe, Dr Anthony Chow, Dr Ron 
Ben Simon and Dr Malcolm Finlay (author). The Ensite catheter was placed via a 9F 
sheath in the left femoral vein into the right ventricular outflow tract under fluoroscopic 
guidance. Patients were formally anticoagulated during non-contact mapping 
procedures, with an activated clotting time (ACT) kept between 250 and 300 with 
boluses of unfractionated heparin. The non-contact mapping balloon was inflated and 
signals checked for consistency across all 64 electrodes. A mapping catheter was 
introduced from the right femoral vein and placed in the right heart and connected to the 
Ensite system. Movement of the catheter around the bounds of the right ventricle 
allowed the creation of a 3D endocardial geometry on the Ensite console. This was 
orientated correctly using fluoroscopy. Recording was commenced and a restitution 
protocol performed.   
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2.3.2.3 Restitution Pacing Protocol 
A restitution study was conducted using programmed electrical stimulation (PES). 
Following 3 minutes of steady state pacing at the RV apex at a cycle length of 600ms, a 
drivetrain of 10 beats was followed by an extrastimulus (S2). The S1S2 interval was 
decremented by 20ms to 300ms, thereafter in 5ms intervals until ERP was reached. The 
ERP was found by increasing CIs by 8ms and then decrementing by further 2ms 
intervals. In patients undergoing second extrastimuli (S3) studies, the S2 extrastimulus 
was set at 10ms above the observed refractory period, and an S3 was delivered at CIs 
progressively decrementing to a minimum of 180ms. In patients undergoing studies 
involving mental stress or pharmaceutical agents, restitution pacing studies were 
repeated during mental stress or drug administration. 
2.3.2.4 Mental stress studies 
I performed all mental stress studies. PES was performed during an active relaxation 
protocol, and again during mental stress in the manner described by Burg et al. (1993). 
During active relaxation, subjects were asked to think of a situation that they found 
subjectively relaxing, and were asked to imagine themselves being in that situation. Lab 
lighting was turned down to a minimum and quiet kept amongst staff. Gentle prompts in 
a clam & reassuring manner were used to encourage the subject’s active memory of the 
situation.  
Mental stress was induced in two forms, mental arithmetic with harsh encouragement 
and anger recall. Data is presented from that which provoked the greatest stress 
response. Lab lighting was returned to full during the stress protocol. Mental arithmetic 
involved subtraction of serial 7s from a four-digit number. Harsh encouragement was 
given according to maintain subjects interest and concentration. During anger recall, 
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subjects were asked to remember a recent situation that made them angry. They were 
asked to relive that situation, and tell the investigator as if describing that situation later 
that same day to a close friend. The investigator then attempted to mildly provoke 
further reaction with mild awkward questioning. Subjective stress was recorded on a 
Likert scale for each protocol, which has been shown to accurately correlate with 
physiological measures of stress (Callister et al., 1992). Intrinsic heart rate and serum 
catecholamine levels were taken as objective measures of stress response. 10mls of 
blood was extracted from the left femoral vein midway through each protocol. Samples 
were rapidly cooled to 4ºC on ice, centrifuged at 10000rpm for 2mins. Plasma was snap 
frozen and stored at -70ºC. Presented comparisons are for peak stress compared to 
relaxation for each patient. 
2.3.2.5 Pharmacological Studies 
PES restitution protocols were performed at baseline and following administration of 
ajmaline 50mg (5mg/ml) into a central vein via a femoral sheath. Periods of sinus 
rhythm were recorded between drive trains enabling comparison of sinus rhythm 
activation.  
2.3.2.6 Data export 
At the end of the case, data was exported to text format for analysis using standard 
export tools. Data was saved in anonymised files on an encrypted external hard drives. 
2.3.3 Human Genotyping 
Dr Giovanni Quarta & Dr Syrris (UCL) carried out human genotyping. 10ml whole 
blood samples were obtained from ARVC patients and family members. Genomic DNA 
was extracted using a commercially available DNA extraction kit (QIAamp DNA 
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Blood mini kit, Qiagen). Index cases were part of a larger patient cohort 
comprehensively screened for mutations in desmoplakin, plakoglobin, plakophilin-2, 
desmoglein-2 and desmocollin-2. Primer pairs for DSP exons were designed in flanking 
intronic sequences and are available from Dr Syrris. Polymerase chain reaction (PCR) 
amplification and direct sequencing on an ABI 3130 Genetic Analyser were performed 
using standard protocols (Syrris et al., 2007; Syrris et al., 2006a; Syrris et al., 2006b). A 
total of 300 unrelated healthy, ethnically matched Caucasian volunteers served as 
controls. 
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2.4 Murine Genotyping and Electrophysiology 
2.4.1 The transgenic mouse and methodology of electrical 
phenotyping 
Cardiovascular biology has been revolutionized by transgenic technology, which has 
enabled investigators to determine exact molecular mechanisms and pathways. Prior to 
the development of transgenic murine models, “classical” physiology had sought to 
determine the cause of disease largely using combinations of surgery and pharmacology, 
techniques that often introduced important co-founders to results & required caution in 
translation of results. Technological advancements now allow researchers to modify 
genes quickly and with great accuracy, enabling the study of specific aspects of 
cardiovascular physiology and biology (Bockamp et al., 2002). Several transgenic 
strategies exist. These include the integration of transgenes by pro-nuclear injection, but 
the targeting of specific genes through homologous recombination in pluripotent 
embryonic stem (ES) cells has allowed the murine model to come to the forefront of 
transgenic mammalian research (Shuldiner, 1996). Gene targeting is performed in ES 
cells in vitro; these cells are then reintroduced into blastocysts, thus creating chimeric 
embryos (Figure 2-9). The resulting mice, with introduced mutations into their germline, 
can be used as founders, and the engineered defect is transmitted into subsequent 
progeny. The mouse is ideally suited to these techniques owing to its transgenic 
versatility, fast reproduction rates and large litters.  
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Figure 2-9 Generation of knockout mice using homologous recombination and embryonic stem (ES) 
cells.  
A: A strategy for generating a knockout genotype using homologous recombination is illustrated. The wild-type locus 
is here shown with five exons (labeled E1 –E5), the gene to be targeted is E3.  The targeting construct will recombine 
with the locus at E2 and E4, thus deleting E3 and introducing a selection marker. Randomly integrated DNA 
constructs will contain the negative selection marker, but homologously integrated DNA will not: removal of non-
homologous DNA outside the flanking region takes place. The negative selection marker can thus be used to select 
for ES cells with correct homologous recombination. P is a promoter driving expression of the selectable marker, PA 
Polyadenlation signal.  
B: Homologously recombined ES cells are injected into a blastocyst, which in turn is placed into a pseudo-pregnant 
recipient mother. The injected ES cells are pluripotent, and will contribute to all tissues in the resultant chimeric 
progeny (including in the germline). Thus breeding from these chimeric mice results in hemizygous knockout mice, 
which themselves can be inbred to give homozygotes and littermate wild-type controls. Adapted from (Bockamp et 
al., 2002)  
2.4.2 Murine electrical phenotyping 
Current understanding of cardiac electrophysiology, particularly cardiac impulse 
propagation and arrhythmogenisis, has been significantly advanced by the study of 
transgenic mice. These have added to existing techniques such as cellular imaging, 
patch clamping and molecular biology to give a broad basic approach to the study of 
cardiac electrophysiology. Furthermore, transgenic mice offer the opportunity to 
complement the study of clinical disease with the in-depth and “clean” studies possible 
in a specific transgenic construct. Single cell experimentation does not reproduce the 
true tissue and organ level physiology that exist in vivo; there is complex tissue 
heterogeneity, with multiple cell types and extracellular matrix that contributes to 
marked regional differences in physiological properties.  These are impossible to 
measure on isolated cells.  
Even more pertinent is the observation that arrhythmia, indeed cardiac function in vivo, 
is not a phenomenon of individual isolated cells, but refers to a tissue-level behaviour. 
This does not to diminish the enormous, fundamental and increasing contribution that 
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molecular and cell biology has, and is, making to the understanding of cardiac 
arrhythmia, but does highlight that an understanding of isolated cell behaviour alone is 
insufficient for a full understanding of cardiac electrophysiology and arrhythmogenesis. 
The transgenic mouse, with its advantages as a physiological tool, is thus well suited to 
the study of arrhythmia, particularly on a tissue level. 
To this end, several technologies have been developed for murine phenotyping 
including cardiac monophasic action potential mapping (ex vivo), cardiac optical dye 
mapping (ex vivo), invasive (in-vivo) electrophysiology and ambulatory ECG telemetry 
and monitoring (in-vivo).  
Monophasic action potential mapping in the transgenic mouse has revealed important 
transchamber heterogeneity in activation and repolarisation in models of Brugada 
syndrome. However, it is limited to point measurements at a single site, and does not 
reveal the spread of excitation or repolarisation wavefronts. Optical mapping has been 
developed to allow electrical wavefront mapping in the intact cardiac preparation 
(Efimov et al., 1994). This technique utilizes the physical properties of wavelength 
dependent light/excitable tissue interactions to directly observe activation and 
depolarization activity across the surface of the heart with excellent spatial-temporal 
resolution. Using this method, mechanisms of arrhythmia induction and maintenance 
have been directly demonstrated, by allowing direct visualization of complex-re-entry 
around lines of conduction block (Girouard and Rosenbaum, 1996; Witkowski et al., 
1998).  
Optical mapping has unquestionably advanced our understanding of cardiac 
electrophysiology. However, it is not without its limitations. First, accurate registration 
of tissue with optical sensing requires the heart preparation, usually Langendorff-
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perfused (Langendorff, 1895), to be held absolutely still during recordings. Cardiac 
motion must therefore cease, and this is achieved with pharmacological excitation-
contraction uncoupling agents. Such uncoupling agents have their own primary effect 
on cardiac electrophysiology, and results must be interpreted with a degree of caution 
(Brack et al., 2013). Second, optical mapping currently provides only a 2D planar view 
of the myocardial tissue. In practice, this has restricted the overwhelming majority of 
studies to the epicardial surface. This becomes a major drawback considering the 
proposed role of tissue-level heterogeneity (e.g. between epicardial and endocardial cell 
layers) in clinical arrhythmogenisis. Some studies have overcome this by employing 
ventricular wedge preparations (Antzelevitch et al., 1998; Antzelevitch, 2001; 
Antzelevitch, 2008; Myles et al., 2010; Myles et al., 2011), and have sought to actively 
examine tissue-level heterogeneities across the myocardial wall. Third, the 3D nature of 
the whole heart preparation makes the true course of a wavefront impossible to 
determine from 2D information alone. Wavefronts and excitation paths may re-enter via 
pathways concealed deep in the tissue, and thus the true nature of tissue reentry and 
excitation remains hidden from a surface map (Akar et al., 2002; Bai et al., 2011). 
Recent developments in cell culture, particularly in embryonic stem cell technology, 
have allowed the study of cardiomyocyte syncytia in vitro (Zhang et al., 2009). 
Confluent stem-cell cell cultures that are reprogrammed to form cardiomyocyte have 
been successfully used to study re-entry. Very recent work has illustrated that these 
techniques may be applied to stem cells isolated from adult human skin or blood in 
individuals with cardiac disease (Davis et al., 2012; Itzhaki et al., 2011; Lee et al., 2012; 
Ma et al., 2013).  
Yet drawbacks from this technology remain (Blazeski et al., 2012). First, the resulting 
cell layers, though exhibiting many features of mature cardiomyocytes, have developed 
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in an artificial medium. The supporting extracellular matrix, fibrous tissue, blood 
vessels and structure found in intact tissue is not, and has never been, present. Important 
developmental interactions may thus be easily missed. Second, the technology is still in 
infancy, and to achieve success at cell fate reprogramming requires intensive resource 
and is by no means assured. Third, the access to tissues from well-characterised patients 
can limit the pursuit of a specific scientific hypothesis, though doubtless this technology 
will inform us further regarding disease mechanisms of our patients. Forth, despite 
being classed as cardiomyocytes, cultured cardiac cells cannot be classified regionally. 
Indeed, currently we cannot reliably distinguish whether a cultured cardiomyocyte is an 
atrial, ventricular or sinus nodal cell. Anecdotally most cultured cardiomyocytes exhibit 
properties of all cardiac cell types to greater or lesser degrees.  In cardiac arrhythmic 
disease, where tissue heterogeneity is centre stage, the homogeneity of cell culture 
preparations is a major limitation. 
Myocardial tissue slice preparations have been proposed as a method by which the 
limitations of cell layer or whole heart electrophysiology studies may be overcome 
(Pillekamp et al., 2005; Camelliti et al., 2011; Bussek et al., 2012). In brief, very thin 
(150-400µm) slices of myocardial tissue are shaved from a block of living tissue using a 
vibrating microtome (vibratome). The electrophysiology of these slices is thus confined 
to a 2-dimensional plane, and this can be measured with electrode microarrays and 
extremely high-fidelity electronic amplifiers. This technique has become established as 
a way of measuring neuronal activity and connections in rodents. Barriers to the use of 
this technique in the murine cardiac preparation include the extreme fragility of the 
murine cardiac tissue, its high sensitivity to oxygen stress and the difficulties of 
achieving reliable stimulation of cardiac slices. Several groups have managed to achieve 
reliable recordings and stimulation from neonatal murine cardiac slice preparations 
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(Halbach et al., 2007; Pillekamp et al., 2005); success has also been claimed for larger 
rodents, including guinea pigs and rats (Bussek et al., 2012), and human ventricular 
tissue (Brandenburger et al., 2012).  However, little published data on adult murine 
preparations exists. A technique described in the mid-2000s by Halbach appears not to 
have been reliably reproduced (Halbach et al., 2006). Even here, tissue was taken from 
mice at 5 weeks, rather than truly adult tissue implied by the paper title.  
The attraction of an adult murine tissue slice preparation as a model for investigation of 
cardiac electrophysiology remains, particularly in light of the mature and unparalleled 
transgenic technology available.  Specifically, a defined tissue-level model of cardiac 
electrophysiology would enable me to begin to dissect the specific biological 
mechanisms underlying our human observations. It was intended to establish a reliable 
tissue slice model of murine ventricular electrophysiology. 
2.4.2.1 Objectives 
This methods chapter aims to: 
1. Describe the animal breeding strategies used and the PCR based genotyping 
approach used to identify mouse cohorts.  
2. Describe the (successful) tissue slice preparation approach. 
3. Describe the utilization and setup of the cardiac slice microarray recording 
procedure and its applicability to the study of tissue-level electrophysiology in 
mice with a G-protein transgenic deletion 
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2.4.3 Animal breeding and genotyping 
2.4.3.1 General Conditions 
Mice were maintained at a UCL animal core facility under stringent UK home office 
guidelines relating to animal welfare (PPL-6732). All mice were kept in individually 
ventilated, pathogen-free, temperature controlled cages (21-23ºC) with 12-hour 
day/night light cycles. Animals had free access to standard rodent chow and water.  
Mice were studied between 12 and 24 weeks of age under standardized conditions.  
2.4.3.2 Transgenic global deletion of individual Gα i2 isoforms and 
breeding 
All physiological studies were performed following an initial mouse breeding 
programme designed to generate specific deletion of individual inhibitory G-proteins. 
Experimental mice from an Sv129 genetic background had selective global deletion of 
Gαi2, abbreviated Gαi2 (-/-). Professor Birnbaumer initially provided the breeding pairs 
of mice, which were used in the 4th generation. These mice were initially generated 
using homologous recombination techniques in mouse ES cells. The gene targeting 
strategies have been previously published, and confirmation of selective G-protein 
deletions at the protein level has been confirmed by Western Blot analysis in various 
tissues including the heart (Rudolph et al., 1996; Jiang et al., 1997).   
The gene targeting approach used was as follows. A gene map schematic of Gαi2 
incorporating intron-exon boundaries is shown. Exon 3 within the Gαi2 locus was 
disrupted in vitro at a unique Ncol restriction site and a neomycin resistance cassette 
inserted. This interruption results in a truncated protein with no biological function. The 
mutation was subsequently incorporated into ES cells by homologous recombination. 
Mutated ES cells containing one copy of the mutated Gαi2 gene as well as one wildtype 
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copy (Gαi2 +/-) were then positively selected for in antibiotic enriched media. Positive 
clones were injected into blastocysts and placed in pseudo-pregnant mice to generate 
“chimeric” animals. Chimeric founder mice incorporating the Gαi2(+/-) mutation at a 
germ cell level were then inbred on an Sv129 background. By intercross of Gαi2 
heterozygotes (+/-), Mendelian genetics predict the progeny would be either (+/+) 
littermate controls, (+/-) Gαi2 heterozygotes or (-/-) Gαi2 deleted.  
2.4.3.3 Mouse Genotyping 
Mice were ear marked for identity purposes at 3 weeks of age. Ear clippings (~2mm 
diameter) were used for genomic DNA isolation. Polymerase Chain reaction (PCR) 
based genotyping was performed on isolated DNA to confirm the genotype of 
individual mice. I performed all stages of the mouse genotyping. 
2.4.3.4 DNA extraction of ear clips 
Ear punch samples were placed in Epindorf tubes. 150µL of tail lysis buffer (3.5ml 2M 
Tris-HCL pH 8.8, 1.66ml 1M (NH4)2SO4, 1.34ml 0.5M MgCl2, 0.5ml Triton X-100, 
92.2ml H2O, 1ml β-mercaptoethanol) was added and the samples heated to 100ºC for 10 
minutes. This aimed to denature mouse proteins. Samples were cooled and 5µL of 
proteinase K (20mg/ml) was added at 55ºC for 12 hours to cause non-specific protein 
digestion. Samples were reheated to 100ºC for a further 10 minutes and spun at 
13000rpm in a tabletop centrifuge. 1µl of supernatant containing mouse genomic DNA 
was used per genotyping PCR. 
2.4.3.5 Gα i2 genotyping 
The following primers were used for Gαi2 genotyping: 
i2F8 5’-GATCA TCCGA GATGG CTACT CAGAA G-3’ 
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i2F14 5’- CAGGA TCATC CATGA AGATG GCTAC- 3’ 
i2R7 5’-CCCCT CTCACTCTTGATTTCCTACTGACAC-3’ 
NeoR2 5’- GCACT CAAAC CGAGG ACTTA CAGAA C-3’ 
PCR conditions are summarized below 
PCR reaction mixture: 
• Thermopolymerase buffer 5µL 
• dNTP’s (25mM) 1µL 
• Mg2+ (50mM) 1.2µL 
• Molecular H2O 37.5µL 
• i2F8 (100µM) 2.5µL + i2R7 (100µM) 2.5µL (Wild Type allele) OR 
• i2F14 (100µM) 2.5µL + NeoR2 (100µM) 2.5µL (Mutant allele) 
• Taq polymerase (5U/µL) (0.35µL) 
• Genomic DNA 1µL 
PCR Profile 
• 94ºC for 5min 
• 94ºC for 1min 
• 62ºC for 1min 
• 72ºC for 2min 
• 72ºC for 10min 
• Samples stored at 10ºC until analysis 
 
 
x30 
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Two PCRs were run per sample. One used the wild type primers (i2F8 and i2R7), 
resulting in the presence or absence of an 805bp fragment corresponding to wild-type 
Gαi2. A second PCR was performed with the primer set specific for the mutant allele, 
i2F14 and NeoR2. This allowed determination of presence or absence of a 509bp PCR 
fragment from the mutant gene. PCR fragments were separated using agarose gel 
electrophoresis.  
 
Figure 2-10 Example of Gel Electrophoresis 
A typical gel electrophoresis is shown. Data from four animals are shown: a homozygote knock out, with a mutant 
509bp band visible, a heterozygote (both 805bp and 509bp bands visible), a wild-type littermate (only 805bp band). 
A heterozygote control, and a DNA-free negative control are also shown. A 100bp ladder is visible on the right. Wt – 
wild-type PCR fragment, Mut – mutant PCR fragment. 
2.4.4 Murine cardiac slicing and electrophysiology studies 
2.4.4.1 Initial attempts and hypotheses 
The development of a novel cardiac tissue slice model for studying cardiac 
electrophysiology presented several challenges. Studies were commenced by using the 
published work of Halbach et al (Halbach et al., 2006) and by studying Langendorff 
techniques with Gareth Matthews and Prof. Chris Huang in Cambridge University. 
Previous tissue slice work had used a low-calcium, Tyrode’s-based (HEPES buffered) 
solution for initial tissue isolation. 2,3-butanedione monoxime (BDM) is frequently 
been used in cell isolation to reduce myocardial work, acting as a myosin inhibitor. 
Wt Wt Wt Wt WtMut Mut Mut Mut Mut
Knock out -/- Hetrozygote +/- Wild Type (+/+) Hetrozygote +/-
+ive control
-ive control DNA ladder
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Cold-cardioplegia had been applied to inhibit contraction. Halbach and colleagues had 
also employed Blebbistatin to inhibit cardiac contraction and prevent apoptosis.  
Initial attempts at reproducing Halbach’s methods were unsuccessful. Apparently living 
tissue slices were occasionally obtained. However, these exhibited uncoordinated 
spontaneous contractions which ceased rapidly. This was taken to signify tissue death. 
No reliable electrical signals were recorded from these tissues.  
An approach to fully inhibit cardiac contraction and to reliably prevent cell death during 
slicing was pursued. A zero-calcium, high-potassium, cold perfusate of the whole heart 
was employed. Blebbistatin is a specific inhibtor of Myosin II ATPase, and as such 
inhibits apoptosis and reduces muscle energy demands. This compound was added to 
the perfusate solution aiming to further inhibit apoptosis and reduce cardiac metabolism. 
It was hoped that this would permit successful tissue slicing, with tissue slices able to 
readapt to physiological solutions. The low temperature and high potassium would 
inhibit cardiac electrical activity by reducing metabolic rate and reducing 
transmembrane potentials. Removing calcium from the solution would reduce 
contractile function and inhibit programmed cell death.  
Hearts were formally perfused with the cardioplegic perfusate via a Langendorff system, 
this allowed blood washout and full perfusion through the tissue. Solutions were based 
on Kreb’s solution; this has the advantage of robust physiological buffering.  
The final, successful, technique is described below. 
2.4.4.2 Cardiac slicing 
Mice were euthanized with cervical dislocation. The thorax was immediately dissected 
and the heart exposed. Cardioplegia was instigated by applying 10mls of ice-cold, 
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oxygenated Ca2+-free Kreb’s solution (119mM NaCl, 4mM KCl, 1mM MgCl2, 1.2 mM 
KH2PO4, 25mM NaHCO3, 10mM glucose, 2mM Na Pyruvate, pH 7.4) directly onto the 
epicardial surface. The heart and great vessels were removed within 20 seconds and 
placed into a dissection dish containing ice-cold Ca2+-free Kreb’s, and a 23 gauge 
cannula was inserted into the aorta under microscopy. The aorta was secured to the 
cannula with a clip, cold retrograde perfusion was commenced initially with oxygenated, 
ice-cold, Ca2+ free Kreb’s at 16.5mls/min. The time taken from cervical dislocation to 
establishment of cold Langendorff perfusion was less than 3 minutes.  
Following perfusion for 2 minutes, perfusate was changed to ice-cold oxygenated 
calcium-free Krebs with high K+ (20mM KCL) and Blebbistatin (Cambridge Bioscience, 
20µM) for 3 minutes. Hearts were removed from the Langendorff perfusion rig and 
placed again into a dissection dish containing cold perfusate. Ventricular tissue was 
dissected from atrial under light microscopy, and the dissected ventricles were 
embedded in low-melt agarose (4% low-melting point agarose in Ca2+-free Kreb’s), and 
then rapidly chilled on ice. The agarose block was orientated and fixed to a magnetic 
stage using cyanoacrylate glue and placed into the cutting chamber of the vibratome. 
This chamber was kept at 4ºC using external ice, and the cutting chamber was filled 
with cold, modified Kreb’s solution (0.6mM Ca2+, K+ 10mM).  
Tissue sections were performed from apex to base at interval thickness 200µm. The 
vibrating PTFE-coated steel blade (Wilkinson Sword, Bucks, UK) was advanced at 
<200µm/sec. x-axis vibration was 2mm at 80Hz. z-axis deviation was calibrated prior to 
every use to be <1µm. 
Cut sections were immediately placed into room temperature, oxygenated low-Ca2+ 
Krebs (4mM KCl, 0.6mM Ca2+) with 10µM Blebbistatin. After 25 minutes, samples 
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were transferred to oxygenated standard oxygenated Krebs (4mM KCl, 1.1mM Ca2+) 
and kept at room temperature until electrophysiological studies were performed. 
2.4.4.3 Cardiac slice EP studies 
The multi-electrode array is a recently developed technology that allows solid-state 
electrical recording from 59 individual electrodes within a dedicated fluid-filled 
recording chamber. This allows mapping of electrical wavefronts over a slice of 
electrically active tissue, e.g. brain, cultured cell layer or, in our case, heart myocardium. 
Stimulation can be performed either through the recording electrodes themselves or via 
an external stimulator. The system consists of removable microarray-plates that can be 
loaded into a recording headstage with integrated amplifier. This communicates with an 
external breakout and stimulator system. The microarray is held at a constant 
temperature by a regulated heating block incorporated into the headstage, a 
magnetically fixed perfusion system also incorporates a temperature-controlled fluid 
warmer. The entire system is computer controlled from an external PC microcomputer. 
To allow visualisation of tissue during experiments, the headstage was mounted on a 
Nikon N5 inverted microscope with 20x objective. 
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Figure 2-11 Experimental setup for tissue slice measurements (Actual and Schematic) 
Photograph shows actual equipment where murine thin cardiac slices were generated and studied. Schematic is 
shown below. Broken lines represent digital control lines. A roller pump provides a continuous flow to the multi-
electrode array within the headstage. 
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Despite being state-of-the-art for neural tissue and cell-culture measurements, several 
limitations of this system in cardiac electrophysiological testing were apparent. 
Pharmacological studies require a smooth transfer of perfusate solutions; this is very 
hard to achieve using manual pipetting without disturbing the tissue slice on the array. 
Similarly, any changes in contact with the fluid-filled recording chamber create artefact 
and electrical interference in the recording system that did not always resolve 
completely. A constant perfusion system, incorporating a thermostatic fluid warmer, 
was built. This allowed simultaneous infusion and removal of perfusate from the 
recording chamber, enabling constant perfusion with fresh solutions. Drugs can be 
added to the infusion with reliable wash-in and washout, whilst avoiding affecting the 
temperature, oxygenation or disrupting the tissue.  
A further major challenge was to electrically stimulate tissue slices reliably. Although it 
was possible to stimulate tissue through the array recording electrodes, these are very 
small (60µM diameter) and thus the current load possible was similarly small. Ensuring 
reliable contact with tissue was difficult, and electrical stimulation through the array 
was not robust. Indeed, on many occasions when stimulation was possible, within a few 
minutes thresholds had risen above voltages possible to deliver directly via the array 
system. The iridium-titanium alloy electrodes have a lower resistance and capacitance 
than standard gold electrodes, yet gold electrodes were available at larger spacings and 
diameters (100µM). However, electrolysis was often visible at gold simulation 
electrodes at the voltages required for electrical capture of slices (as evidenced by 
microscopic gas-bubble formation on the electrodes).  
Therefore, an external stimulation electrode was built (by myself) to allow stimulation 
via an external stimulus isolation unit. A bipolar simulation electrode was built from 
two short lengths of 500µm-diameter silver wires. These were fixed in epoxy resin and 
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soldered to shielded cabling. The wires were fixed and stabilised to a plastic housing 
using epoxy resin, and then acid-cleaned (using 100% acetic acid) and moulded into 
shape. The housing was itself shielded with aluminium foil, electrically grounded and 
mounted onto a micromanipulator. This allowed placement of the stimulation electrode 
anywhere on a tissue slice. Gentle force could be applied to ensure reliable tissue 
contact. 
Simulation was via a stimulus isolation unit (DS-2A, Warner Instruments, MA, USA), 
itself driven from a Grass S88 Stimulator (Natus Neurology, RI, USA).  Initially, 
outputs were driven via PC control, but pulse timings were found to be unreliable (with 
an error of the digital-out signal of ±100ms). The S88 unit was used for signal/stimulus 
control. 
2.4.4.4 Tissue slice recording protocol 
Sections were placed in the recording chamber and carefully positioned manually so 
that left ventricular tissue overlay the measurement electrodes. A 1cm diameter metal 
ring with an overlying nylon mesh (Harp-slice grid, Multielectrode systems) was used 
to hold the tissue flat in place on the electrode grid and ensured adequate tissue 
electrode contact. The recording chamber was mounted in the headstage and perfusion 
commenced at 2mls/min. Tissue was allowed to equilibrate for 1 minute before 
electrode placement. The bipolar stimulating electrode was carefully lowered to just 
contact the tissue slice on the left ventricular tissue, but not move the slice on the array. 
Stimulation was started at 5Hz with a monophasic 1ms pulse, and real-time recording of 
electrical activity commenced. The stimulus voltage increased until electrical capture 
was apparent. Usually a tiny manual increase in the pressure of the stimulus electrode 
on the tissue preparation was necessary to ensure reliable threshold parameters to be 
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obtained. The stimulus voltage was reduced until electrical capture was lost, the lowest 
voltage stimulus that could reliably capture was taken as the stimulus threshold. Cardiac 
signals were recorded at 10kHz. A simulation protocol was performed with steady state 
pacing at 200ms, stimulation during recording was performed at twice threshold.  
Around 30 seconds of pacing activity were recorded for each state for each slice. 
Perfusate solution containing drugs was washed in over 30 seconds at 20mls/min. Slices 
were then stimulated at 5Hz for 2 minutes before threshold was determined and 
recording commenced. 
2.4.4.5 Electrogram analysis 
The large quantity of data acquired from each tissue slice experiment necessitated 
further development of electrogram analysis tools building on my experience with 
human recordings. Electrograms were exported to ASCII format, from which they could 
be imported into Matlab, specifically via ECGsplitter. Around 20-30 seconds of 
continuous, high quality signals were selected and exported to a .mat file. I extensively 
modified code originally written for human electrogram processing to analyse murine 
signals. As the data analysed was predominantly from steady state pacing, signals were 
divided into 3-beat sections. Pacing artefacts were identified automatically and used for 
identification of stimuli. Manual windowing allowed activation time, defined as the 
most negative downstroke of the electrogram, to be performed. Inconsistent 
electrograms and those that did not have a clear activation time were excluded.  
56 signals were obtained from every activation of each slice. Over a 30 second segment, 
stimulating at 5Hz, around 9000 signals required analysis. Even with an automated 
system, this was arduous work to define each activation time from each and every signal. 
Signal averaging of all signals from a segment was therefore used, and the activation 
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time was calculated on the averaged signal for each electrode. 
Classical measurement of conduction velocity relies on knowledge of the path of 
activation, in 2D planar surface this can be complex to determine. Another approach is 
to use the overall activation gradients as measured across the entire tissue. To do this, 
the overall gradient in activation time was assumed to be able to give a precise 
time/distance measurement, the inverse of this equates to velocity. A topographical 
function, gridfit.m,  was used to fit a 2D least-squares regression surface to activation time 
data across the entire electrode array grid (D'Errico, 2010). The activation gradients can 
be measured at each point of the fitted surface, and the mean of these gradients was 
taken as the overall mean activation gradient. The inverse of this figure gives a measure 
of conduction velocity.   
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Figure 2-12 Calculation of conduction velocity from regression surface 
A typical regression surface used for calculation of conduction velocity is shown. The x and y axes represent 2D 
positions. The height of the grey filled circles gives the activation time measured at that location. This z axis is 
inverted (i.e. early activation = high, late activation = low). A regression surface is fitted to these co-ordinates and 
activation times, which here is colour-scaled to represent activation time (red = early activation, blue = late 
activation). At any point on this surface, the slope (G, ) can be calculated in a Cartesian fashion (G = √(Gx2 + Gy2 ), 
where Gx is the gradient in the x plane and Gy is the gradient in the y plane).the inverse of this value (i.e. 1/G) is the 
conduction velocity at that point. Data presented uses the mean of values from across the entire slice. 
Activation time was taken as the time of local activation as measured from the stimulus 
artefact. Dispersion of activation was defined as the time difference between earliest 
and the latest activation measured on the array.  
2.4.4.6 Future work 
MEA high-density mapping on cardiac slice tissue will allow the tissue 
electrophysiology of the murine slices to be determined. The role of Gαi2, and how 
intracellular signalling can contribute to the development of arrhythmia will be 
observed using restitution protocols and pharmacological intervention, including 
sympathomimetic (isoprenaline) and cholinergic agents (carbachol). 
G
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2.5 Statistical analyses 
All statistical computing was performed in R software (R v 2.1.14, R Foundation for 
Statistical Computing, Vienna, Austria (Team R, 2010)). Continuous parametric data 
are presented as mean±SD or, in the case of non-parametric data, median [interquartile 
range], unless otherwise specified. Comparisons in which a single measurement was 
taken for each subject, e.g. VERP, dispersion of repolarisation time, AG, r2, MID were 
made using student’s t-test with correction for multiple comparisons. Continuous 
parametric data derived from electrogram data were modelled using mixed-effects 
linear regression and statistical significance was inferred from the model (Pinheiro et al., 
2009). In brief, models with and without co-variates under examination were compared 
using ANOVA, a probablitiy of models with and without the covariate being different 
from one another can be assigned, and the statistical importance of that co-variate 
inferred. Visual estimates of 95% confidence intervals of the mean for continuous data 
were constructed using local linear regression (loess function). Quantile regression with 
bootstrapping was used to compare non-parametric continuous data (Koenker, 2009). 
100 bootstrap replications were used. Mixed-effects logistical regression was used to 
construct predictive models aiming to differentiate RVOTE and ARVC patients based 
on electrogram data (Imai et al., 2009). Recursive partitioning (a.k.a. classification and 
regression trees, CART) is a decision-learning technique that enables optimal splits in a 
group formed on different observations to occur (Therneau et al., 2010). Once a split is 
made, the same process in run on the child groups until no further gains can be made 
(hence recursive). This enables discovery of optimum decision strategies and cut-offs 
rapidly, the outputs are easily understandable and testable. This technique was applied 
to surface ECG data to determine optimum cut-offs that may enable diagnosis of ARVC 
from a mixed group of patients. A p value of <0.05 was regarded as statistically 
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significant.  
2.5.1 Power Calculations 
ARVC study: Power calculations were performed based on combined definite and 
probable ARVC against normal patients based on assumed conduction delay data from 
patients with Brugada syndrome (Lambiase et al, 2009). Assuming a true difference in 
means between hysteresis in ARVC from controls of 10ms, with a standard deviation of 
12ms, 19 patients in each group would have an 80% power to detect a difference 
between groups with an alpha of 0.95.  We were mindful that study numbers would be 
limited by patient availability and recruitment.  
Mental Stress studies: Assuming a ARI of 240±SD of measurements 8ms, 12 subjects 
will have a 90% power to detect 8ms change and 80% power to detect 7ms true change 
(Paired data). 
Murine study: This was an exploratory study generating pilot data; therefore power 
calculations were not formally developed. Previous studies had shown marked 
differences in ERP parameters using 6 animals in each group (e.g. Zuberi et al. 2010) 
and this was used as a basis to plan experiments.   
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Chapter 3 RESULTS: One-dimensional cable theory, 
combined mapping and modelling study 
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3.1 Introduction 
Functional block and wavebreak are necessary events in triggering and sustaining the 
development of chaotic human arrhythmias, particularly VF, the rhythm underlying the 
majority of sudden cardiac death (Chow et al., 2004). Large quantities of theoretical 
data exist, seeking to explain how interactions between activation and repolarisation 
may explain development of functional block in the absence of overt pre-existing 
heterogeneity of conduction. Notably, one-dimensional fibre models have been used to 
explain “at-a-distance” functional block, i.e. how an activating wavefront may impinge 
upon a prior wave of activation (Otani, 2007; Gilmour et al., 2007). These frameworks 
incorporate activation potential duration (APD) restitution, describing the shortening of 
the action potential with decreasing of the diastolic interval following the previous beat, 
and conduction velocity restitution, the slowing of cell-cell conduction with shortening 
of diastolic interval. Such a model recently underwent a qualitative validation by Gelzer 
et al (Gelzer et al., 2008), where it was used to predict whether combinations of up to 5 
extrastimuli could initiate VF in a canine model. 
A major criticism of this approach has been the question of relevance of models derived 
from single fibres to the behaviour of the entire in-vivo human heart, and thus whether 
such models could be relevant to clinical practice. Although one-dimensional models 
offer simplicity and allow a clear understanding of the passage of a wavefront along a 
defined pathway, cardiac tissue tends to act as an electrophysiological syncytium in 
three dimensions. However, single-fibre models can potentially obviate the need for 
knowledge of the precise conduction pathway through 3D tissue, an advantage when 
considering that pathways of activation remain impossible to define accurately in-vivo. 
If an assumption of constancy of activation path is made, then a 1-D model should be 
 
110 
useful in predicting boundary conditions for functional block along that path. Few 
practical solutions to the integration of directly recorded electrophysiology into 
computer simulations have been proposed. A robust method for building such 1-D 
models from patient-derived data presents an avenue whereby simulation may be used 
for clinical benefit e.g. risk stratification, diagnosis or quantitative assessment of 
electrophysiology substrate behaviour (e.g. advanced electrophysiological phenotyping). 
Action potential restitution has been extensively described, theoretically, experimentally 
and clinically. But few studies have approached APD restitution in the context of in-
vivo repolarisation time, and the cumulative effects of conduction delay and APD 
restitution on the whole human heart has not been approached. Descriptions of the 
effects of APD and conduction velocity restitution interactions on repolarisation times 
remain superficial, yet a firm grasp of such interactions is necessary for comprehensive 
understanding of arrhythmogenisis. 
Data acquired from human electrophysiological studies was integrated into one-
dimensional models, and this approach validated by testing whether responses to 
sequential premature stimuli could be predicted in a quantitatively accurate manner. 
This serves as a validation of the clinical relevance of activation-repolarisation 
interactions. This chapter then describes how such a technique can be used to predict 
functional block, and suggest a methodology by which the boundary conditions for at-a-
distance block can be derived. Finally, the experimental paradigm allowed examination 
and prediction of the behaviour of cardiac activation and repolarisation at sites close to 
a stimulus. This addresses issues raised from previous studies into modulation of 
dispersion of repolarisation in humans. 
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3.2 Results 
3.2.1 Patient Demographics 
11 patients were enrolled in the study, aged 29±10 years, 7 female. All patients had 
structurally normal hearts on echocardiography, and underwent EP studies for 
symptoms consistent with paroxysmal supraventricular tachycardia. Final diagnoses 
were atrioventricular re-entrant tachycardia (5 patients), paroxysmal atrial fibrillation 
(1). No arrhythmia was induced in 5 patients. Six of these patients underwent S3 studies 
and were included in the S3 validation.  
3.2.2 Activation time, ARI restitution and Repolarisation Curves 
The dynamics of how activation time, ARI, repolarisation time (RT) and diastolic 
interval (DI) varied with the coupling interval of the first extrastimulus were examined. 
This is illustrated in Figure 3-1. Note that these are represented against coupling interval 
to enable unbiased comparison between measures, rather than against diastolic interval 
(as is standard convention with ARI/APD restitution curves).  
As coupling interval decreases from steady state, ARI restitution is observed, and both 
ARI and repolarisation time shorten. But as coupling intervals shortened further towards 
ERP, the effects of conduction velocity restitution became apparent (as illustrated by 
increasing activation times). This prevents further decrease in local diastolic intervals, 
and hence ARI restitution is restricted. The local repolarisation time effectively 
represents the cumulative effect of ARI and conduction velocity restitution; together 
these produced a distinctive repolarisation time curve illustrated in Figure 3-1. 
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Figure 3-1 Interactions of Activation, ARI and DI leading to repolarisation dynamics 
The responses of diastolic interval (DI), activation time and ARI to shortening coupling interval are shown, with the 
overall repolarisation time dynamic shown in the top panel. 
As paced intervals decrease, diastolic intervals decrease initially in a linear fashion (bottom panel). The reduction in 
DI is associated with a non-linear reduction in ARI (restitution). As coupling intervals become very short, activation 
time increases due to the effect of conduction velocity restitution acting between the stimulus site and the recording 
electrode. 
Activation time increases prevent further reduction of local diastolic interval (bottom panel), which is seen to level 
off. ARI restitution is blunted at these short coupling intervals. Repolarisation time thus increases because of 
increasing activation times.   
Representative patient data from RV (Star– early activating site, cross- mid activating site, circle- late activating site, 
dotted lines represent smoothed dynamics). 
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3.2.3 Model fitting to S2 data 
One-dimensional models were fitted to clinically acquired S2 data in all 11 patients 
using the recursive method described in section 2.2.2. ARI restitution curves were 
accurately described by a simple exponential model (Coefficient of determination, r2 
=0.966 [95% Confidence Interval 0.963 – 0.968], p<0.0001). Activation time curves 
were similarly accurately reproduced following our derivations of conduction velocity 
restitution, (r2 = 0.993 [0.992 – 0.993], p<0.0001).  
3.2.4 Activation times following sequential premature stimuli 
To show that prediction of activation times following sequential extrastimuli was a 
reasonable standard by which to assess the accuracy of our model, we compared the 
activation dynamics following S2 and S3 stimuli. At similar coupling intervals, AT 
following a premature S3 was significantly shorter than after an S2 (AT normalized to 
steady state: 1.1 following S3 (95% confidence interval 1.1 – 1.2) vs. 1.6 following S2 
(1.5 – 1.7), p <0.0001). ERP of S3 was shorter than ERP of S2 (<186±8 vs. 222±25ms, 
p<0.0001). More activation delay existed after an S3 pre-ERP than after an S2 (39±28 vs. 
33±16ms, p =0.0003). Activation dynamics were thus significantly different following 
S2 and S3 stimuli, with the ERP of an S2 considerably shorter than that following the 
steady state beats. 
3.2.5 Validation of 1D models 
We tested whether the one-dimensional model, incorporating both ARI and CV 
restitution, could explain and predict the observed variation in activation dynamics 
following S2 and S3 stimuli. This serves as a quantitative validation of the 1D model 
incorporating CV and ARI restitution. Validation was performed using data from 6 
 
114 
patients who underwent S3 protocol. The coefficient of determination (predicted values 
vs. measured), R2, was 0.902 [95% Confidence Interval: 0.890 – 0.911] (p<0.0001, 
Figure 3-2). The high predictive accuracy possible with this method serves as a 
quantitative validation of this one-dimensional model of cardiac activation in human 
hearts.  
 
Figure 3-2 Correlation of observed and predicted activation times following a second extrastimulus  
The correlation of modeled S3 activation time with measured S3 activation is shown. Each patient is represented by 
individual symbols. r2 = 0.90. 
3.2.6 Simulating modulation of dispersion of repolarisation 
Simulations based on patient data enable examination of electrophysiology which 
otherwise remains impenetrable through traditional experimental methods. We 
examined how dispersion of repolarisation varied with shortening of S2 coupling 
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interval. True dispersion of repolarisation, the difference from the earliest repolarisation 
to the latest repolarisation, has both a spatial and temporal component. It is very hard to 
measure repolarisation time accurately very close to the stimulus site due to stimulus 
artefact. But the most significant repolarisation gradients will be close to the stimulus 
site following a close-coupled S2; the area immediately at the stimulus site is exposed to 
very little delay prior to activation, whereas further sites only a very short distance away 
experience significant activation delay. A patient-based simulation allows appreciation 
of these gradients (Figure 3-3). In the example shown the dispersion of repolarisation 
increased from 41ms to 70ms between mid to late activating sites, yet increased 
fourfold from 25 to 100ms between earlier activating sites. Thus the induction of 
repolarisation gradients by premature stimuli occurs very close to the stimulus site. 
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Figure 3-3 Increase in dispersion of repolarisation with decreasing coupling intervals 
Repolarisation times from 3 sites are shown against coupling intervals. The early activating site can be considered 
equivalent to the stimulus site, and is not measured clinically due to artifact. This early site is exposed to only 
minimal activation time increase at short coupling intervals, thus the repolarisation time is approximately equal to the 
ARI at this site. The mid and late activating sites do exhibit an increase in dispersion of repolarisation (broken 
arrows), but this is minor in comparison to the increase from the early to mid site (solid arrows). Thus, there is a 
marked spatial increase in the repolarisation gradient near the stimulus site following premature extrastimuli. 
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3.2.7 Validation of repolarisation time predictions against ionic 
cellular simulations 
Repolarisation times of S3 responses are difficult to measure experimentally, the 
induced conduction delay with close coupled beats leads to repolarisation of early-
activating sites occuring at a similar time to distant site activation. This makes 
interpretation of the small repolarisation currents almost impossible to reliably 
distinguish from the unipolar electrogram. Therefore, we validated whether our S3 
repolarisation predictions would be valid by comparing them to the dynamics of 
simulations of repolarisation produced using the Ten-Tusscher cardiac cell model. For 
S3 responses, there was close agreement between repolarisation times determined from 
our model and repolarisation times acquired using the ionic model (Figure 3-4, 
coefficient of determination, r2 = 0.997 [95% Confidence Interval 0.993 – 0.999], 
p<0.0001). This supports the validity of our model in comparison to full ionic cellular 
models undergoing sequential premature extrastimuli.  
 
Figure 3-4 Examples of ventricular action potentials from ten Tusscher model, used for validation 
of S3 APD restitution 
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Examples of action potentials used for validation of S3 APD prediction. APD = Action potential duration. 
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3.3 Discussion 
Using a combination of physiological measurement and simulation, this study 
demonstrates that the complex dynamic interactions between activation and 
repolarisation induced by sequential extrastimuli can approximated in terms of ARI 
(APD) and CV restitution. This serves as a strong validation of a personalized 
computational approach incorporating biologically acquired variables and it serves as an 
extension and validation in humans of previous animal work (Gilmour et al., 2007). Our 
technique provides a platform by which individual patient data may be incorporated into 
computerized simulations and serves as an example of a method by which the gap 
between fundamental cardiac simulation and clinical science can be bridged. 
This study is the first to quantitatively validate a one-dimensional model of cardiac 
conduction in man. Such patient-based models provide a method by which 
physiologically acquired data may be interrogated in a computerized simulation. We 
have shown that endocardial physiology can be adequately modelled by simple 
mathematical descriptors of CV and ARI restitution curves, and confirm the relevance 
of one-dimensional conduction models incorporating both these features to human 
cardiac electrophysiology. Our validation of a straightforward one-dimension model can 
allow further in-depth examination of human physiology in a manner that would not be 
possible experimentally, for both ethical and practical reasons. 
The presented modelling is founded on the work of Otani, Gilmour and Fox (Otani, 
2007; Fox et al., 2003; Gilmour et al., 2007; Gelzer et al., 2008; Gelzer et al., 2010). 
Seminal work by this group, along with the single fibre models of Cherry & Fenton 
(Cherry and Fenton, 2004; Cherry and Fenton, 2007), provided initial validation of the 
use of one-dimensional conduction simulation in biological systems. The ability of 
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such a model to predict whether large variations of long-short CIs would induce VF in 
normal and cardiomyopathic canines was a powerful demonstration of the physiological 
relevance of such simulations (Gelzer et al., 2008; Gelzer et al., 2010).  
We have enhanced these models by fully deriving CV restitution; allowing better 
approximation to the actual behaviour of the activation wavefront and observation of 
the heterogeneity introduced by sequential extrastimuli. This adds to our earlier 
description of the modulated dispersion of repolarisation in humans (Hanson et al., 
2009), and addresses questions rising from this work (Poelzing and Rosenbaum, 2009). 
CV restitution is often assumed to operate over the entire conduction path in a similar 
manner, obscuring the importance of the spatial differences in CV restitution. Our 
validation also sought a high fidelity correlation of activation times rather than a binary 
outcome. The large datasets acquired from the multiple recording electrodes used in 
each patient (rather than only one in the canine studies) enabled an accurate validation 
of this concept in humans. 
The degree of latency has been described as being important in determining the 
initiation of VT or VF due to programmed electrical stimulation in earlier clinical 
studies (Avitall et al., 1992), yet the mechanism of this has been unclear. Our 
explanation of CV restitution, and of a mechanism by which cumulative interactions can 
set up conduction heterogeneities is consistent with these previous descriptions. 
Knowledge of these timing dynamics may help determine susceptibility to arrhythmia 
in channelopathies (Nam et al., 2010; Lambiase et al., 2009) or a suspected 
cardiomyopathy. The demonstration that patient-specific modelling can predict 
initiation sites of clinical arrhythmia underlines the importance of ARI and CV 
interactions in human arrhythmogenisis. 
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Of interest is the variation between our predicted/modeled dynamics and those observed. 
Although we achieved a very good agreement, it was not perfect. Indeed the error 
between prediced and observed behaviour appeared to differ to some degree between 
individuals. This may be explained to a degree by the sequential nature of the data 
collection. The complex nature of the biological phenomenon that we are trying to 
observe is more likely to be important in producing the error. Several things could affect 
this, autonomic change being one of them. Furthermore, ion channel dynamics and cell 
activation dynamics will only be approximated by exponential mathematical functions: 
even when we show such apparently excellent agreement between these descriptions 
and the measured results. As such, this apparent limitation serves to highlight the 
importance of obtaining biological data experimentally; rather than only relying on 
simulation to predict experimental responses.  
3.3.1 Study Limitations 
We used clinically acquired data to observe and explain the complex interactions seen 
following sequential extrastimuli. These are considered central to the initiation of 
cardiac arrhythmia. We did not expect to, nor did we induce arrhythmia in any patient 
undergoing prospective evaluation, and the contribution of these mechanisms in clinical 
arrhythmogenisis was not fully examined. Prospective patient data was acquired from 
contact electrodes; simultaneous mapping from the entire endo- and epicardial surface is 
unfeasible in conscious patients. However, as a result of lack of 3D geometry, 
conduction path distances were derived from timing data and knowledge of electrode 
spacings. The demonstration that these techniques can effectively predict wavebreak 
and arrhythmia initiation requires confirmation in prospective studies. 
By design, our modelling and simulation was relatively simple and was limited to a 
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one-dimensional system. This did not allow examination of wavebreak, arrhythmia 
development or re-entry, & observations are limited to assumptions of homogenous 
properties. The APD and CV restitution models used in this paper are in the form of 
exponential equations, this assumed behaviour is based on the tendency of experimental 
data and on equations used in previous studies. Biological behaviour would be expected 
to deviate from these simple exponential models, which in turn will result in 
discrepancies between simulation and clinical measurement. The use of derivations 
allowing direct fitting of ionic models to clinical results, perhaps by using an iterative 
approach, will improve the fidelity of such patient-derived simulations. 
The success of our model at predicting local activation times following an S3 stimulus 
makes it tempting to assume that it will retain predictive accuracy for S4, S5 and so on. 
This is unlikely. Though the principles demonstrated remain valid, our model did not 
include myocardial memory effects, post-repolarisation refractoriness or anisotropy. 
These may have increasing importance with longer extrastimuli sequences, and ARI 
restitution dynamics may change significantly as a consequence of these (Shimizu et al., 
2000; Kobayashi et al., 1992). Despite a very high agreement in predicting S3 ARI 
restitution obtained from a complex ionic model, even these ionic models may still not 
fully reproduce these less studied phenomena. However, our model’s simplicity made it 
accessible to the incorporation of clinical data, and the robust prediction and 
demonstration of S3 wavefront dynamics (which do not require knowledge of S3 ARI 
restitution) remains impressive. 
3.3.2 Future studies 
This study provides important information to assist electrophysiological characterisation 
of myocardial diseases and phenotypes. Some of the techniques we describe may be 
 
123 
applicable to clinical practice e.g. determining an individual patient heart’s boundary 
conditions for functional block as a method for arrhythmic risk stratification. All data 
was acquired in patients with normal hearts under baseline conditions. Further studies 
should examine the modulation of changes in conduction/repolarisation interactions 
under conditions of autonomic stress or drug interactions. More complicated models, 
such as those based on ionic cellular models could be applied to the data, possibly using 
our method as an intermediary step to allow parameter fitting. This could produce more 
detailed and realistic simulations, extending the described parameters into 3 dimensions. 
Furthermore, new technologies such as non-invasive body surface mapping may allow 
acquisition of whole heart activation and repolarisation dynamic data.  
Specific future uses of the described method may have an early application in patients at 
risk of inherited ventricular arrhythmias, particularly Brugada syndrome or 
arrhythmogenic right ventricular cardiomyopathy (ARVC). Both of these conditions 
have well described changes in invasive electrophysiology, yet risk stratification is 
incomplete. Patient specific models could give valuable diagnostic information & help 
quantify the risk of arrhythmia in such patients. Pharmaceutical testing may also benefit 
from such analysis, as a method to determine arrhythmogenicity of subtle changes in 
electrophysiological responses after drug challenge. Furthermore, a bullish use of this 
method would be as an adjunct in early clinical assessments of new anti-arrhythmia 
agents, to lend support to an investigational compound’s antiarrhythmic properties, or 
otherwise.  
We have further studied a series of patients with restitution curves performed before and 
after Ajmaline challenge to induce sodium channel blockade. This data remains to be 
analysed, 12 lead ECG changes in sinus rhythm will also be related to underlying 
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electrographic and electrophysiological parameters. 
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3.4 Conclusions 
Conduction and repolarisation interactions in humans can be described in terms of 
restitution of CV and APD. Simulations based on clinically acquired data can be used to 
successfully predict complex activation patterns following sequential extrastimuli. Such 
modelling techniques may be useful as a method of incorporation of clinical data into 
predictive models 
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Chapter 4 RESULTS: Acute mental stress 
significantly alters activation and 
repolarisation dynamics towards a pro-
arrhythmic state 
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4.1 Introduction 
The ability of conscious mental activity to influence the risk of cardiac arrhythmia has 
been well recognized, and is illustrated by numerous striking observations illustrated 
previously (1.5 above). Controlled data have showed ICD shocks to be temporally 
associated with periods of mental stress (Lampert et al., 2009; Abisse et al., 2011). In a 
series of elegant studies, mental stress induced by standard psychometric tests increased 
T-wave alternans and arrhythmia threshold in series of ischemic heart disease patients 
with implantable cardioverter defibrillators (Lampert et al., 2007; Lampert et al., 2009). 
Furthermore, previous works have also documented increased arrhythmogenicity in 
animal models during mental stress (Krantz et al., 2001). These studies have confirmed 
a clear link between conscious activity and the risk of arrhythmia, but there are few data 
documenting the direct effects of such activity on cardiac ventricular electrophysiology.  
Taggart et al. demonstrated the shortening of the activation repolarisation index (ARI), 
a well-validated surrogate of action potential duration (APD) in human ventricles in 
response to isoprenaline (Taggart et al., 2003). A steepening of the ARI restitution was 
also observed, which may imply an increased susceptibility to arrhythmia. Human work 
into these effects has been very limited, though. It has been hypothesized that mental 
stress can contribute to arrhythmia by increasing heterogeneities of repolarisation and 
activation (or conduction velocity) throughout the heart. These effects may thus amplify 
pre-existing heterogeneity, for example due to ischemic heart disease or 
cardiomyopathy, and thus predispose to conduction block, conduction wavebreak and 
arrhythmogenisis. But currently no evidence exists for pro-arrhythmic changes in any 
directly measured cardiac electrophysiological parameter in conscious humans during 
mental stress.  
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We hypothesized that mental stress would induce pro-arrhythmic changes in cardiac 
electrophysiology by increasing heterogeneity of conduction and repolarisation in the 
heart. We tested this by performing electrophysiological studies on patients with 
apparently normal ventricles during rest and during a controlled mental stress.  
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4.2 Chapter Aims 
This chapter aims to demonstrate alterations in activation and repolarisation dynamics 
induced in a physiological manner i.e. with induced mental stress.  
The specific hypotheses to be addressed are: 
• Modulation of activation and repolarisation dynamics occurs as a result of 
changes in constitutive autonomic tone. 
• Such changes in activation and repolarisation dynamics may predispose to 
arrhythmia. 
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4.3 Results (Mental Stress) 
4.3.1 Patient population 
16 patients were enrolled (12 female, 4 male, median age 34 [range 22-64]). Four 
patients did not undergo full restitution stimulation protocols and results are presented 
from 12 patients (9 female, 3 male) who completed at least one mental stress protocol 
satisfactorily. 
Final diagnoses were: 
Atrioventricular nodal re-entrant tachycardia (7 patients) 
Atrioventricular re-entrant tachycardia (3 patients) 
No inducible arrhythmia (2 patients, i.e. Normal EP study) 
4.3.2 Efficacy of mental arithmetic on induction of mental 
stress 
All twelve patients reported low stress during the relaxation protocol (2.4±0.7, 1= no 
stress at all, 10 = most stressed possible) and raised stress during mental arithmetic 
(7.1±0.7, p < 0.01).  Objective measures of stress induction included an increase in the 
sino-atrial rate and an increase in blood pressure (Figure 4-1).  
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Figure 4-1 Induction of mental stress: non-invasive indicators 
Blood pressure and pulse rate (as inverse of RR interval) were measured between episodes of ventricular stimulation. 
Diastolic & systolic pressures and pulse rate rose with induction of mental stress. Data from maximal stress is shown.  
Red dots represent paired patient measurements of heart rate. Box plots represent blood pressure measurements.  
Serum catecholamine measurements were attempted, but two attempts at assays 
(performed in the clinical biochemistry laboratory at The Royal London hospital) were 
unsuccessful.  The primary (A) sample test failed due to a technical error in the mass 
spectroscopy process. A secondary (B) sample was subsequently attempted, but 
noradrenaline and adrenaline levels were below test sensitivity levels in the majority of 
samples.   
4.3.3 Mental stress reduces steady state conduction times 
Measurements were collected across all catheters. Activation times, measured as the 
time from pacing artefact to local activation, were reduced in the RV 6±5% (p <0.01) 
and by 2±7% and 2±5% in the LV and epicardium respectively (p= n.s.). Multi-level 
regression models were employed to investigate whether the apparent reductions in 
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activation time were due to increase in conduction velocity or reduced latency at the 
pacing site. Reductions in activation time with mental stress did not interact with the 
measured steady-state activation time (a surrogate measure of distance from stimulus 
site, Pearson’s coefficient r2 = 0.002 [95%Confidence Interval -0.02, 0.02, p>0.9]). This 
implies the reduction in activation times occurred close to the pacing site, rather than 
along the entire conduction course. 
4.3.4 Steady State ARI is reduced during mental stress 
In steady state, ARI’s were longer in the LV endocardium than in the epicardium (LV: 
237±32, Epicardium: 204±30ms, p<0.001) or RV endocardium (206±28ms, p <0.001). 
A weak correlation between ARI and activation time was observed in the epicardium 
and RV endocardium (coefficient of correlation r2: Epicardium: -0.06 [95% Confidence 
Interval -0.09, -0.04], p<0.001; RV: -0.14 [95% Confidence Interval -0.22, -0.06], 
p<0.01), but not in the LV (0.04 [95%Confidence Interval -0.03, 0.12], p=  n.s.). 
ARI was reduced during mental stress across all sites (p<0.001), with a greater 
reduction in the LV endocardium than in the Epicardium or RV (LV: -8.1 [95% 
Confidence Interval -10.2, -6.0] ms; Epicardium: -5.0 [-5.8, -4.2] ms, p<0.001; RV: -4.2 
[-6.3, -2.1] ms reduction in ARI, p<0.001, Figure 4-2 inset). The combined reduction in 
activation time and in ARI leads to shorter absolute repolarisation times (i.e. the time 
from stimulus to local repolarisation of tissue at the measurement site), (Reduction in 
repolarisation time, LV: -10.4 [-16.2, -4.6] ms; Epicardium: -6.8 [-9.0, -4.4] ms; RV: -
5.6 [-11, 0.14]; p<0.001 for comparisons with baseline). The greater reduction in 
repolarisation time seen within the LV reached statistical significance compared to the 
Epicardium or RV (p= 0.03).  
No difference in overall ARI dispersion was observed during mental stress (Rest: 70 
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[ 95% Confidence Interval 58-81] ms, Stress: 74 [57-91] ms, p= 0.31). However, mental 
stress reduced the absolute dispersion of repolarisation during steady state by 14ms 
[95%Confidence Interval 6,22ms], from a median dispersion of repolarisation at rest of 
140ms (p<0.001).  
4.3.5 Dynamic changes in AT and ARI during mental stress 
Mental stress reduced the effective refractory period (ERP) from 228±23 to 221±21ms 
(p<0.001), consistent with the reductions observed in ARI.  
As coupling intervals of S2 stimuli were reduced towards ERP, a marked increase in 
activation time occurred in both rest and stress. Despite dynamics being similar, the 
reduction in activation time observed with stress in steady state was maintained 
following close coupled premature extrastimuli (mean reduction in activation time at 
coupling intervals <50ms above ERP = 7.9 [95%Confidence Interval 7.1, 8.7] ms, 
p<0.001). The degree of reduction in activation time was weakly inversely correlated 
with the distance from stimulus site, as given by the activation time in steady state 
(slope = -0.15 [95% Confidence Interval -0.20, -0.11], p<0.001, pseudo-r2 = 0.15). 
4.3.6 Restitution of ARI 
 The reduction in ARI during mental stress was maintained throughout the restitution 
curve, as were the regional variations in ARI across the ventricle (Figure 4-2 & example 
data, Figure 4-3). Marked inter-chamber variability was observed in restitution slopes, 
with the epicardium exhibiting the shallowest restitution slope (slope [95% Confidence 
Interval] = 0.55 [0.46, 0.64]), and steeper restitution in the LV endocardium (1.0 [0.81, 
1.3], p<0.001) and RV (0.78 [0.56,1.00], p<0.001) all comparisons. Maximal restitution 
curve slopes (Smax) were not significantly greater during stress in the LV endocardium 
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or RV, but a slight increase in slope was observed in the epicardium (∂Smax = +0.07 
[95% Confidence Interval: 0.05, 0.10, p<0.01]).   
 
Figure 4-2 ARI and ARI restitution with mental stress 
The restitution response of ARI to decreasing diastolic intervals (DIs) is shown (left ventricle data). Combined data is 
shown using loess regression with shaded band indicating 95% confidence intervals. There is a significant reduction 
in ARI across all diastolic intervals (p<0.05, by mixed-effects regression). The maximal slope of restitution (Smax) 
did not appear steeper during mental stress than during baseline conditions. Inset: Changes in ARI from steady state 
values are shown. All data is normalised to the mean steady state value for each individual electrode site, thereby 
preserving measurement error. A decrease in ARI in steady state pacing occurred across all sites (asterisk indicates 
p<0.05).  
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Figure 4-3 Example ARI Restitution Data from Right Ventricle 
The restitution response of ARI to decreasing diastolic intervals (DIs) is shown (right ventricle data).  
Increases in activation time at short coupling intervals and ARI restitution have a 
cumulative effect on times of absolute repolarisation across the myocardium. This leads 
to a distinctive J-shape response in absolute repolarisation time to a reducing coupling 
interval (as previously observed, e.g. Figure 3-3). The heterogeneity in ARI restitution 
across the myocardium, coupled with those resulting from mental stress lead to changes 
in repolarisation gradients across the myocardium (Figure 4-5). These can be expressed 
in terms of dynamic modulation of dispersion of repolarisation.  
4.3.7 Mental stress significantly shortens repolarisation time 
across all coupling intervals 
Decreases in activation time (due to increases in conduction velocity) and shortening of 
ARI have a cumulative effect on times of repolarisation across the myocardium. The 
effects of mental stress thus result in a marked decrease in repolarisation time across the 
myocardium (Steady State: RV 222ms (Rest) vs. 217ms (Stress), LV 310ms (Rest) vs. 
305ms (Stress), Epicardium 302ms (Rest) vs. 294ms (Stress). P<0.001 all comparisons, 
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Figure 4-4).  As the coupling interval was shortened, relative changes in comparison to 
steady state persisted, with epicardial changes becoming more marked. The shortening 
of ARI is the major contributor to this reduction in repolarisation time, and the patterns 
of repolarisation time shortening reflected those of ARI.  
 
 
Figure 4-4 Repolarisation dynamics during restitution. 
This graph shows decreases in the mean±95% confidence interval repolarisation time in the RV endocardium (RV), 
LV endocardium (LV) and in the LV epicardium (LV epi). Lines represent LOESS regression. Confidence intervals 
are represented by shaded areas. To allow comparisons of dynamics from all patients across multiple sites, values are 
normalised to steady state values in each relevant chamber. Pacing interval is normalised to ERP during active 
relaxation. Repolarisation time is lower during mental stress throughout all chambers, with variations in dynamics of 
repolarisation across each chamber. 
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coupling intervals were examined. During steady state pacing, no significant change in 
dispersion of repolarisation was observed across all measured sites, or across the 
LV/Epicardium, as measured by either the total dispersion (i.e. time difference between 
earliest and latest repolarisation site) or the standard deviation of repolarisation times 
(an alternative measure of the dispersion of repolarisation times). However, a sharp 
increase in dispersion of repolarisation was observed during stress at coupling intervals 
approaching ERP, this was not apparent at baseline relaxation (Figure 4-5). Dispersion 
of repolarisation at coupling intervals pre-ERP increased to 126±11% of steady state 
(±SEM, p = 0.09) during stress, but did not increase during relaxation (87±6%). The 
increase in standard deviation of repolarisation times did reach statistical significance 
however (122±7% during stress vs. 87±6%, p = 0.03). 
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Figure 4-5 Dispersion of Repolarisation 
The dynamics of dispersion of repolarisation are shown, normalised to mean dispersion during steady state pacing in 
baseline conditions. Pacing interval is normalised to ms above ERP. There is a marked increase in the dispersion of 
repolarisation during stress as pacing intervals approach ERP during stress which is not present at rest. 
Representative example patient data is shown in the inset.  
4.3.9 Arrhythmias associated with mental stress 
One patient developed ventricular arrhythmia during mental stress (anger recall stage) 
following a single short-coupled S2. The triggering PVC has a near identical 
morphology to the paced beats suggesting it was arising close to the pacing site, 
however the onset of the local electrogram of this beat was later than the onset of the 
surface depolarisation, which would argue against catheter tip pressure as a triggering 
factor. Arrhythmia did not occur during the relaxation phase at any coupling interval. 
0.9
1.0
1.1
1.2
1.3
0 100 200 300
 Pacing Interval 
 (ms above ERP)
D
is
pe
rs
io
n 
of
 R
ep
ol
ar
is
at
io
n 
(n
or
m
al
is
ed
 to
 s
te
ad
ys
ta
te
 b
as
el
in
e)
Baseline
Stress
0.50
0.75
1.00
1.25
1.50
0 100 200 300
PI (normalised to ERP)
D
is
pe
rs
io
n 
 o
f r
ep
ol
ar
is
at
io
n Baseline
Stress
 
139 
No other sustained arrhythmia was observed. No arrhythmia was induced at similar 
coupling intervals at rest.  
 
 
Figure 4-6 Arrhythmia induced during mental stress protocol 
An anger recall protocol was being performed, the patient recounting recent disagreements with a work supervisor. 
Ventricular catheters were placed from the right groin; a small movement of the left leg immediately prior to the S2 
delivery was responsible for the electrical baseline variation. 
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4.4 Discussion 
4.4.1 Principal Findings 
In this chapter, alterations in activation and repolarisation in response to induction of 
mental stress have been demonstrated. Specifically, key findings are: 
• Activation times are shortened in response to mental stress, implying increases 
in tissue excitability or conduction velocity. 
• A reduction in ARI occurs in response to mental stress. 
This reduction in ARI has a spatial component.  It is not uniform across all chambers 
and predominantly shortens within the LV. 
• Repolarisation gradients are dramatically increased following close-coupled 
extrastimuli during mental stress, but not during rest. 
• The steepness of ARI restitution did not change during mental stress. 
4.4.2 Discussion of findings  
These findings show that alteration of mental state in humans is sufficient to induce 
changes in tissue level cardiac electrophysiology, and specifically shortening of the 
cardiac action potential occurs during mental stress, but that the degree of this 
shortening depends on the location within the heart.  A small but statistically significant 
reduction in activation time indicates that conduction velocity is increased and/or tissue 
excitability is increased in response to mental stress. Furthermore, these changes have a 
cumulative effect.  
An important and novel finding is that dispersion of repolarisation was markedly 
increased at short coupling intervals during stress, yet this increase was not seen at 
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baseline conditions. ERP was reduced during stress, so that the shortest coupling 
interval possible was shorter during stress than at rest. The short coupling intervals 
allow access to the right side of the steep conduction velocity restitution curve, thus 
there is more delay in activation times in stress than in rest. Together with heterogeneity 
in ARI changes across the heart, this acts to increase the dispersion of repolarisation at 
short coupling intervals. The decrease in ERP during stress indicates that tissue 
refractoriness is decreased under stress conditions. This may also impact upon 
excitability. 
This mechanism of increased dispersion of repolarisation secondary to the activation 
and repolarisation changes induced by autonomic effects provides a plausible 
explanation for the arrhythmogenic consequences of mental stress. An increased spatial 
dispersion of repolarisation has previously been shown to be arrhythmogenic in animal 
and computer models (Antzelevitch, 2008; Gilmour et al, 2007). Pre-existing 
heterogeneities in repolarisation and conduction (e.g. in the peri-scar region around an 
old infarct) would be likely to be amplified by autonomic change, and repolarisation 
gradients thus increased. This mechanism may also play a role in the timing of 
arrhythmias in inherited arrhythmic syndromes; many of which have well-described 
autonomic features of arrhythmia predisposition e.g. Increased sympathetic stimulation 
in LQT type 1 (Akar et al, 2001). The effects of mental stress described here could be 
sufficient to allow a spontaneous ventricular ectopic beat to initiate wavebreak, re-entry 
and clinical arrhythmia at a time of very heightened sympathetic drive, whilst appearing 
benign in resting conditions. This is nicely illustrated here where a single VE with a 
coupling interval of 225ms triggered VF but the same paced coupling interval with 
beats triggered from the same site during rest conditions was not arrhythmogenic. 
We did not observe a marked increase in the maximal slope of ARI restitution during 
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mental stress. This is in contrast to the work of Taggart et al, who noted a significant 
increase in restitution slope during isoprenaline administration in humans (Taggart et al., 
2003). Notably, a similar experimental paradigm to this earlier work was used, 
including the use of ARI as a surrogate for action potential duration and similar baseline 
pacing intervals. Thus this appears to be a genuine finding, which may be accounted for 
by the induction of a more subtle increase in intrinsic sympathetic activity through 
mental stress versus the use of incremental isoprenaline and adrenaline infusions. In 
these circumstances β-receptor activation is likely to be super-physiological. The 
physiological induction of sympathetic activity was in the context of preserved 
parasympathetic activity, thus this work illustrates intrinsic dynamics of repolarisation 
whilst autonomic regulation is preserved.  
Further work on this dataset will concentrate on determining changes in dispersions of 
activation and repolarisation, in transmural and apical-basal axes as well as across the 
entire heart. Sinus rhythm ECGs will be compared during rest and mental stress, aiming 
to relate underlying electrophysiological parameters to the surface ECG changes. 
4.4.3 Strengths and Limitations  
This study is the first to directly assess human cardiac electrophysiology during mental 
stress induction. Subjects acted as their own controls, and the use of computer-aided 
analytic tools allowed large quantities of data to be processed and analysed. Relatively 
subtle phenomena could thus be confidently observed. Several limitations of this work 
exist. 
Though subjects had structurally normal hearts, these studies were performed on 
patients just prior to treatment for supraventricular tachycardia. Despite a clinical 
understanding that these patients have “normal hearts”, it may be that they have an 
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altered electrophysiological autonomic response. It would be very difficult to ethically 
perform a similar study on subjects who were not undergoing a medically indicated 
cardiac catheterisation procedure. 
The invasive procedure used to measure cardiac electrophysiology is liable to cause 
anxiety in itself, however anxiolytic agents would of course be liable to affect the 
results of the study and make stress induction difficult or impossible. Though the active 
relaxation protocol was chosen specifically to address this, it is likely a background 
anxiety remained. 
The serum catecholamine assay failure was disappointing. However, the observed 
increase in sinus rate and increase in blood pressure, as well as the subjectively reported 
increase in stress during mental stress versus active relaxation allows us to be confident 
that a level of autonomic response to our psychometric stimulation protocols occurred. 
We did not expect to arrhythmia to occur as a result of our protocol during the study, 
though the observation of an episode of (non-sustained) polymorphic ventricular 
tachycardia in one patient during the stress protocol lends credence to the assertion that 
mental stress can be pro-arrhythmic, but can only be viewed as being circumstantial 
evidence in this case as its reproducibility could not be assessed.  
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Chapter 5 RESULTS: Arrhythmogenic Right 
Ventricular Cardiomyopathy manifests as 
abnormal activation – repolarisation prior 
to overt disease 
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5.1 Introduction 
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle 
disorder characterised by a high incidence of ventricular arrhythmias. Early in the 
disease’s course, before the classic histological features of right ventricular myocyte 
loss & fibrofatty replacement become manifest, there is a sub-clinical “concealed phase” 
(Cox et al., 2011; Thiene et al., 1988b). This presents a major diagnostic and clinical 
management challenge because arrhythmias and sudden death may arise in the absence 
of significant clinical and pathological changes. The recent identification of specific 
desmosomal protein mutations in up to 40% of ARVC patients provides an opportunity 
to study the pathophysiology of ARVC (Delmar and McKenna, 2010), specifically 
whether delayed conduction and a pro-arrhythmic substrate occur in the absence of 
significant fibrosis.  
Abnormal desmosomal proteins are known to be associated with reductions in Cx43 
(Cx43) expression at the gap junction, this may adversely affect cardiomyocyte 
electrical coupling. However, there appears to be considerable conduction reserve in 
ventricular myocardium such that Cx43 reductions of up to 95% reduce transverse 
conduction velocity (CV) by only 15% and longitudinal conduction by 58% (van Rijen 
et al., 2004). This has prompted a search for other factors implicated in maintaining 
conduction reserve, loss of which may exert deleterious pro-arrhythmic effects. It has 
been posited that desmosomal proteins also directly interact with ion channels at the 
intercalated disc (Sato et al., 2009; Delmar and McKenna, 2010). Plakophilin-2 (PKP2) 
and the sodium (Na) channel, Nav1.5, not only interact but reduced PKP2 expression 
leads to reduced Na+ current peak density and altered channel kinetics as well as 
significant reductions in CV in cultured rat neonatal cardiomyocytes suggesting that ion 
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channel function is disrupted in some forms of ARVC. Recently, our group 
demonstrated a murine model with conditional genetic deletion of one allele of 
desmoplakin (DSP) in the adult heart (DSP +/-) shows reduced conduction velocities 
and increased arrhythmias compared to wild-type (Gomes et al., 2012). This murine 
model was employed because it results in a clinical phenotype more equivalent to the 
clinical disease as opposed to transgenic mutant desmoplakin overexpression model 
which results in a more severe phenotype than that usually seen in patients. Both young 
(2 month old) and older mice (6 month old) were studied to investigate whether 
electrophysiological changes occur before overt structural anomalies. 
We added to this earlier study by Dr John Gomes, UCL, by comparing the cardiac 
electrophysiology of patients with known desmosomal mutations (DSP group) but 
without overt structural disease. We hypothesised that conduction and repolarisation  
abnormalities may be present despite apparent early disease.  
These early manifestations of ARVC pose a significant diagnostic challenge, especially 
in differentiating benign outflow tract ventricular ectopy from ARVC.  This holds 
significant prognostic implications as sudden death may occur in the concealed phase 
before structural changes appear (Cox et al., 2011; Thiene et al., 1988b).  Although 12 
lead ECG anomalies may precede structural changes, these can be transient or non-
specific (Quarta et al., 2010). This problem of recognising early ARVC is reflected in 
recent changes to the consensus diagnostic criteria, which highlight the increasing 
importance of familial disease and genetic marker (Marcus et al., 2010). Early 
recognition of disease has potentially important management implications; including 
avoidance of exercise training, ICD prophylaxis and targeted family screening.   
Studies have demonstrated that patients with ARVC exhibit slow conduction within the 
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right ventricle and low endocardial bipolar voltages, indicative of endocardial scar 
(Tandri et al., 2009; Corrado et al., 2008). However, these studies all investigated 
patients with established clinical disease and structural abnormalities & do not represent 
the more typical diagnostic dilemma of identifying the concealed phase.  
We extended our studies on the dynamic conduction and repolarisation differences 
between desmoplakin mutation carriers and control (Gomes et al., 2012), to compare the 
dynamic electrophysiological changes in early ARVC versus patients with outflow tract 
ectopy (RVOTE). In this study we specifically investigated a population including 
patients who qualify as “definite ARVC” in the modified Task Force Criteria because of 
a definite family history/mutation carrier status. We thus identified patients with early, 
concealed non-structural disease. 
We hypothesised that patients with early ARVC would exhibit slowing of conduction & 
repolarisation changes compared to RVOTE patients under conditions of electrical 
stress, even prior to detectable structural disease being present on conventional imaging. 
Further, we hypothesized these myocardial electrophysiological changes would 
manifest on the surface ECG to facilitate the development of a straightforward 
diagnostic test.  
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5.2 Comparison of DSP+ patients to controls 
5.2.1 Patient demographics and structural abnormalities 
The demographics and clinical features of the DSP study subjects are shown in Table 2; 
mean age was 44(±15) years. These patients had been identified in families with 
desmoplakin mutations and a diagnosis of ARVC based upon the most recent Task 
Force criteria (see Table 8-1).  
Su
bje
ct 
No
 
Ag
e 
(M
/F)
 Mutation 
RV
 
Ab
no
rm
ali
ty 
T 
wa
ve
 
inv
ers
ion
 
 
Sm
all
 Q
RS
 
S w
av
e 
De
lay
 
SA
EC
G 
NS
VT
 
SV
T 
PV
Cs
 
>5
00
/24
h Inducible 
VT at EP 
study 
FHx  ICD Criteria 
Maj/Min 
1 43 F E274f 
X288 
- - + - - + + + - - + 1/1 
2 50 F S507F - - + - - + - + - Major + 1/1 
3 61 F T586fsx5
94 
- + - - - - - - - Minor + 1/0 
4 28 F T586fsx5
94 
- - - - - + - - - Major + 1/1 
5 72 F S507F LVEF 
35% 
- - + + - - + - Major + 1/2 
6 53 F T586fsx5
94 
- + - - + - - - - - + 2/1 
7 37 M E274fsX2
88 
- - - - + + - - - + - 1/2 
8 22 M S922fsX9
28 
- - - - + + - - + - + 1/2 
9 40 F N408K 
and 
R941X 
- - - + + + - - - Major - 1/2 
10 33 M T586fsx5
94 
- - - - - + - + - Major - 1/1 
Table 5-1 Patients studied with Desmoplakin mutations 
The patients had well preserved left ventricular function except one subject (no 5) who had an ejection fraction of 
35%. No other patients had significant RV or LV wall motion abnormalities meeting Task Force Criteria for ARVC. 
The 12 control subjects with SVT and structurally normal hearts had an equivalent mean age of 44 (±21) years and 
sex distribution (3M:9F). (SAECG: signal averaged ECG, SVT: sustained VT, PVC: premature ventricular 
contraction, VT: ventricular tachycardia, EP study: electrophysiological study, FHx: family history, ICD: implantable 
cardioverter defibrillator) 
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5.2.2 DSP+ patients have slowed depolarization of the RV 
 
Figure 5-1 Isochronal maps during RV apical pacing 
Normal heart is illustrated on left, Desmoplakin on right. 
Figure 5-1 illustrates the isochronal maps recorded during RV apical pacing at 400ms 
obtained from a control and DSP mutation carrier (DSP+) respectively. There are clear 
differences in depolarization time in the RV between the 2 patients. Overall activation 
of the RV took almost 2 times longer to propagate across the chamber compared to the 
control in this example.  The isochrones are homogeneously separated in most of the 
DSP+ RV. However, in the group data mean endocardial activation time in patients 
with DSP disease was not significantly different from controls either in sinus rhythm 
(41±8 vs. 40±5 ms in controls) or with steady state RV apical pacing at 400ms cycle 
length (42±13 vs. 42±8ms). Conduction velocities were assessed, the mean slowest 
conduction velocity was reduced in the desmoplakin mutation carriers (Figure 5-2), and 
r2, a measure of heterogeneity of conduction was also reduced compared to normal 
Normal 
DSP + 
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controls. 
  
Figure 5-2 DSP mutation carriers have decreased conduction velocities 
DSP carriers have a significantly reduced conduction velocity in sinus rhythm compared to normal controls. R2, a 
measure of homogeneity of conduction, was reduced in desmoplakin patients compared to controls. (Courtesy Dr E. 
Ciaccio) 
5.2.3 DSP+ patients have increased conduction delay induced 
by premature stimuli 
 
Figure 5-3 Induced conduction delay in DSP+ patients is increased compared to normal patients 
The figure shows regression curves created with multilevel non-linear regression using SPSS 11.  This demonstrates 
how the time from stimulation to local tissue activation varies with coupling interval of S1S2 stimulus (PI - pacing 
interval). The blue line shown the increase in control patients, the red in patients carrying a mutation in DSP. As 
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S1S2 stimulus interval decreases, an increase in activation delay is seen. This increase is greater in DSP+ patients 
than in normal controls. The curves are significantly different (p<0.05 by multilevel non-linear regression).  
 
 
Figure 5-4 Mean increase in delay is increased in DSP+ hearts 
Overall DSP+ patients’ hearts had significantly more prolonged AT restitution curve 
profiles versus controls at coupling intervals <250mss (P<0.001) (Figure 5-3)). These 
delays were also significantly different in each of the 3 RV regions-RVOT, body and 
apex between the DSP mutation carriers and controls (P<0.001 per region). Furthermore, 
statistically significant regional conduction delays (increased mean increase in delay, 
MID) occurred in the RVOT measuring 38% greater than controls (Figure 5-4).  
5.2.4 DSP hearts have more fractionation than controls 
Electrograms were analysed using our fractionation algorithm. DSP+ hearts had a 
significantly greater degree of fractionation versus controls and this fractionation was 
most marked in the RVOT (Figure 5-5). Figure 5-6 demonstrates this regionality of 
fractionation in subject 8, with examples of EGM morphology in RVOT & apical sites.  
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Figure 5-5 DSP+ patients have increased fractionation at the RV apex and RV outflow tract 
 
 
Figure 5-6 Example colourmap of fractionation distribution from two patients 
On the left is shown data from a DSP+ patient, on the right a normal control. Example electrograms are illustrated. 
There is increased fractionation in the DSP+ patient in a patchy distribution. 
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5.2.5 DSP+ hearts exhibit increased heterogeneity in ARI 
The mean ARI of all the segmental restitution curves at 400mec baseline cycle length in 
the DSP+RV and control RV during RV apical pacing were compared. Analysis of all 
the curves by model fitting and testing for interaction confirmed significant differences 
in the ARI at RVOT, RV body versus apex in DSP+ patients at both long and short 
coupling intervals which did not occur in controls. In control subjects the ARI curves 
showed a significant ARI prolongation only in the RVOT as compared to the apex over 
a large range of coupling intervals (p<0.001) but the mean RV body ARI curves were 
similar to the apex.  However in the DSP+ patients, the RV body & RVOT both had 
significantly greater ARI prolongation than the apex (P<0.001). 
Not only were there differences between regions in the DSP+ group data, differences in 
the ARI restitution curves could be identified between equivalent RV regions in the 
patient populations. The ARI curves in control subjects show a profile in which they 
maximise and then curve downwards with increasing coupling intervals.  This profile 
was similar at the RVOT, body and the apex. In the DSP+ group, the ARI curves had a 
significantly different profile.  The curves at the apex, RV body and RVOT showed a 
more linear profile in this range of coupling intervals. The ARI values for any given 
coupling interval were longer in the RV body and RVOT for DSP+ patients versus the 
same regions in controls (P<0.001).  This indicates that there is a large interval 
dependent dispersion of ARI in the DSP+ patients. The maximal slopes of ARI 
restitution curves were compared between control and DSP+ subjects. The odds of a 
segment having a maximal restitution slope, Smax, of 1 or more in the whole heart was 
significantly higher in the DSP+ group. The odds of having a segment with a Smax >1 
was 99% higher (95% Confidence Interval: 13%-351%, p=0.017). Although this 
measure has been associated with an implication of increased likelyhood of disordered 
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arrhythmogenisis, this association has not been proven in clinical investigations.   
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5.3 Comparison of ARVC patients with RVOT ectopy patients 
Following the successful comparison of patients with desmosomal disease only, this 
study was expanded to include a wider group of patients with ARVC but no overt 
structural disease. Comparisons were made to patients with benign right ventricular 
outflow tract ectopy as well as a group of normal controls.  
5.3.1 Patient demographics 
22 patients with definite (12 patients) or probable (10 patients) ARVC were studied 
(mean age 46±11 years) (Marcus et al., 2010). The patients had no major structural 
features of ARVC with only 2 demonstrating minor modified Task Force imaging 
criteria. The signal averaged ECG was positive in 13 cases (8 mutation positive) (Syrris 
et al., 2006b; van der Zwaag et al., 2009; Sen-Chowdhry et al., 2007; Norman et al., 
2005; Elliott et al., 2010; den Haan et al., 2009; Gerull et al., 2004). 10 desmoplakin 
mutation carriers have been described elsewhere, different aspects of their 
electrophysiological data are presented her (Gomes et al., 2012). Importantly the 12 
definite ARVC patients met the criterion because of their mutation carrier/family 
history status and therefore represent a group of patients with very early disease 
preceding the development of diagnostic structural abnormalities. Detailed demographic 
details are given in Table 5-2. 
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17 47 F DSG2 V158G  - - - - + - -     Maj - 1 1 
18 36 M DSG2 - V392I  - - - - + - - -   Maj - 1 1 
19 45 F NIL - - - - +      Maj  1 1 
20 55 M NIL - - - - + - - -   Maj - 1 1 
21 54 F Nil - + - - - - - +   - - 1 1 
22 57 F Nil - - - - NA + - +   - - 0 2 
Table 5-2 Demographics of Definite and probable ARVC patients. 
Abbreviations: Age (M/F): Male/ Female, RV: Right Ventricle, TW: T-wave, SAECG:  signal averaged ECG, 
NSVT: non-sustained ventricular tachycardia, SVT: sustained ventricular tachycardia, PVCs: premature ventricular 
contractions, VT: ventricular tachycardia, FHx: family history of ARVC in 1st degree relatives, ICD: implantable 
cardioverter defibrillator, Maj: Major, Min: Minor. 
25 consecutive patients with monomorphic ventricular ectopy (9652±8444 beats/24h), 
structural normal hearts and normal resting ECGs underwent non-contact mapping and 
EP studies. 14 of these patients had >18m follow-up with no recurrence of ventricular 
ectopy off antiarrhythmic medication, and no features suggestive of ARVC. These 
patients were analysed as the RVOTE group (age 45±14 years). Twelve further patients 
undergoing EP studies ± ablation for SVT with structurally normal hearts acted as 
Normal controls (age 43±18 years). 
5.3.2 Sinus rhythm measurements were similar between 
groups 
No significant differences in RV activation times, ARI or repolarisation time were 
observed between groups in sinus rhythm (Table 5-3).  
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Groups Normal RVOTE Definite ARVC 
Probable 
ARVC 
 n = 12 n = 14 n = 12 n = 10 
Baseline HR 81±17 92±18 85±9 94±11 
ERP 212±23 210±13 205±16 214±18 
Sinus Activation Time (ms) 71±19 76±25 81±19 80±19 
Sinus Repolarisation Time 
(ms) 302±44 311±49 320±40 317±42* 
Sinus ARI (ms) 230±49 235±44 239±38 237±38 
Steady State AT (ms) 79±29† 58±24* 75±22† 79±28† 
Steady State ARI (ms) 194±25 201±20 203±23 204±19 
Steady State RT (ms) 273±46 260±32 278±35 282±39† 
Mean AT pre ERP (ms) 104±33 92±29 123±30†† 117±35† 
Mean ARI pre ERP (ms) 161±26 166±26 170±28 167±26 
Mean RT pre ERP (ms) 265±51 258±44 293±50† 284±52 
Change in AT pre ERP (ms) 26±16 34±14 48±21***† 38±21* 
Change in RT pre ERP (ms) -7±22 -2±22 15±29*† 1±29 
Maximum ARI Restitution 
Slope (ms) 0.68±0.41 0.83±0.41 0.77±0.4 0.87±0.48 
Fractionation at ERP 2.4±0.5 3.4±1.1 3±1*† 3.1±1.1 
Fractionation in Steady State 2.5±0.6 3.4±0.9 3.1±1.1* 3.3±1* 
Fractionation in Sinus 
Rhythm 3±1.4 3.44±1.66 2.84±1.31† 2.91±1.1† 
Mean Increase In Delay 3.7±10.3 4.1±5.6 6.5±5.6*† 7.4±15.4 
Table 5-3 Detailed Surface ECG measurements 
Note: Activation and Repolarisation times are given as means±SD for all measurements throughout ventricle. HR: 
Heart Rate, ERP: effective refractory period, ARI: Activation Recovery Index, AT: Activation Time, RT: 
Repolarisation Time, Significance codes: * p<0.05 vs. Normal, ** p<0.01 vs. Normal, ***p<0.0001 vs. Normal, † 
p<0.05 vs. RVOTE, †† p<0.01 vs. RVOTE  
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5.3.3 ARVC patients have increased uniformity of conduction in 
sinus rhythm, but no significant reduction in activation 
gradient 
Differences in slowest measured activation gradient (a measure of slowest endocardial 
conduction in sinus rhythm) between groups did not reach statistical significance, 
although activation gradients in ARVC and RVOTE groups were 20% lower than 
controls) (see supplemental results). r2, a measure of uniformity of conduction, was 
higher in both ARVC groups and in normal controls than in the RVOTE patients 
(definite ARVC: 0.94±0.07, probable ARVC 0.94±0.05, RVOTE 0.85±0.12, Normal: 
0.94±0.07, p<0.05 vs. RVOTE). There were no differences between either of the ARVC 
or normal control groups. 
5.3.4 Activation and repolarisation increases in ARVC during 
steady state pacing are subtle 
In steady state pacing, RV activation took significantly longer in probable ARVC 
patients than in RVOTE subjects (98±22ms vs. 77±22ms, p= 0.01), this did not reach 
statistical significance in the definite ARVC group (91±21ms) or normal controls 
(94±28ms). There was a trend to longer repolarisation times in the ARVC groups when 
compared to the RVOTE group (definite ARVC: 308±19 p= 0.07, probable ARVC: 
307±16ms p= 0.05, RVOTE: 299±32ms), but no group was significantly different from 
normal (303±42ms).   
5.3.5 Premature stimuli accentuates abnormal conduction 
slowing in ARVC 
VERPs were similar across groups. AT’s increased to a greater degree in the definite 
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ARVC patients (48±21ms) than in other groups (probable ARVC 37±21, RVOTE 
34±14, Normal 26±16, p<0.001, Figure 3a). The absolute AT pre-VERP was also 
longer in definite ARVC patients than in RVOTE patients (definite ARVC: 123±30ms, 
116±35ms, RVOTE 92±28ms, p<0.001, Figure 5-7 Slow conduction induced with 
premature extrastimuli). There was a trend towards longer absolute ATs in ARVC at 
VERP when compared to Normal controls (104±33ms, p= 0.1).  
The activation delay curves were plotted against coupling intervals for each electrode in 
every patient. Mean increase in delay, a measure of cumulative conduction delay over 
all coupling intervals, were greater in the ARVC patients (definite ARVC: Median 7.0 
[Interquartile range 3.6 – 9.3] vs. 3.1 [0–5.1] ms2, probable ARVC: 6.3 [3.3 – 9.5]) than 
in RVOTE patients (4.3 [1.4-7.1] ms2, p < 0.01) or Normal controls (3.4 [0 – 5.2] ms2, 
p<0.001). 
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Figure 5-7 Slow conduction induced with premature extrastimuli 
A. Example 3D colourmaps showing activation times in steady state and at ERP. The change in activation delay in 
ARVC patients is greater than in Normal Controls & RVOTE patients. Color scale represents local activation time 
relative to pacing stimulus. B. Notched box plot of change in activation times from steady state to ERP. Values are 
normalized to steady state. Notches indicate approx. 95% confidence intervals.  
 
5.3.6 Local Repolarisation Time (RT) is longer in ARVC, and 
displays different dynamics 
Local RT’s were plotted against coupling interval (Figure 5-8). Normalising to VERP 
allowed effective comparison of the AT and RT dynamics at both short and long 
coupling intervals. The change in RT at VERP compared to steady state was +15±30ms 
in the definite ARVC group, whereas it was shorter in other groups (probable ARVC 
+1±19ms, RVOTE -2±23ms p= 0.01, Normal -7±22ms p<0.01).  
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Figure 5-8 Changes in repolarisation time with premature stimuli 
Panel A: Repolarisation dynamics are distinct between definite ARVC and RVOTE at almost all coupling intervals 
and at all locations. There is a marked increase in repolarisation time at short coupling intervals in definite ARVC 
compared to RVOTE patients and Normal. Transparent color indicates 95% confidence intervals. Coupling intervals 
are normalised so that 0ms = ERP. 
Panel B shows change in repolarisation time at ERP compared to steady state. There is greater increase in 
repolarisation times in the outflow tract compared to the apex evident across all groups. This increase is significantly 
greater in the definite ARVC group. 
 
5.3.7 ARI restitution slopes were similar between groups 
The maximum slopes of ARI restitution curves, Smax, were marginally steeper in the 
probable ARVC and RVOT groups compared to normal, but there was no statistically 
significant difference between the definite ARVC group and any other group (definite 
ARVC: 0.77±0.40, probable ARVC: 0.87±0.48, RVOTE: 0.83±41, Normal: 0.68±0.41; 
p<0.05). Shallower Smax were seen in the outflow tract than in the body or apex in all 
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groups (Outflow tract: 0.71±48, body: 0.83±0.44,apex: 0.84±0.41, p<0.001).  
There were no significant differences in the odds ratio of having Smax>1 in any segment 
between patient groups. 
5.3.8 RVOT ectopy patients exhibit increased fractionation 
 In sinus rhythm, more fractionation was observed in RVOTE patients than in definite 
or probable ARVC or normal controls (Figure 5-9 Global Fractionation). However, 
during pacing at steady state, RVOTE and both ARVC groups had more fractionation 
than normal controls. At coupling intervals approaching VERP, the RVOTE group & 
probable ARVC groups appeared more fractionated than the definite ARVC group 
(p<0.05), which in turn remained more fractionated than controls (p<0.001).  
 
Figure 5-9 Global Fractionation 
Panel A shows a notched boxplot of global mean fractionation index. Fractionation is significantly increased in OTE 
and ARVC patients compared to normal. Panel B shows example electrograms (light grey) and their mathematical 
differentials, from which fractionation index (FI) was calculated. Panel C shows three example colourmaps of 
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distribution of fractionation. Higher levels of fractionation are seen in both OTE and ARVC. 
5.3.9 Logistic Regression models can help to distinguish ARVC 
from RVOT ectopy intracardiac measurements 
Single intracardiac predictors were generally poor at differentiating definite ARVC 
from RVOTE, but an increase in the local activation time of >47ms at ERP compared to 
in steady state pacing gave a sensitivity of 70% and a specificity of 74% in predicting 
definite ARVC over RVOTE. A mixed-effects logistic regression model was used to 
combine predictive variables. The best performing model combined (i) degree of AT 
prolongation in steady state & pre-VERP (ii) repolarisation time in sinus rhythm and 
(iii) degree of fractionation in sinus rhythm & at short coupling intervals pre-VERP. 
This model had an area under curve of 0.85 (p<0.001) and had peak sensitivity and 
specificity discriminators of 83% and 72% respectively.  
 
Figure 5-10 Logistic Model of Definite ARVC vs. RVOTE 
A comparison of the ability of individual intracardiac measures to distinguish definite ARVC from benign RVOTE. 
Individual factor receiver-operating characteristic curves are shown in colours. The optimum mixed effects logistic 
model is demonstrated by the solid black line. Detailed parameters of this model are given below. The grey dot-dash 
line shows equality. 
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 Estimate Std. Error 
z p 
Random 
Effects 
    
Location 0.26±0.51    
Fixed Effects     
(Intercept) 3.57 0.78 4.57 <0.0001 
Change in AT pre-VERP -0.03 0.01 -5.83 <0.0001 
Fractionation in Sinus 
Rhythm 
0.37 0.06 6.11 <0.0001 
Fractionation at VERP 0.40 0.08 4.76 <0.0001 
Repolarisation time (Sinus 
Rhythm) 
-0.01 0.00 -3.12 <0.001 
Steady State AT -0.05 0.00 -10.1 <0.0001 
Table 5-4 Coefficients of the logistic regression model for intracardiac predictors of ARVC 
5.3.10 The Paced Surface ECG can be used as a surrogate for 
intracardiac electrophysiology 
Although the optimum logistic model constructed from intracardiac signals has a 
reasonable diagnostic potential, the intracardiac non-contact mapping protocol and 
analysis is too complex to recommend as a practical clinical test. Therefore, corollaries 
to features identified by endocardial mapping on the surface ECGs of the study patients 
were examined. 
Absolute surface ECG measurements of activation and repolarisation did not distinguish 
between RVOTE and ARVC groups at baseline and pre-ERP (Table 5-5), furthermore 
absolute measurements of surface ECG inscriptions might be very sensitive to the 
patient-specific placement of the pacing electrode. We thus concentrated our recursive 
partioning analysis on measurements of hysteresis, lead by our observations of 
important changes in intracardiac activation/repolarisation. A greater increase in 
activation time at ERP compared to steady-state was observed in the definite ARVC 
group than in the other groups, measured as an increase in time from pacing artefact to 
QRS onset (latency), pacing artefact to nadir of S wave and pacing artefact to end of 
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QRS complex (J-point), (Figure 5-11). The paced QT interval was increased at ERP (c.f. 
steady state) in definite ARVC patients. No significant change was observed in other 
groups.  
 
  Definite ARVC Probable ARVC Normal RVOTE 
  
(mean ± SD, ms) (mean ± SD, ms) (mean ± SD, ms) (mean ± SD, ms) 
Steady State 
Latency 34±9 39±11 37±10 42±13 
Stim. To QRS peak 81±19 95±15 85±13 90±11 
Stim. To J-point 142±32 159±9 147±18 149±22 
Stim. To Tpeak 269±24 268±40 269±21 270±24 
Stim. To Tend 347±20 361±17 351±28 342±26 
QRS duration 107±28 120±12 110±15 107±22 
Tpeak to Tend 78±13 94±37* 82±14 72±10 
QT interval 313±19 322±24 314±25 300±29 
Pre-ERP 
Latency 66±15 66±11 62±14 66±18 
Stim. To QRS peak 128±20 135±16† 115±18 128±22 
Stim. To J-point 191±36 193±15 171±24 180±29 
Stim. To Tpeak 271±25 264±18 264±32 265±26 
Stim. To Tend 383±23 375±28 368±30 359±33 
QRS duration 125±32 126±14 109±14 115±28 
Tpeak to Tend 112±17* 111±23* 104±18 94±19 
QT interval 316±24 309±27 306±27 293±32 
Hysteresis 
(Pre-ERP 
minus 
Steady 
State) 
Latency 32±12 27±12 24±9 24±8 
Stim. To QRS peak 47±13†† 40±13 30±19 38±15 
Stim. To J-point 50±12*†† 33±17 24±24 32±19 
Stim. To Tpeak 1±19 -4±31 -5±25 -5±15 
Stim. To Tend 35±23† 14±21 17±22 17±22 
QRS duration 17±14†† 6±11 -1±20 8±18 
Tpeak to Tend 34±19 17±45 22±16 22±17 
QT interval 3±22 -13±20 -7±20 -7±21 
Table 5-5 Paced Surface ECG parameters 
HR: Heart Rate, ERP: effective refractory period, ARI: Activation Recovery Index, AT: Activation Time, RT: 
Repolarisation Time, Significance codes: * p<0.05 vs. Normals, ** p<0.01 vs. Normals, ***p<0.0001 vs. Normals, † 
p<0.05 vs. RVOTE, †† p<0.01 vs. RVOTE 
Time from pacing artefact to the end of the T-wave was used as a surrogate marker of 
complete repolarisation of the ventricles. This interval increased in definite ARVC 
patients more than in either RVOTE patients or the probable ARVC group (Figure 
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5-11).  
 
Figure 5-11 Measurements taken from paced surface ECG.  
The penultimate and final drive train stimuli, plus a single premature stimulus are shown (vertical lines). The three 
measurements shown are those used in the recursive partition analysis. The median value over all six limb leads was 
used. 
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Figure 5-12 Example of Paced Surface ECGs 
Representative ECGs from a definite ARVC patient, a patient with RVOT ectopy and a patient with a normal heart 
are shown. There was a significantly greater increase in the pacing artifact to J-point inflection just prior to ERP in 
the patients with ARVC than in patients with RVOT ectopy or with normal hearts.  
5.3.11 Diagnostic utility of paced ECG changes (CART analysis) 
A change in the time from the pacing artefact to the end of the QRS complex of +48ms 
(pre-ERP minus steady state) gave a sensitivity of 67% and specificity of 88% in the 
diagnosis of definite ARVC (Figure 5-13). A change in QRS duration of -6ms or lower 
was insensitive (sensitivity 50%) but specific (specificity 85%) for RVOTE. Further 
portioning based on a change in the time from stimulus to the peak of the T-wave of 
greater than - 11ms distinguished possible ARVC and normal groups, with sensitivity 
and specificity of 71% and 59% respectively. 
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Figure 5-13 Results of CART analysis 
Panel A shows the optimum recursive partition tree. An increase in the time from the stimulus to the end of the paced 
QRS complex (J-point) of >48ms gave a sensitivity of 67% and specificity of 88% for definite ARVC. B and C show 
raw data for the principal branches. These measurements were able to distinguish any ARVC patient from 
RVOTE/Normal patients with a sensitivity of 67% and specificity of 84%. 
5.3.12 Further work 
Data will be re-examined to observe how different genotypes related to phenotypic 
expression of conduction delay. A larger cohort of genotyped ARVC patients without 
evidence of structural heart disease on MRI would allow optimisation of the diagnostic 
algorithm proposed in the CART analysis to increase the paced-ECG algorithm’s 
sensitivity and specificity. 
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5.4 Discussion 
5.4.1 Principal observations 
Our major finding has been the identification of conduction abnormalities that exist 
prior to the development of structural abnormalities in early ARVC. Our initial study in 
patients known to carry mutations of the desmoplakin gene was extended to a wider 
group of patients with ARVC and detailed electrophysiology of these patients was 
compared to that of patients with benign outflow tract ectopy.  
The differentiation of ARVC from benign outflow tract ectopy is clinically important to 
ensure the institution of prognostically significant treatment and lifestyle 
recommendations. The recent revision of diagnostic criteria for ARVC has placed 
increased weight on family history and gene status (Marcus et al, 2010). This 
emphasises the probability of disease development but not necessarily the presence of 
disease. This is the first study to examine differences in conduction and repolarisation 
kinetics in an ARVC population that we have identified with earlier disease than 
customarily reported.  
The key findings include: 1) Marked conduction delay in patients with early ARVC 
when pacing at short coupling intervals, which was not evident in sinus rhythm. 2), 
Progressively longer local repolarisation times as coupling intervals decrease towards 
VERP in ARVC patients versus normal controls & RVOT ectopy subjects. 3) Marked 
differences in fractionation at short coupling intervals pre-VERP throughout the right 
ventricle between patient groups, with more fractionation in both ARVC and RVOT 
ectopy patients. 4) Surface ECG corollaries of conduction/repolarisation dynamics 
provide diagnostic information - an increase in the time from pacing stimulus to full 
ventricular activation (defined as paced complex J-point) of greater than 48ms gave an 
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88% specificity and 68% sensitivity of distinguishing definite ARVC from other groups. 
Previous studies have demonstrated electrophysiological abnormalities in established 
ARVC with significant structural disease, including prolonged RV ATs in sinus rhythm 
and low endocardial bipolar electrogram voltage (Tandri et al., 2009; Corrado et al., 
2010). However, this has not been validated for the clinical differentiation of benign 
RVOT ectopy or VT from early ARVC. At least 40% fibro-fatty replacement is 
required before detectable attenuation of endocardial voltages occurs and thus disease 
expression in the early concealed phase will be missed (Corrado et al., 2010; Avella et 
al., 2010). 
Our initial study of desmoplakin mutation carriers demonstrated that these patients have 
significantly greater mean increases in delay during an S1-S2 restitution protocol, 
particularly in the outflow tract compared to SVT control (Gomes et al., 2012). The 
question arose as to whether these changes in conduction and repolarisation dynamics 
could be utilised to differentiate benign outflow tract tachycardia from concealed 
ARVC. We therefore investigated cases with little or no imaging abnormalities plus 
patients classed as borderline ARVC using updated consensus criteria. Importantly, it 
was primarily the family history of ARVC or mutation carrier status that allocated these 
patients to the “Definite ARVC” group. In the absence of gene testing, 4/12 of the 
definite ARVC cases would be regarded as borderline. This implies that in a population 
of combined probable and definite cases the predictive accuracy of this partitioning 
method may be increased. Indeed, when both groups are combined, the classification 
tree was able to distinguish any ARVC patient from a combined group of 
RVOT/Normals with a sensitivity of 67% and specificity of 84%.  
The patients with more advanced disease did not demonstrate global RV activation 
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delays in sinus rhythm, but it was more marked at short coupling intervals during RV 
pacing. The dynamics of repolarisation were also significantly affected, amplifying 
effects of conduction delay in ARVC creating significantly more prolonged 
repolarisation times pre-VERP than steady state versus controls and RVOT ectopy 
patients.  
5.4.2 Endocardial Electrophysiological changes in RVOT 
ectopy 
Two phenomena were observed in the RVOT ectopy patients: consistently shorter RT’s 
versus SVT and ARVC cases and increased fractionation. The shorter RT’s may reflect 
a memory phenomenon induced by the high ventricular ectopic burden promoting 
shortening in ARI as a result of ion channel current remodelling & cause local myocytes 
to be more susceptible to activation. The high degree of fractionation in benign RVOT 
ectopy patients similar to that seen in ARVC deserves comment. Conduction delay and 
fractionation occurs in ARVC due to early fibrofatty replacement and/or dissociation of 
preferentially conducting myocardial pathways through worsening gap junction 
coupling & possibly Na channel downregulation (Gomes et al., 2012; Delmar and 
McKenna, 2010). However, the conduction delays measured in benign RVOT ectopy 
patients were indistinguishable from normal hearts, yet significantly more fractionation 
existed. Cellular and theoretical work has indicated that a single plane of non- or slowly 
conducting fibroblasts could facilitate ectopic formation through source-sink 
mismatching & fractionation in one direction of activation, but preserving conduction in 
another (Xie et al., 2010; de Bakker and Wittkampf, 2010). This hypothesis could be 
tested using differential pacing in a future study. In the ARVC patients, higher r2 values 
indicating uniformity of conduction were observed compared to RVOT ectopy cases. 
Similarly, we have reported more uniform conduction in Brugada Syndrome vs. control 
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(Lambiase et al., 2009) suggesting that diseases that promote dissociation of the 
myocardial layers whether due to structural or ion channel differences reduce the 
contribution of activation from the Purkinje network breaking through the endocardium 
to allow more homogeneous & consistent endocardial activation & wavefront 
propagation. 
Taken together, features of conduction delay, increased repolarisation times and mild 
fractionation at short coupling intervals pre-VERP would support a diagnosis of early 
ARVC over that of a benign RVOT ectopy, with a logistic model demonstrating a 
positive predictive value of 80% from the presented data.  These differences can also be 
identified simply using paced-QRS-T-wave parameters.  
This study confirms that reduced conduction reserve develops early in ARVC before 
detectable structural RV changes ensue. This has important implications since sudden 
cardiac death can occur in patients with minimal histological changes in the sub-clinical 
phase of ARVC and thus a more sophisticated clinical evaluation using dynamic 
conduction-repolarisation changes is require (Thiene et al., 1988b). In a recent study, a 
positive signal averaged ECG correlated with the size of reduced endocardial voltage 
regions and histological evidence of cardiomyopathic disease but had a low sensitivity; 
21% cases studied still had evidence of major RV structural abnormalities on imaging, 
indicating that static surface ECG markers may be too insensitive in the concealed 
phase (Santangeli et al., 2010). In a recent study of examining ventricular ectopic 
morphology in ARVC, the extent of structural disease was not described (Haqqani et al., 
2012).  This study illustrates that dynamic surface ECG conduction-repolarisation 
parameters are of diagnostic value. 
5.4.3 Relationship to Conduction-Repolarisation interactions 
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This study has partially confirmed our hypothesis that conduction and repolarisation 
dynamics are altered in arrhythmogenic disease, namely ARVC. We observed marked 
dynamic conduction changes in the ARVC group, which were able to differentiate this 
group from normal subjects or those with benign RVOT ectopy. However, 
repolarisation changes in early disease appeared secondary to alterations in conduction 
dynamics. In the earlier study of desmoplakin mutation carriers, we also observed 
regional differences in ARI in patients with disease. This was not the case in a latter 
group of patients with early disease.  
5.4.4 Study limitations 
The human mapping technique evaluates endocardial electrophysiology and thus mid-
myocardial and epicardial effects of ARVC could not be assessed. This is important 
since structural changes manifest epicardially prior to progressing endocardially 
(Haqqani et al., 2012). Although differences in myocardial electrophysiology between 
benign RVOT ectopy patients followed for >18 months post ablation and ARVC were 
identified, a prospective long-term follow-up study this patient cohort would be 
required to confirm these observations.  
5.4.5 Conclusions 
Early ARVC exhibits greater conduction delay and dispersion of repolarisation, 
particularly at short coupling intervals, than either normal hearts or benign RVOT 
ectopy. Fractionation is mildly increased in early ARVC, but also significantly in 
benign RVOT ectopy.  
The dynamic differences in conduction, repolarisation and fractionation manifest on the 
surface paced ECG & can help refine the early identification of ARVC patients from 
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those with benign outflow tract ectopy. 
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Chapter 6 RESULTS: A Murine Optimised Tissue 
Slice Model highlights increases in 
conduction velocity by sympathomimetics 
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6.1 Introduction 
The study of cardiac tissue electrophysiology is limited by the experimental 
preparations available. Though many biological and in silico models exist of cardiac 
disease (e.g. Janse et al., 1998; Gehrmann and Berul, 2000; Clayton et al., 2011), access 
to genetically modified tissue, which allows the dissection of mechanistic pathways, has 
been limited. This is principally due to the difficulties in handling murine cardiac tissue 
ex vivo (Halbach et al., 2006). 
However, despite the apparent differences in cellular electrophysiology from larger 
mammals, the murine heart has been established as an important model of cardiac 
electrophysiology. The short generation times, large litters and relative ease of 
performing specific genetic modifications has led to increased interest in the genetically 
modified mouse as a tool for investigation of arrhythmia mechanisms. This is despite 
caveats of the murine model, which exhibits shorter action potentials and different 
repolarising currents compared to humans (Kaese and Verheule, 2012). This has 
enabled important insights into the pathogenesis of various electrophysiological 
syndromes, including Brugada syndrome (Papadatos et al., 2002), ARVC (Sato et al., 
2009; Lombardi et al., 2011; Gomes et al., 2012) and cholinergic polymorphic 
ventricular tachycardia (Liu et al., 2006; Cerrone et al., 2005; Watanabe et al., 2009). 
This work has been performed in vivo, in vitro (i.e. as single cell investigations) or in 
whole heart Langendorff preparations, for which 2D measurements are limited to the 
epicardial surface (for example Remme et al., 2006). 
The differences between the human and murine action potential are summarised below. 
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Figure 6-1 Comparisons of Human and Murine action potentials and their contributing ionic 
currents 
Representative human and murine action potentials are shown with the phases labeled (top). Below is a schematic of 
the contributing currents, with sodium in red, calcium in green and potassium currents in blue. Principal interspecies 
heterogeneity occurs between the repolarising currents. (Adapted and redrawn from Nerbonne, 2004) 
 The most important contrasts are in the repolarisation dynamics between the species, 
the voltage-gated rectifying K+ current being the most diverse (Pond and Nerbonne, 
2001). In the mouse, repolarisation is governed by a different set of potassium currents 
than in the human, with predominant repolarisation determined by IKslow  activation. The 
transient outward current (Ito) also plays a role. The voltage-gated rectifying currents 
have a shorter time-course of activation in the mouse than in the human, which accounts 
for the shorter action potential in the murine heart. The heart rate ranges of the species 
can account for the marked interspecies differences in Phase 2 and 3 of the action 
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potential; the resting murine heart rate of around 5 – 10 Hz requires a far more rapid 
repolarisation than the human (Knollmann et al., 2007). However, the principles of 
regulation of repolarisation (such as phosphorylation, calcium-dependence and voltage 
gating) are similar across higher species. 
In contrast, the rapid upstroke of the action potential varies very little between the 
species. This similarity is highlighted by the successful translation of disease models of 
syndromes of conduction disease; both from human to mouse and vice-versa (Nerbonne, 
2004). The sodium channel, desmosomes and connexions are all highly conserved 
elements of cardiac electrophysiology, adding confidence that patterns and mechanisms 
elucidated in the mouse might at least be relevant to human physiology and disease.   
Despite these advantages, the murine ventricle has proven a difficult source of tissue for 
investigation of electrophysiological mechanisms. Whereas guinea-pig, rabbit, dog, cat 
and human hearts (e.g. Bussek et al., 2012; Myles et al., 2011; Allison et al., 2007; 
Camelliti et al., 2011; Brandenburger et al., 2012) have all been shown to be amenable 
to tissue level investigation, the mouse heart appears underused. This is likely to the 
fragility of murine ventricular tissue & whereas the myocytes from large species have 
been robust to tissue slice techniques, murine hearts have been almost exclusively 
investigated either in vivo, on the Langendorff preparation or in cellular preparations 
(Sabir et al., 2008). Establishing tissue dissection and recording techniques from the 
murine heart offers considerable opportunity for novel investigation of cardiac 
arrhythmia physiology (Pillekamp et al., 2005).  
Specifically, I wished to use a murine tissue technique to establish whether conduction 
velocity and tissue excitability was affected by sympathetic stimulation. Furthermore, 
access to genetically modified animals enabled investigation into the intracellular 
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signalling responsible for the effects uncovered in the wild type tissue. 
6.1.1 G-protein coupled receptors and their role in 
arrhythmogenisis 
In the human heart, β-adrenoceptors (β-AR) are coupled to heterotrimeric G-proteins 
(Gilman, 1987). The coupling of a ligand to the receptor causes a conformational 
change and effects the subsequent dissociation of both the receptor from the G proteins, 
and a dissociation of the G-protein’s constitutive elements into Gα and Gβγ subunits. 
Both of these subunits have intracellular signalling properties. The predominant β-AR 
subtype expressed in the normal ventricle, β1, is coupled to the stimulatory G-protein Gs 
in the ventricle (Grimm and Brown, 2010). When dissociated from the Gβγ subunit, 
Gαs acts to stimulate adenyl-cyclase, and thus raises intracellular cAMP. A rise in 
cytoplasmic concentrations of this second messenger in turn stimulates Protein Kinase 
A (PK-A) by binding to regulatory PK-A subunits and allowing the release of active 
catalytic PK-A subunits, through which β-AR stimulation is thought to ultimately have 
its primary effects. A second β-AR subtype, β2, is also coupled to the inhibitory alpha-
subunit Gαi, which tends to oppose the Gs-mediated actions.  
The predominant muscarinic receptor expressed in the (murine) ventricle is the M2 
receptor. Likewise consisting of a seven-transmembrane element, this receptor couples 
to an inhibitory G-protein. Recent work by our group has established that in the 
ventricle the G-protein Gαi2 is responsible for principle intracellular effects of 
muscarinic stimulation (Zuberi et al., 2008; Zuberi et al., 2010).  Knockout of this 
protein results in a cardiac electrical phenotype, with action potential duration 
lengthening at low heart rates, steepening of the restitution curve and predisposition to 
ventricular arrhythmia. This can be seen in the light of unopposed sympathetic effects. 
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Increased accumulation of a repolarisation reserve (due to IKslow upregulation in the 
mouse) allows rapid repolarisation at short coupling intervals. But at longer coupling 
intervals diastolic intervals are too long to allow this accumulation of channels in 
easily-recruited states. Thus the effects of raised cAMP upon L-type Ca channels 
dominates, and acts to increase calcium transients, and the action potential extends. At 
short coupling intervals, the repolarisation reserve will accumulate, the action potential 
shorten and hence the restitution curve will become steeper (Grimm and Brown, 2010). 
This combination appears highly arrhythmogenic, as was detailed by the easily induced 
ventricular arrhythmias and sudden death in these mice.  
The effects on sympathetic stimulation on conduction velocity in cardiac muscle have 
not been fully described. A single investigation into the effects of isoprenaline on 
canine Purkinje fibres was performed by Packer and colleagues (Cragun et al., 1997). 
This showed increased conduction velocities with sympathetic stimulation following the 
administration of flecanide, but this work does not appear to be reproduced. This work 
can be seen as demonstrating that adrenergic stimulation may overcome conduction 
slowing induced by a class 1 antiarrhythmic. However, it does not tell us if adrenergic 
stimulation has constitutive effects on conduction velocities. 
Indeed, absolute conduction velocities can be very difficult to measure in the intact 
heart. A measurement of activation gradients allows the determination of conduction 
velocity over a field of interest robust to conduction direction or manual measurement 
of conduction paths. More importantly, it is easy to compare results from different 
experimental preparations and under different conditions. Even if the conduction path 
apparently changes due to e.g. induced conduction block, conduction velocities should 
be comparable to an extent. This technique was used to measure conduction velocities 
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derived from our experimental preparation.  
I aimed to examine whether sympathomimetics did have tissue level effects on 
conduction velocity, a phenomenon implied by our observation of reduced activation 
times during mental stress. I also aimed to determine whether this represented an effect 
purely governed by β-AR signalling, or whether parasympathetic stimulation also has a 
role. 
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6.2 Hypothesis 
I hypothesised that sympathetic stimulation increases conduction velocity via second-
messenger effects at the tissue level, which may be antagonised by parasympathetic 
stimulation.  
To test this hypothesis, a novel murine tissue slice technique was developed. This 
allowed electrophysiological studies to be performed on very thin (~200µm thick) slices 
of myocardial tissue using a multi-electrode microarray. Initially, investigations aimed 
at proving the experimental paradigm valid. Subsequently, the response of tissue 
conduction to isoprenaline was tested, with attempts to antagonise this response using 
the parasympathetic agonist Carbachol. 
Finally, mice deficient in the inhibitory G protein Gαi2, which is the G-protein effector 
linked to the muscarinic M2 receptor. Tissue from these animals was used to further 
elucidate parasympathetic effects on conduction velocity. 
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6.3 Results 
6.3.1 Validation of cardiac slice analysis 
Consistent success at obtaining viable ventricular slices was achieved using the method 
described in 2.4.4 above, with 13 of 14 attempts yielding viable tissue slices.  
A stepwise approach to validation of our signal analysis methodology was taken. 
Validation was performed in 6 slices obtained from 3 mice. A total of 633 individual 
excitations following stimulation were examined, with a median of 54 electrode sites 
examined per slice. Raw signals and averaged signals demonstrated very similar 
waveforms, with far less noise apparent on the averaged signals (Figure 6-2). 
 
Figure 6-2 Raw and averaged signals 
On the left, raw signals obtained from the MEA are shown. 86 signals following paced stimuli were averaged to give 
the resultant smooth waveform, shown on the right. 10 electrograms from separate electrodes are shown in different 
colours. 
Activation times (ATs) derived from raw signals and those from the averaged-signals 
were compared. There was an excellent agreement between ATs from averaged signals 
and the mean of ATs derived from the raw signals (r2 = 0.97). We compared the 
activation gradient surfaces derived from the signal averaged signals and those derived 
from raw signals. Panel B shows an example regression surface of activation (Z axis), 
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with ATs from the averaged signals represented by grey filled circles. Panel C shows 
the same surface, but now surfaces derived from every constituent raw activation are 
shown in translucent green. ATs for raw used for each surfaces are shown as green 
points. There is excellent agreement between regression surfaces from the two methods.  
 
Figure 6-3 Validation of Signal Averaging 
A: Comparison of activation times (AT) derived by two methods. The x axis shows ATs from signal averaged ECGs. 
The y axis shows the mean of ATs from the raw signals constituent in the respective averaged signal. B and C show 
typical least-squared regression surfaces created using the gridfit function, showing how an activation gradient 
surface can be fitted over the ATs. B shows a single surface created from signal-averaged data, C shows surfaces 
created from all the raw data used to make the averaged signals (green, translucent). Raw data points are shown as 
green points. The grey surface in C (partially hidden by green surfaces) is identical to that in B, this fits entirely 
within regression surfaces created from raw (non-signal averaged) dara. 
  
To show that the values for conduction velocity obtained by the activation gradient 
A
B C
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method were valid, these values were compared with those obtained from a rough 
distance/time method (d/t method). The difference between the maximum and minimum 
AT (in ms) was divided by 1.6mm, the length of one dimension of the array. The 
resultant value gives an estimate of conduction velocity across the tissue. This technique 
discounts activation paths entirely, and assumes homogenous wavefront activation 
across the slice and MEA i.e. a direct pathway of activation. This results in a propensity 
for the conduction velocity to be significantly underestimated. It is also sensitive to 
erroneous AT measurements. Nonetheless, it is useful as a “face” validation of our 
gradient derived technique. 
There was a significant correlation between conduction velocities obtained by the 
activation gradient method and those from the d/t method (slope = 1.93±0.25, r2 = 
0.2889, p<0.0001). This should not be taken as a comparison of the gradient method 
against a gold standard, but rather a proof of concept and confirmation that realistic 
conduction velocities were obtained by the gradient method. Occasional higher than 
expected values were obtatined by the gradient method. It may be that from time to time 
activation wavefronts may have spread across the tissue preparation in a discontinous 
manner. This could have lead to several areas of tissue activating simultanously and 
thereby a higher (or even falsely high) conduction velocity than expected being 
measured.  
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Figure 6-4 Comparison of Conduction velocities obtained by two methods 
There was a significant relationship between CV as estimated by an activation gradient method and the 
approximation achieved by a rough distance/time methodology. Some high values for conduction velocity were 
occasionally observed with the gradient method. 
 
6.3.2 Isoprenaline decreases pacing thresholds and increases 
conduction velocities 
Initial confirmation of effect of isoprenaline on thresholds and conduction velocities 
were performed on 11 slices obtained from 3 wild-type mice. Pacing thresholds were 
defined as previously described. There was a marked drop in the threshold required for 
consistent capture of ventricular slices in the presence of isoprenaline, from 0.92±0.13V 
to 0.49±0.07V (p<0.01), with a strong trend in dose response (p= 0.07 for trend). 
Similarly, conduction velocities rose markedly in the presence of isoprenaline from a 
baseline value of 0.15±0.01ms-1 to 0.22±0.01ms-1, an increase of nearly 50% (p<0.0001).  
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Figure 6-5 Effect of Isoprenaline on Conduction Velocity & Stimulus Threshold 
Slices (n = 11) were exposed to isoprenaline in increasing concentrations; the effect on conduction velocity and 
threshold is shown. Isoprenaline markedly increased conduction velocity, this was accompanied by a decrease in 
threshold. (Error bars: ±SEM) 
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Figure 6-6 Representative Conduction velocities on microarray 
A & B: Example colour maps of conduction velocity across the microarray are shown at baseline (A) and in the 
presence of isoprenaline 100nM (B). Colour scale is in ms-1, and is relevant to both figures, with red indicating high 
conduction velocity and blue low. The isochronal lines join identical activation times (times in seconds following 
stimulus), and are constructed without regression smoothing (i.e. from raw data). Stimulation was from the upper 
right corner (external stimulus). There are higher conduction velocities with isoprenaline.  
C & D: Original electrogram data used to construct maps A & B are shown. The blue dot indicates electrode location, 
the red asterisk indicates the moment of activation on the electrogram. Blue arrows indicate vector of activation 
gradient, the length of arrow being proportional to the calculated gradient (thus inversely proportional to the 
conduction velocity).  
E: Microscope view of tissue slice (representative) on microarray (20x magnification) with superimposed 
electrograms. Electrograms with noise or non-interpretable signals are not shown.  
6.3.3 Carbachol antagonises the effects of isoprenaline on 
conduction velocity 
The response to isoprenaline and carbachol was tested in 11 slices obtained from 6 
wild-type mice. This was compared to 13 slices obtained from 4 Gαi2-/- mice. 
Carbachol (10µM) antagonised the effect of isoprenaline (100nM) in the wild-type 
slices, reducing conduction velocity from 0.26±0.01 ms-1 to 0.23±0.01ms-1 (p<0.05). 
Gαi2 deficient slices had a trend to lower baseline conduction velocity than the wild-
type slices to which they were compared, but this did not reach statistical significance 
(Wt: 0.21±0.01 ms-1 , KO:0.15±0.01ms-1, p=0.07). There was an increase in conduction 
velocity in response to isoprenaline in Gαi2-deficient slices, with a similar proportional 
increase as the wild-type controls. In contrast to wild-type slices, carbachol did not 
reduce conduction velocity in the Gαi2 deficient slices (0.18±0.01 with isoprenaline to 
0.19±0.01 with carbachol, p= n.s.). 
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Figure 6-7 Effect of Isoprenaline and Carbachol on Gαi2 -/- slices 
Isoprenaline (100nM) was infused into cardiac tissue slices on the microarray. An increase in conduction velocity is 
observed in both WT (n = 11) and Gαi2-/- (n = 13) slices. This is antagonised by carbachol (10µM) in the WT, but not 
the Gαi2-/-, slices. (Error bars : ±SEM) 
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Figure 6-8 Effect of Isoprenaline and Carbachol on Thresholds in wild-type and Gαi2 -/- slices 
Changes in thresholds in response to isoprenaline and carbachol in wild-type and Gαi2 deficient slices are shown, 
normalised to baseline values. There was a significant decrease in thresholds with isoprenaline in wild-type slices, 
but changes due to carbachol did not reach statistical significance. (Error bars: ±SEM) 
Thresholds were reduced in Gαi2 deficient slices in the presence of isoprenaline 
(0.58±0.12V to 0.44±0.11V), but, in contrast to wild-type controls, this did not reach 
statistical significance (p= 0.11).  The small increase in thresholds observed with 
carbachol in wild-type slices did not reach statistical significance, nor was a significant 
increase seen in Gαi2 deficient slices. 
6.3.4 Isoprenaline reduces dispersion of activation 
The dispersion of activation (defined as the time difference between the earliest and the 
latest activation measured) was examined in the presence of isoprenaline and carbachol. 
Isoprenaline 100nM reduced the dispersion of activation in wild-type slices from 13±1 
to 9±1ms (p= 0.07), there was a slight, but non-significant, recovery with carbachol. 
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No significant changes in dispersion of activation were observed in Gαi2 deficient slices. 
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6.4 Discussion 
6.4.1 Principal findings 
In this study a novel tissue slice and micro-array recording technique for adult murine 
cardiac tissue was developed. β-AR stimulation has been shown to enhance conduction 
velocity. Furthermore, muscarinic stimulation acting through the inhibitory G-protein 
Gαi2 negatively regulates this effect. This presents a novel potential mechanism of 
stress-induced arrhythmia by enhancement of conduction through increased sympathetic 
tone and/or decreased parasympathetic tone. It also confirms that increased conduction 
velocity is at least partially antagonised by activation of cardiac muscarinic receptors 
acting via Gαi2. 
6.4.2 Value of results 
Conduction velocities in cardiac tissue have been inaccessible to study for several 
reasons. Firstly, as previously explained in this thesis, the exact pathway of cardiac 
conduction in the intact myocardium is very hard to determine. By using a quasi-2D 
tissue whilst retaining tissue structure to a greater extent, a conduction path can be 
visualised within the tissue. Nonetheless, determining an accurate conduction velocity is 
complex, and several methodologies were required to ensure that a reproducible value 
could be determined.  
First, signals were averaged from many (between 50 and 100) individual slice 
stimulations. This dramatically reduced the noise in signals analysed, furthermore signal 
averaging followed by analysis is a far lighter computational process than repetitive 
signal analysis followed by averaging determined parameters. Without this process, the 
amount of data generated would be overwhelming and analysis overly time consuming.  
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Second, a derivation of the activation gradient in the tissue was used to determine 
conduction velocity. Activation gradients have been used previously to determine 
conduction velocity in vivo in humans, but were limited by lack of knowledge of exact 
conduction paths. Only the velocity of the slowest activating area of endocardium could 
be determined in these methods, which have principally used non-contact mapping data. 
A 2D linear regression algorithm was used to determine the optimum and true activation 
gradient over the measured tissue. Originally, this method was used for automated 
analysis of cartographic data, but it fits our requirements superbly as it minimised 
chance error and prevents single outlier activation signals from grossly affecting 
conduction velocity.  The mean gradient over the entire tissue slice was used to derive 
velocity. Using these methods it was possible to determine reliable and consistent 
measurements of conduction velocity in the tissue slices. 
Previous work has documented an increase in conduction velocity in cardiac tissue in 
the presence of isoprenaline. Packer and coworkers showed that dog Purkinje fibres 
treated with Flecanide would increase conduction velocities in the presence of 
isoprenaline (Cragun et al., 1997). However, the effect of parasympathetic agents on 
conduction velocity has not to our knowledge been previously documented. The 
presented work shows that conduction velocity increases due to isoprenaline can be 
antagonised by carbachol, and that this antagonism acts through Gαi2. The increased 
excitability of the tissue (i.e. the ease at which cells within the tissue may depolarise 
causing an action potential) was implied by decreases in pacing threshold. This may be 
seen as allegorical to increased clinical ectopy during stress or isoprenaline 
administration, and stands as a potential mechanism for increases in conduction velocity. 
The observation of increases in conduction velocities in the presence of 
sympathomimetic agents deserves comment. Our measured conduction velocities were 
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low in comparison to published data from whole heart preparations (e.g. Mirnov et al. 
2008). Manual checking of these data confirmed that conduction velocities within our 
preparation were lower than those previously described in intact tissue. This may be due 
to disruption in cell-cell communication brought about during the slicing process; 
aniostropy in particular may have been increased in this process due to physical 
disruption along strands of tissue. This was not directly investigated.  
It may be that minor tissue disruption may have made our preparation more sensitive to 
sympathetically mediated conduction velocity changes than would be observed in intact 
tissue. Such a situation could arise if minor disruption to desmosomal and connexin 
intercellular connections were rescued by increased cycling of membrane proteins under 
sympathetic drive. Increased recruitment of connexin to the cell membrane would lead 
to reductions in intercellular impedance, an eased passage of current from cell to cell 
and consequently an increase in conduction velocity. Recent data demonstrates co-
trafficking of Connexin 43 with Nav1.5 sodium channels; an increase in membrane 
sodium channel concentration at the cell membrane would also lower cell-cell 
impedance by adding to a "sodium channel reserve" (Rhett et al, 2012). Action potential 
upstroke would be more rapid and higher conduction velocities thus result. 
Downstream effects on cellular calcium stores provides a third way for sympathetic 
stimulation to increase apparent conduction velocities. The downstream effects of 
adrenergic agonist stimulation include phosphorylation of the Ryanodine receptor 
(RYR2), the L-type calcium channel and phospholamban, which is responsible for 
regulation of SERCA activity. This may be via direct phosphorylation via the cAMP/ 
Protein Kinase A pathway and/or Ca2+/Calmodulin Kinase II, though there is debate 
over whether the latter of these pathways represents a direct or indirect pathway 
(Grimm and Brown, 2010). The net consequence, however, is an increase in Ca++ 
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uptake and release from the sarcoplasmic reticulum. Thus the calcium transients 
involved in the action potential will increase. These increases in Ca++ transients will be 
expected to increase sodium-calcium exchanger activity, raising the membrane potential 
and thus facilitate depolarisation of the cell. The tissue level consequence of these 
changes would be expected to be an increase in conduction velocity as end result.  
Tissue disruption in our preparation may have increased the senility of our assay to 
conduction velocity changes. It may be that increases in conductivity due to cell-cell 
connection upregulation and increases in calcium transients could overcome 
intracellular barriers in an all-or-nothing manner on a cell-to-cell basis. A strongly non-
linear relationship between intercellular conductance and conduction velocity may 
result (van Rijen et al 2006, Dhillon et al. 2013). A tissue-level result of this would be 
that an experimental preparation that itself poses constraints on conduction velocity 
might be more sensitive at revealing changes in this metric. 
The presented work provides a novel platform by which tissue level consequences of 
molecular perturbations can be examined. This study establishes that adult murine tissue 
slices from genetically modified animals can be examined with this tissue-slice model. 
There is significant potential to study more than just steady state activation times and 
excitation, as has been demonstrated. Repolarisation and repolarisation dynamics are 
potentially amenable for study using this system. Though the T-wave visible on many 
electrograms is indistinct, techniques to exclude far-field signal and highlight local 
repolarisation (such as using cross- or star- laplacians (Coronel et al., 2000)) are 
certainly feasible. A further development would be to couple the direct electrical 
mapping using the microelectrode array system with optical mapping of voltage, 
calcium or other fluorescence-labelled dynamic markers of electrical or regulatory 
activity. In this study, re-entrant arrhythmias were not convincingly demonstrated in 
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slice preparations. However, this may primarily due to limitations in the stimulation 
system used. Computer control and automated programming of this will enable more 
arrhythmogenic stimuli trains to be administered.  
6.4.3 Limitations 
There are several important limitations to this work. 
First, the relevance of murine tissue to clinical human arrhythmia may be questioned. 
Clearly species variability is important, particularly in the repolarising phase. 
Nonetheless, important corollaries between activation and activation/repolarisation 
kinetics and regulation of cardiac behaviour appear to exist across mammalian species. 
These are particularly notable in activation dynamics. This limitation may be addressed 
by demonstrating living human cardiac tissue slices using the same ex vivo system. This 
is possible with biopsy samples acquired intraoperatively, and some early work has 
shown that this is at least possible.  
Second, the tissue slice technique may profoundly alter tissue dynamics. Tissue 
disruption may accentuate anisotropy and reduce/prevent conduction. This may explain 
the low conduction velocities measured compared to standard reference values 
(approximately 70cm.s-1, e.g. van Rijen et al 2006, Dhillon et al. 2013). Nonetheless, 
contemporary control samples enable comparisons to be drawn. 
Third, the tissue preparation ionic behaviour may have been severely disrupted by the 
exposure to calcium free, high potassium modified Kreb’s perfusate during initial 
suspension of animation. Attempts were made to minimise this by ensuring that tissue 
slices were exposed to normo-calcaemic, normo-kalaemic solution for at least 30 
minutes prior to attempt of measurements. Nonetheless, irreversible disruption of 
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important cellular processes by this method has not been ruled out. 
Fourth, the experimental process did not allow myocyte orientation to be determined. 
Ventricles were sliced in the short axis, measurements were by necessity mainly 
acquired from the mid-myocardium. We are unable to determine whether the effects on 
the epi- or true endocardium would be different from those described. The issue of 
tissue slice orientation could be addressed by immunohistochemical assessment of 
myocyte orientation using standard techniques post procedure. 
Fifth, the effects of isoprenaline on the morphology of the electrograms acquired from 
the multi-electrode array were not quantified.  
Sixth, the stimulation control used required arduous manual selection of timings. It was 
impossible to perform reliable restitution curves and determine ERP whilst managing 
the perfusion system and tissue viability. A computerised controller for the stimulus 
generator will be required for repetitive S1S2 protocols, and for more complex 
arrhythmogenic protocols. 
6.4.4 Further Work 
Several further stages are required to complete this investigation. Improved stimulus 
protocols are required to establish the arrhythmogenicity of the tissue preparation and to 
examine ERP. Likewise, the contribution of anisotropy to conduction velocity dynamics 
should be examined. Repolarisation must be examined formally, and it will be 
important to test apparent tissue conduction velocities using the activation gradient 
technique against manually plotted distance/time measures.  
Furthermore, questions remain regarding longevity of tissue slices, and optimal tissue 
storage conditions are yet to be determined.  
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6.5 Conclusions 
The murine tissue slice technique yields viable myocardial tissue, which can be 
examined using the multielectrode array system. Reproducible measurements of 
conduction velocity and measurements can be obtained from this. 
Isoprenaline administration increases conduction velocity and tissue excitability, these 
effects are antagonised by carbachol. This antagonism is dependent on Gαi2-mediated 
signalling.  
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Chapter 7 Overall Discussion 
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7.1 Summary of achievements 
This thesis has addressed the overarching hypothesis: activation and repolarisation 
dynamics are subject to modulation by autonomic stress and disease- using several 
different experimental series and techniques.  
First, human studies on normal individuals were used to test the validity of one-
dimensional conduction models in the clinical setting. I was able to model the dynamics 
of activation and repolarisation using simple parameters and assumptions. These 
successfully predicted activation-repolarisation interactions following serial premature 
extrastimuli. This provides a framework by which biologically acquired data on 
conduction velocity and repolarisation dynamics may be incorporated into more 
complex simulations. The ability of a simple, patient specific model to recapitulate 
human conduction dynamics is notable, and validates earlier work (such as those by 
Gelzer et al. (2008)) in the human. Moreover, it establishes that activation and 
repolarisation dynamics are reproducible in the human and do follow patterns expected 
from theoretical wave models. This technique does not currently enable observation of 
wavebreak and determination of the spatial patterns of arrhythmia determination as 
presented. However, confirmation of these dynamics may be important in future patient-
specific simulation model constructions utilising additional extrastimuli from dynamic 
restitution protocols.  
We have demonstrated that activation and repolarisation dynamics were modifiable by 
conscious mental stress, thus demonstrating in vivo direct cardiac electrophysiological 
effects of purely psychological stimuli. A key observation was the marked increase in 
dispersion of repolarisation at short coupling intervals during mental stress. This 
provides a plausible mechanism for the arrhythmogenic effects of acute mental stress. 
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A small apparent increase in conduction velocity during mental stress was noted. 
Measurements from different chambers of the heart allowed determination of gradients 
in repolarisation times in the normal heart. These observations enable us to translate 
observed cellular mechanisms with the societal-level observations of sudden death in 
extreme emotional stress. We did not confirm that sudden death in heightened 
emotional circumstances was due to these interactions, but the dynamics of activation 
and repolarisation do show significant alterations during mental stress. As such they 
could facilitate re-entry and wavebreak. Future studies will confirm if these are 
responsible for increased arrhythmia susceptibility. 
In order to further determine if conduction velocity and repolarisation interactions were 
affected by autonomic tone at the tissue level, a novel murine cardiac slice model was 
developed. This allowed the testing of the effects of direct tissue beta-receptor and 
muscarinic receptor stimulation on cardiac conduction. Beta-receptor stimulation 
increased conduction velocities, and muscarinic activity acting through Gαi2 
antagonised them. This is important as the Gαi2 -/- mouse has a propensity to ventricular 
arrhythmia and sudden cardiac death, in the absence of structural abnormality. It has 
been thus viewed as model of mental-stress induced arrhythmia, though a caveat to this 
is that actual spontaneous arrhythmias have not been directly observed in vivo in this 
model, merely sudden death of undetermined cause.  The observations from both wild 
type and knockout mice confirm that conduction (as well as previously reported 
repolarisation (Zuberi et al., 2010)) can be affected by autonomic stimuli. It also 
confirms that activation and repolarisation are both under significant autonomic control, 
and that the parasympathetic system has important effects on cardiac conduction 
dynamics. Stimulation protocols that would be able to reliably determine VERP in the 
tissue slice preparation or that could induce arrhythmia have not been fully tested at the 
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time of writing; this work is currently on going. It will be an important further 
demonstration of the validity of this technique to fully recapitulate observations from in 
vivo and cellular studies in the tissue preparation.  
Finally, these concepts have been used to show that activation and repolarisation 
dynamics can be modulated in human disease, specifically in early arrhythmogenic 
cardiomyopathy prior to the onset of overt structural changes. Activation dynamics, but 
not steady state conduction properties, appear to be affected early in this disease. These 
dynamics can be used to differentiate early ARVC from benign right ventricular 
outflow tract tachycardia. I suggest that this could be the basis of a clinically useful test 
to allow differentiation of pre-clinical ARVC from benign outflow tract tachycardia. 
However, though my data convincingly demonstrate electrophysiological  differences, it 
was not confirmed that the measurement of J-point hysteresis would be clinically useful 
with the available data. To do this, a significant prospective study would be required, 
examining patients presenting with outflow tract tachycardia. We did not observe that 
repolarisation dynamics were independently affected in this disease; rather they 
appeared to change secondary to activation delays. The interplay between conduction 
and repolarisation in disease will be best studied in animal models in the first instance, 
for example by using the murine knockout models of ARVC with tissue-slice 
technology. 
A significant achievement has been methodological. Establishing the thin-slice murine 
model enables tissue level study of cardiac conduction and (possibly) repolarisation in 
the knockout mammal. This experimental paradigm will be useful in exploring the 
complex molecular interactions that contribute to arrhythmia generation and regulation. 
Signals acquired from this system are very similar to those observed in clinical studies, 
and thus this paradigm lends itself towards clinical translation. Further methodological 
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achievements include my extensive use of automation for data management and 
analysis. 
The successful integration of patient-acquired data into a predictive model stands as a 
conceptual proof of this pathway of investigation. However, an ideal predictive model 
would operate using defined parameters derived non-invasively. This may be from 
global ECG data (such as ECG-I technology (Rudy, 2009; Wang et al., 2011)), which 
could be used to develop patient-specific models of arrhythmogenic risk incorporating 
myocardial structure, conduction-repolarisation dynamics and changes in autonomic 
tone. It is conceivable that electrophysiologically relevant genomic data could even be 
incorporated in defined conditions. The ultimate aim of this would be to create accurate 
personalised arrhythmia predictive models in specific disease states.  
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7.2 Further work 
Further integration of the different techniques and data described in this thesis would 
significantly strengthen the assertion that wavebreak could be promoted by the 
modulation of dynamics in activation and repolarisation observed in the three 
experimental conditions: mental stress, ARVC and in the Gαi2 -/-model of arrhythmia. 
Ongoing work with Lei Xu and Dr Ben Hanson of UCL continues to examine whether 
the mathematical 1-D models validated in our study can be used to establish changes in 
the conditions for functional block. Specifically, they are examining whether functional 
block is more likely to occur during mental stress compared to baseline conditions.  
Such techniques can be applied to whole-ventricular data (e.g. acquired using non-
contact mapping or new technologies such as ECG-I (Cuculich et al., 2010; Rudy, 
2009)) to form whole-chamber or even whole heart simulations. Knowledge of regional 
heterogeneity in functional block thresholds could conceivably be a useful tool in 
cardiac risk prediction. It would attempt to measure induced heterogeneity in 
substrate/trigger interactions, and could be calculated using our 1-D model derivation.  
The series of human experiments where mental stress was induced through 
psychometric protocols was very challenging to perform within the confines of the 
invasive catheter lab. In order to extend these observations, I would seek to perform 
non-invasive measurements of cardiac activation and repolarisation. As previously 
mentioned, several new technologies seek to solve the inverse problem by using cardiac 
MRI data integrated with very high-density ECG electrode jackets. This may allow 
appreciation of regional activation and repolarisation changes during testing. Adopting a 
non-invasive approach would be technically far less challenging and allow more 
complex and more detailed psychometric protocols to be employed in a serial fashion. 
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Dr Lambiase and Professor Taggart, at the Heart Hospital, UCL, are seeking to obtain 
such information from patients with predisposition to stress-induced arrhythmias, 
particularly Long-QT patients. 
Our dataset of electrophysiological measurements in patients with very early stage 
ARVC is unique, but the use of the non-contact array is cumbersome. The first patients 
in this data set were studied eight years ago, since then the non-contact array has fallen 
out-of-favour as a clinical tool as its limitations in mapping dilated cardiac chambers 
have been highlighted. This thesis has shown that the dynamic conduction changes that 
may be a hallmark of early ARVC can be identified using the surface ECG alone.  This 
could be further examined in an ARVC population with ICDs, and in patients 
undergoing catheter ablation for suspected benign outflow tract tachycardia. Thus 
whether our identified criteria of J-point hysteresis represents a useful clinical 
diagnostic observation could be critically appraised. 
The thin-slice multielectrode array preparations represent a potentially useful new 
approach to electrophysiological examination. They allow reliable and consistent 
examination of tissue level electrophysiology in a pseudo-2D structure, retaining tissue 
architecture and could be extended to patients. Preliminary work has established that 
human atrial tissue (acquired intraoperatively) can be used on our array system. Other 
groups have reported successful use of human ventricular tissue with a similar 
technique (Brandenburger et al., 2012; Bussek et al., 2012; Camelliti et al., 2011). The 
potential as a translational tool is obvious. Further work needs to be also performed on 
murine preparations to establish their longevity and structural integrity. 
Initially, further work will concentrate on completing electrophysiological assessments 
of Gαi2 -/- tissue using the microarray by more complex stimulation protocols. A 
practical limitation is utilising a manual stimulator (over the several hours of an 
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experiment) whilst ensuring tissue viability and homeostasis. It is essential to replace a 
manual stimulator control with a fully automated system. Unfortunately, the digital 
outputs that would allow us to sync an external stimulus with the multi-electrode array 
inbuilt stimulator are not real time, i.e. they exhibit an inconsistent latency of around 
several hundred milliseconds. To address this, I have already instituted an Arduino™-
based microcontroller to control stimulator timings. This can be flexibly programmed to 
any complexity of stimulator protocols thus consistent data to establish ERP and 
arrhythmia induction should be achievable.  
There are several further technical advances that could be achieved using the tissue-
slice and multi-electrode array. It would be conceptually straightforward to couple our 
direct electrical recording with optical mapping. Initially, voltage sensitive dyes would 
allow determination of repolarisation phases. Further imaging could study calcium flux 
or metabolic activity in slices during stimulation & arrhythmia.  
The tissue-slice system holds several advantages over classical whole heart preparations 
for examining the systems biology of cardiac conduction and arrhythmia. First, many 
comparable samples can be acquired from a single animal. This actively contributes to 
the principle of “three R’s” (Reduction, Refinement and Replacement), but also allows 
pharmacological studies to occur on serial slices rather than having to rely on washout 
stages. Second, cardiac cellular and tissue function can be studied in isolation, yet with 
tissue structure intact. Third, mature adult tissue can be used, rather than the immature 
monolayers of cultured myocytes. Fourth, highly regional tissue samples can be 
obtained. This makes it possible to compare functional electrophysiology of the right 
versus left atrium, right versus left myocardium and potentially epi-, mid- and 
endocardial electrophysiology. I look forward to developing this system to further 
elucidate the functional regulation of cardiac arrhythmia. 
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